Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRP,Agouti-related protein,42296,-0.221816647904095,0.00506771072797985,-0.231749360930936,-0.211883934877255,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.152390531982018,0.0032261825790783,0.146067214127025,0.158713849837012,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCG,Pro-glucagon,41843,-0.561612507011133,0.0120912529952457,-0.585311362881815,-0.537913651140452,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.205895317565151,0.00504507975319856,-0.215783673881421,-0.196006961248882,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFGE8,Lactadherin,42137,-0.240142125023477,0.00427469310605602,-0.248520523511346,-0.231763726535607,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.274299000420952,0.00622880197031574,-0.286507452282771,-0.262090548559134,0
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.125766186785873,0.00319026850002192,0.11951326052583,0.132019113045916,1.11253692925364e-308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.147442009673994,0.00387890934135106,-0.155044671983042,-0.139839347364946,1.00051639589207e-297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS8,Prostasin,42080,-0.153955336532458,0.00417268786739556,-0.162133804752554,-0.145776868312363,5.52224632875325e-284
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.105267173255175,0.00294213500437096,0.0995005886466075,0.111033757863742,5.19130652009709e-268
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYY,Peptide YY,39575,-0.338896641972809,0.0100569999858016,-0.35860836194498,-0.319184922000638,5.72665747338692e-237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.289202177295526,0.00866300311514611,-0.306181663401213,-0.27222269118984,3.50489969623893e-233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9,Complement component C9,39990,0.190029041317126,0.00581834774603157,0.178625079734904,0.201433002899348,9.77824350566547e-224
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.283533356029402,0.00888848724381923,-0.300954791027288,-0.266111921031516,2.53989995574929e-215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.0925680468004408,0.00293718067106427,-0.0983249209157267,-0.0868111726851548,2.00084800642255e-210
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOF,Apolipoprotein F,39990,0.0824745146270167,0.00262420074533123,0.0773310811661675,0.0876179480878659,5.38330289193939e-208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPL,Lipoprotein lipase,42145,0.148847407648166,0.00487902837090987,0.139284512041182,0.158410303255149,9.3462466085193e-198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN1,CCN family member 1,42047,-0.217651666067988,0.00728318086276096,-0.231926700559,-0.203376631576977,4.80789297875787e-190
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.0978276137919951,0.00328258499190869,-0.104261480376136,-0.0913937472078541,3.88420881922494e-189
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.195052065242487,0.00661661065293267,-0.208020622122235,-0.182083508362739,4.45908064969606e-185
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.377391504522574,0.0128926641804485,0.352121882728895,0.402661126316253,9.54523450667088e-183
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFASC,Neurofascin,42296,-0.0865493145684669,0.00296525644618019,-0.09236121720298,-0.0807374119339537,9.57499381178432e-182
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.184877724983661,0.00635647629089894,-0.197336418513822,-0.172419031453499,1.84793971863946e-180
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0885437672512284,0.00308195079637032,-0.0945843908121143,-0.0825031436903426,3.311303724382e-176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MVK,Mevalonate kinase,41913,-0.240957396615974,0.00841191267684147,-0.257444745462583,-0.224470047769364,3.61411614694261e-175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS4,Galectin-4,42123,-0.164371895919768,0.00574245157855766,-0.175627101013741,-0.153116690825795,5.28533424930526e-175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.245010593096305,0.0086439614152709,-0.261952757470236,-0.228068428722374,9.38029016685607e-172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOM,Apolipoprotein M,42199,0.0818735253365404,0.00289114386370549,0.0762068833636776,0.0875401673094031,1.82703791067586e-171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.23042206616469,0.0083231599998329,-0.246735459764363,-0.214108672565018,4.59360430801946e-164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADIPOQ,Adiponectin,39979,0.192519401324907,0.00702856951508352,0.178743405075344,0.206295397574471,5.07484098547028e-160
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.134586466953228,0.00493434028209374,-0.144257773906132,-0.124915160000324,1.53021673734918e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH,Parathyroid hormone,39649,-0.232720714229048,0.00850857010337827,-0.24939751163167,-0.216043916826427,1.97195428127144e-159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.252207107013406,0.00926053556626737,-0.27035775672329,-0.234056457303522,2.86652061121114e-158
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.139077503935813,0.00516279297729921,-0.149196578171319,-0.128958429700306,1.17646115130889e-155
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPY,Pancreatic prohormone,42089,-0.281428233452096,0.0105004262964371,-0.302009068993113,-0.26084739791108,3.26147761253183e-154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY1,Aminoacylase-1,42145,-0.170656117045761,0.00642802054880959,-0.183255037321427,-0.158057196770094,1.92279706530802e-151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSD,Cathepsin D,41225,-0.111903511702128,0.00423315554258415,-0.120200496565593,-0.103606526838663,6.26663059847139e-150
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.387385506321015,0.0149528935547048,-0.416693177688237,-0.358077834953794,2.0294206308603e-144
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.143679105676569,0.00557944372089813,-0.154614815369529,-0.132743395983609,9.48037555836706e-143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0924827925658502,0.00359339856448654,-0.0995258537522438,-0.0854397313794566,1.15715457564206e-142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0612800709675017,0.00242035973271756,-0.0660239760436281,-0.0565361658913753,3.10551125078781e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.169299490840156,0.00668621875060492,-0.182404479591341,-0.15619450208897,3.56646879976125e-138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.177255871785704,0.00703696646777356,-0.19104832606254,-0.163463417508868,7.53551481860399e-137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.086979689903419,0.00346728917543458,-0.0937755766872707,-0.0801838031195672,9.32721055647312e-136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0865497695786023,0.00345651063677876,-0.0933245304266887,-0.0797750087305159,2.49067044314669e-135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC13,Mucin-13,41839,-0.133768828928815,0.0053972378116765,-0.144347415039701,-0.123190242817929,1.34786900241721e-132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.129054319097722,0.00525855174359222,-0.139361080515163,-0.118747557680281,3.34403113667628e-130
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FURIN,Furin,42181,-0.0828702502979125,0.00338822972854835,-0.0895111805658672,-0.0762293200299577,2.52718389812528e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELN,Elastin,39958,-0.0873271880059914,0.00357054495645638,-0.0943254561206459,-0.0803289198913369,8.63546017632789e-129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGF,Placenta growth factor,42296,-0.0655402341225714,0.00268792204957973,-0.0708085613397477,-0.0602719069053951,1.39249231278362e-128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.121660206437174,0.00502293377521065,-0.131505156636587,-0.111815256237761,7.1197331129882e-127
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.215472411518073,0.00890891228375458,-0.232933879594232,-0.198010943441914,4.78352912275578e-126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0800937434841036,0.0033234474070261,-0.0866077004018747,-0.0735797865663324,4.61393774951958e-125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.138854859770544,0.00577982604736579,-0.150183318823381,-0.127526400717707,6.49612407147239e-125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0808374364066964,0.00336766481420548,-0.0874380594425391,-0.0742368133708536,1.03167323017634e-124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.078029499209641,0.00325975978541072,-0.084418628389046,-0.071640370030236,4.47509073333496e-124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.140451344706822,0.00591976066946906,-0.152054075618981,-0.128848613794663,6.22446551609739e-122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.128239565752727,0.00541452111794605,-0.138852027143901,-0.117627104361553,1.55228010853809e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MME,Neprilysin,42070,-0.18917717643528,0.00800032779096641,-0.204857818905574,-0.173496533964985,3.73686486472115e-121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.0749126810541102,0.00317425079454476,0.0686911494968024,0.0811342126114179,3.33132930722326e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.137474523648842,0.00583806755437759,-0.148917136055422,-0.126031911242262,9.69600131944304e-120
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.204223296469302,0.00871221812354619,-0.221299243991453,-0.187147348947151,3.82398416522372e-119
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG2,Secretogranin-2,42193,-0.0790895810677626,0.00339362429987993,-0.0857410846955273,-0.072438077439998,7.87771209967563e-118
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0743079102833426,0.00319109845564857,-0.0805624632564138,-0.0680533573102714,1.23848325807911e-117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.130270695227189,0.00562011942079175,-0.141286129291941,-0.119255261162437,1.47251689818599e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.136594376713153,0.00590158398296024,-0.148161481319755,-0.125027272106551,2.76857828892586e-116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.201544485965865,0.00873400377112788,-0.218663133357276,-0.184425838574455,1.39221528862827e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.120258668075161,0.00521596987590934,-0.130481969031944,-0.110035367118379,6.49133824712365e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.0938920053247704,0.00408290638736678,-0.101894501844009,-0.0858895088055315,7.93385393281694e-115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.124153701786443,0.00545683181764551,-0.134849092149028,-0.113458311423857,1.75435190547191e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.0661653394244168,0.00290967753927009,-0.0718683074013862,-0.0604623714474474,2.18367391096104e-112
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.106674700203334,0.00470834840634184,-0.115903063079764,-0.0974463373269036,1.33207070013021e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.279061519382037,0.0123543261378576,-0.303275998612238,-0.254847040151836,6.05534919577977e-111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.138893772166969,0.00617334018142638,-0.150993518922564,-0.126794025411373,4.8433232365831e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0840691218878725,0.00373924489692735,-0.0913980418858501,-0.0767402018898949,6.46633473266596e-110
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.193145070892238,0.00861886208487372,-0.210038040578591,-0.176252101205886,3.28862099334457e-109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0795826357724205,0.00356512958683173,-0.0865702897626107,-0.0725949817822303,1.92838090240761e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOD,Apolipoprotein D,39468,0.0973510705127853,0.00435551277402214,0.0888142654757019,0.105887875549869,3.15581195301351e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.33183985331231,0.0149022324213371,-0.361048228858131,-0.302631477766489,6.27157273540297e-108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0860359941168922,0.00388900300727474,0.0784135482226337,0.0936584400111507,1.39894906448973e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.183104054341417,0.00827857473197047,-0.19933006081608,-0.166878047866755,1.65782291119576e-106
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0775658933247503,0.00355771266158855,-0.0845390101414638,-0.0705927765080367,1.26760243772721e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0835101022561012,0.00383729193028798,-0.0910311944394657,-0.0759890100727368,3.00971502540117e-103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.10859797943678,0.00501764014144525,-0.118432554114013,-0.0987634047595472,3.66772956108133e-102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0772680280646343,0.00358153239253741,-0.0842878315540076,-0.0702482245752609,3.32478491155033e-101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.10425275421859,0.00485079447554265,0.0947451970465265,0.113760311390654,1.80767978401695e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0750840071759853,0.00350148269980934,-0.0819469132676116,-0.068221101084359,2.3935274298597e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0611231292570215,0.00285413036369988,-0.0667172247698732,-0.0555290337441697,9.65390489319273e-100
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.201783300382254,0.00944518690332394,-0.220295866712769,-0.183270734051739,1.36252701384996e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0621305588749647,0.00291249955776402,-0.0678390580081822,-0.0564220597417472,4.91383570922234e-99
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.109998211870467,0.00517098886308653,-0.120133350042117,-0.0998630736988174,1.84223774206993e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.106785435413327,0.00502560613818315,-0.116635623444166,-0.0969352473824878,3.0153666876907e-98
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.0974442486774918,0.00461112557919578,0.088406442542268,0.106482054812715,1.5011759385717e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST3,Cystatin-C,42184,-0.0624809437916915,0.00295700817670688,-0.068276679818037,-0.056685207765346,1.55955541293387e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.15867814092118,0.00751134637821238,-0.173400379822477,-0.143955902019884,3.41486613466577e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.0805146552181945,0.00381990028115069,-0.0880016597692499,-0.0730276506671392,4.66895158679467e-97
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0942924534613393,0.00448948227296237,-0.103091838716346,-0.085493068206333,2.01971660345377e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.184580874856606,0.00881038441470887,-0.201849228309436,-0.167312521403777,6.2621567638467e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0913223321936036,0.00436114316551235,-0.0998701727980078,-0.0827744915891994,7.51153426753197e-96
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0977196478353465,0.00470449010825831,-0.106940448447533,-0.0884988472231602,2.42517380849802e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MENT,Protein MENT,39736,0.0512024989402821,0.00246305340637463,0.0463749142637878,0.0560300836167764,3.35895014227261e-94
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0479554036006111,0.00232103314539112,-0.0525046285655777,-0.0434061786356445,2.10035340207161e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.263112762480974,0.0127611607461386,-0.288124637543405,-0.238100887418542,4.880794235407e-93
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0701637942213294,0.00341052755086274,-0.0768484282210204,-0.0634791602216385,1.20516812527052e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0823293680736158,0.00400887045472695,-0.0901867541648806,-0.074471981982351,2.47032991142972e-92
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.118976829636936,0.00584092057412387,-0.130425033962218,-0.107528625311653,1.29874818266574e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.162295236976921,0.00797988538266938,-0.177935812326953,-0.146654661626889,2.40621807098775e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.176175344413208,0.00868266252918159,-0.193193362970404,-0.159157325856012,3.64332441279321e-90
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELE,E-selectin,42310,-0.105388893758258,0.00521115580296179,-0.115602759132063,-0.0951750283844531,1.22320506361388e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0732987224964957,0.00363570624767379,-0.0804247067419364,-0.0661727382510551,4.43729877211348e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.138228077863674,0.00686186313578465,-0.151677329609812,-0.124778826117536,5.94375344024625e-89
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.160061650843005,0.0079758258071687,-0.175694269425056,-0.144429032260955,2.84912040880006e-88
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.101038570650942,0.00505850279206779,-0.110953236123395,-0.091123905178489,1.6871198995229e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUOM,Fucose mutarotase,39736,-0.133727701957103,0.00668896277458511,-0.14683806899529,-0.120617334918916,2.17244595374232e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0819469134843436,0.00410609359370538,-0.0899948569280061,-0.073898970040681,2.24660532339714e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSO,Cathepsin O,42296,-0.0631121812660873,0.00316250804764766,-0.0693106970394767,-0.0569136654926979,2.29161754032483e-87
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.164071592413824,0.00826754426292543,-0.180275979169158,-0.147867205658491,2.06887647403555e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.135867180553194,0.00684435968256897,-0.149282125531029,-0.122452235575359,3.10546676992327e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.168813623311658,0.00852908942700307,-0.185530638588584,-0.152096608034732,5.98473309440777e-86
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.0897851587246157,0.00454324520901755,-0.0986899193342902,-0.0808803981149413,1.05811312803639e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AREG,Amphiregulin,42070,-0.0797595381949924,0.00404970975237319,-0.0876969693096439,-0.071822107080341,3.72970678226753e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBP,Protein AMBP,42239,-0.0410014041806987,0.00208429012107297,-0.0450866128180017,-0.0369161955433957,5.66032720995143e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.122127014585155,0.00620868538097502,-0.134296037931866,-0.109957991238444,5.8281647762418e-85
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH2,Cadherin-2,42145,-0.0715311387544132,0.00364996680244518,-0.0786850736872057,-0.0643772038216207,2.37173263811362e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0652713868817128,0.00333478504568145,-0.0718075655712484,-0.0587352081921771,3.80006261405681e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.110661436287537,0.00565994417883267,-0.121754926878049,-0.0995679456970254,6.13826563124349e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.106232280306016,0.00543947023642261,-0.116893641969405,-0.0955709186426279,8.69734904037848e-84
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0684949180097149,0.00350910510621512,-0.0753727640178966,-0.0616170720015333,1.06086710931059e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.154263036224325,0.00790151302739087,-0.169750001758011,-0.138776070690639,1.62970906587796e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYNU,Kynureninase,42296,-0.09144302676519,0.00470050939700847,-0.100656025183327,-0.0822300283470534,3.57040007400228e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGRN,Agrin,42185,-0.0720270885659218,0.003707987341201,-0.0792947437546757,-0.0647594333771678,6.3182805204995e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHK,Ketohexokinase,39638,-0.127057059776857,0.00653867469085016,-0.139872862170923,-0.114241257382791,9.96803629244801e-83
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.066880523067178,0.00345659367016379,-0.073655446660699,-0.0601055994736569,2.6312684459159e-82
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.053134041879194,0.00275932698311804,-0.0585423227661053,-0.0477257609922826,1.53578500730204e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.073685724127247,0.00383092461597026,-0.0811943363745487,-0.0661771118799453,2.37681357384239e-81
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0652518563205158,0.00342904606483536,-0.0719727866075931,-0.0585309260334385,1.73571426474821e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.052555818623693,0.00277195213353372,-0.057988844805419,-0.0471227924419669,3.79182224614339e-79
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REN,Renin,42145,-0.158888813756355,0.00840748058815032,-0.175367475709129,-0.14241015180358,1.20201160856534e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.10481333343784,0.00554732028533595,-0.115686081197098,-0.0939405856785813,2.17400001406394e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.100876526392923,0.00535641859667815,-0.111375106842412,-0.0903779459434334,4.05508320078708e-78
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0803655608246048,0.00428564474375426,-0.0887654245223632,-0.0719656971268465,1.79329172104859e-77
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0470853641918541,0.00253112298595404,-0.0520463652443241,-0.0421243631393842,2.67928683189401e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OCLN,Occludin,39934,-0.0858206328280327,0.00460779951877,-0.0948519198848219,-0.0767893457712435,2.75360770126492e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0706212577544342,0.0038012778729477,0.0631707531234567,0.0780717623854117,4.16071769164934e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0972062854865471,0.00523395140314363,-0.107464830236709,-0.0869477407363856,4.65181931883419e-76
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.10669365344743,0.00576427431348558,-0.117991631101861,-0.095395675792998,1.53499059748736e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.192179105784799,0.0103872132464202,-0.212538043747783,-0.171820167821816,1.81962849647732e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0520063153919269,0.00282111680523378,0.0464769264536687,0.0575357043301852,8.43943645311187e-75
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.10971326204433,0.00597586229616213,-0.121425952144808,-0.0980005719438521,3.51011677112811e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0625268735819522,0.00341132817428025,-0.0692130768035415,-0.0558406703603629,4.02589105398118e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.202337298609511,0.0110597726506065,-0.224014453004699,-0.180660144214322,7.11409505502486e-74
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.074537328824606,0.00407721153045006,-0.0825286634242881,-0.0665459942249239,1.38636470882657e-73
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0666974422815973,0.00368818401480569,-0.0739262829506165,-0.0594686016125782,2.96417872333642e-72
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0599718558699504,0.00334352594341567,-0.0665251667190451,-0.0534185450208557,4.13192256893839e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0393793613718204,0.00219614921488121,0.0350749089106533,0.0436838138329876,4.40148607506544e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XCL1,Lymphotactin,42262,-0.101217205377515,0.00565339641741047,-0.112297862355639,-0.0901365483993902,7.09740610300696e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.099340300006032,0.00554595272709867,-0.110210367351145,-0.0884702326609186,8.94418779640018e-71
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS9,Galectin-9,42129,-0.0578555088228947,0.00325484792658104,-0.0642350107589935,-0.0514760068867958,6.84638678467742e-70
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0524477043945985,0.00295875696399409,-0.0582468680440269,-0.0466485407451701,1.57927444575358e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0773251471935906,0.00437154168913664,-0.0858933689042984,-0.0687569254828828,3.0968178124475e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.098930102254938,0.00559376355554712,0.0879663256860656,0.10989387882381,3.32295738040305e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.0910757232957795,0.00514985903983039,0.0809819995777119,0.101169447013847,4.59889246880217e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0682200958466512,0.00386304408824753,0.060648529433686,0.0757916622596164,5.08610665757522e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.131982426200279,0.00747412703250232,-0.146631715183983,-0.117333137216574,5.27966021136292e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0544999791888548,0.00308978297352621,-0.0605559538169661,-0.0484440045607434,7.25779538385797e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0519693983414827,0.00294391534974125,-0.0577394724269755,-0.0461993242559898,8.00005427787295e-69
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0740563442328937,0.0042073904786665,-0.0823028295710801,-0.0658098588947074,1.41270743325363e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.125586594178514,0.00713334869195589,-0.139567957614747,-0.11160523074228,1.94004648692273e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0685648071468671,0.00390081166435278,-0.0762103980089986,-0.0609192162847357,3.06897952558952e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F9,Coagulation factor IX,42199,-0.0333470777859811,0.00190163932579775,-0.0370742908645447,-0.0296198647074175,4.26869110887091e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0528304970892719,0.00301886357261617,0.0469135244869442,0.0587474696915996,7.90281437848386e-68
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.101439661932556,0.00582600167461387,-0.1128586252148,-0.0900206986503131,5.34159558929644e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0558034862250788,0.00321187024557261,-0.0620987519064011,-0.0495082205437565,6.87541921647116e-67
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0683439565568773,0.00394145662799049,-0.0760692115477387,-0.060618701566016,1.2374207548961e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.138069642906823,0.00796598210853364,-0.153682967839549,-0.122456317974097,1.39822624105049e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0727493421104149,0.00419729936551514,-0.0809760488668246,-0.0645226353540052,1.40237441800536e-66
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0633004568129972,0.00370047139973053,0.0560475328695254,0.0705533807564691,6.43999495299643e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN2,Nectin-2,42129,-0.0548508362389673,0.00321072212896949,-0.0611438516117475,-0.0485578208661871,9.37089884478652e-65
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0494530279966199,0.0028924370928774,-0.0551222046986596,-0.0437838512945802,1.05260250445607e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0558110485281859,0.00327351201695451,-0.0622271320814168,-0.0493949649749551,1.66409698171729e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.070026658103168,0.00410544268371875,-0.0780733257632567,-0.0619799904430792,2.05779991592544e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH1,Cadherin-1,41697,-0.0708100911920436,0.00417707107261037,-0.0789971504943599,-0.0626230318897272,8.87855259463668e-64
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.120801037083808,0.00713562383493211,-0.134786859800275,-0.106815214367341,1.22528413175456e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.102559417906449,0.0061001534591553,-0.114515718686394,-0.0906031171265048,8.56180264559695e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0632292491701843,0.00376076178567253,-0.0706003422701025,-0.0558581560702662,8.62965338514725e-63
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0289091641305765,0.0017252984980957,0.0255275790743089,0.032290749186844,2.14468849774718e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.132819397822213,0.00793867497970389,-0.148379200782433,-0.117259594861994,4.32705330961565e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.0742475514689247,0.00444699873946218,-0.0829636689982705,-0.0655314339395788,5.77425905937474e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPO,Erythropoietin,42119,-0.12613002970099,0.007566624171797,-0.140960613077712,-0.111299446324268,9.06021868513772e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0731696950292121,0.00439049825185712,-0.081775071602852,-0.0645643184555721,9.46904251470312e-62
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXN,Paxillin,41839,-0.0884885432564297,0.0053186729834185,-0.09891314230393,-0.0780639442089295,1.57384882321382e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0802659053239791,0.00482655048480132,-0.0897259442741897,-0.0708058663737685,2.34137142249369e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.11318634706627,0.0068238920305993,-0.126561175446245,-0.0998115186862955,3.4912185141757e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.073667878770653,0.00444560876706275,-0.0823812719540959,-0.06495448558721,4.4760238950746e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0449373457313533,0.00271657442931172,-0.0502618316128043,-0.0396128598499023,7.14858993351939e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.0912182352482769,0.00551973117940877,-0.102036908359918,-0.0803995621366357,9.39978381245989e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0666180220007351,0.00403169446437291,-0.074520143150906,-0.0587159008505642,9.61241772069464e-61
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0871697142378125,0.00529394293025993,-0.097545842381122,-0.0767935860945031,2.48382369316367e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0611218462224091,0.00371834502556924,-0.0684098024725248,-0.0538338899722934,3.84720334927104e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0490854844454329,0.00298770038787052,-0.0549413772056591,-0.0432295916852067,4.55195848974723e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0466634355869054,0.00284158019020747,-0.052232932759712,-0.0410939384140987,5.09574249178356e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.104239500314314,0.00634985215930581,-0.116685210546554,-0.0917937900820749,5.60716818620966e-60
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0829703961140677,0.00506796380292202,-0.0929036051677948,-0.0730371870603405,1.17572900246932e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.110001065647545,0.00672778344097072,-0.123187521191848,-0.0968146101032424,1.59346947694172e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0467192232492684,0.00285617313357364,0.041121123907464,0.0523173225910727,1.83720662863791e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMA,Granzyme A,42296,-0.0575180472422865,0.00352325473097849,-0.0644236265150043,-0.0506124679695686,2.36986732482648e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0740225160345928,0.0045316727713981,-0.082904594666533,-0.0651404374026525,2.73756501568108e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_E,,42119,-0.0496586636812105,0.00304628732124594,-0.0556293868308525,-0.0436879405315684,3.53629637933083e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.104792965350321,0.00643812600751215,-0.117411692325045,-0.0921742383755973,5.14057770060507e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2AP,CD2-associated protein,42145,-0.106656143106636,0.0065546392707325,-0.119503236077272,-0.0938090501360004,5.66257123036494e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS2,Trypsin-2,42217,-0.0965308607797114,0.00593722677280378,-0.108167825254407,-0.084893896305016,6.95743243616322e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.127345463826006,0.00783917969093142,-0.142710256020231,-0.11198067163178,8.61875112934983e-59
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN3,Contactin-3,42137,-0.0476948280530423,0.00293863180629078,-0.0534545463933722,-0.0419351097127123,1.10207132427329e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.129243157863335,0.00796380535249557,-0.144852216354227,-0.113634099372444,1.47860153553352e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0667181399165042,0.00411867861653465,-0.0747907500049121,-0.0586455298280963,1.82075385636541e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.11066015858445,0.00683826981212035,-0.124063167416206,-0.0972571497526943,2.37796333730325e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0440461306549712,0.00273259165611726,-0.049402010300961,-0.0386902510089814,8.37844444938025e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F7,Coagulation factor VII,42194,-0.0518532784030514,0.00322238978036966,-0.058169162372576,-0.0455373944335269,9.97332982539916e-58
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0508251852309678,0.0031592241568391,-0.0570172645783724,-0.0446331058835631,1.06358103489962e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.113052279103324,0.00704146301786409,-0.126853546618337,-0.09925101158831,1.78880968921859e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.054541362863259,0.00339795537406914,-0.0612013553964345,-0.0478813703300835,1.90719778039338e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.054087722471746,0.0033703639011633,-0.0606936357180261,-0.0474818092254659,2.52044124020994e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANG,Angiogenin,42152,-0.0545479766217067,0.00340540116187751,-0.0612225628989867,-0.0478733903444268,3.20042490622599e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0657519133658944,0.00410179421502891,-0.073791430027351,-0.0577123967044377,3.33400614413228e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG2,Desmoglein-2,42137,0.0449102886953457,0.00280621154346252,0.0394101140701591,0.0504104633205322,4.00866063740499e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.0500992780256899,0.00313076605522833,-0.0562355794939374,-0.0439629765574424,4.11386347809773e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0577265706812414,0.00361454782027736,-0.064811084408985,-0.0506420569534978,6.76552584348184e-57
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0519443032074919,0.00326216577194984,-0.0583381481205136,-0.0455504582944702,1.41520468564695e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.127344616019119,0.007999622885894,-0.143023876875472,-0.111665355162767,1.53637829086452e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0844978149894004,0.00531083462911795,-0.0949070508624716,-0.0740885791163293,1.72182874806146e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0567614415727135,0.00357249994854383,-0.0637635414718594,-0.0497593416735676,3.06932886779008e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0605532128885203,0.00381887379082379,-0.0680382055185349,-0.0530682202585057,4.02353211723526e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0913887147615447,0.00578154110232295,-0.102720535322098,-0.0800568942009917,8.77857226568235e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.056740269951124,0.00358985319669427,-0.0637763822166448,-0.0497041576856032,8.9642354126581e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0456465623529419,0.00288851640408368,-0.051308054504946,-0.0399850702009379,9.36757064390267e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.173217247786813,0.0109609229848118,-0.194700656837044,-0.151733838736581,9.38055227949581e-56
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0915998118672819,0.00580544108910731,-0.102978476401932,-0.0802211473326316,1.37471126582542e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOT,Angiomotin,39736,-0.0631354646094475,0.00400261444456671,-0.0709805889207983,-0.0552903402980967,1.88123316688418e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEP,Leptin,42145,-0.113956426279555,0.0072319664119358,-0.128131080446949,-0.099781772112161,1.89971487781275e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0551430928362615,0.00351760731589962,0.0482485824970982,0.0620376031754247,6.68142285279306e-55
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.110923137671608,0.00710025721031496,-0.124839641803825,-0.0970066335393905,1.57007821620351e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0377402230401873,0.00241400166395142,-0.0424716663015321,-0.0330087797788425,1.62226235641129e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0461931906837357,0.00295750182358169,-0.0519898942579558,-0.0403964871095156,1.62842028200402e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPH,Hephaestin,39958,-0.0454889994175763,0.00291234504078307,-0.0511971956975112,-0.0397808031376415,1.97596151005498e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.106722527741654,0.00685010031019542,-0.120148724349637,-0.0932963311336712,2.94614349137335e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.181463175864222,0.0116559989332179,-0.204308933773329,-0.158617417955115,4.34173666555333e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH1,Somatotropin,42129,0.287196616785811,0.0184712300355126,0.250993005916206,0.323400227655415,4.79088477969002e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.103330381188862,0.00664197956045168,-0.116348661127347,-0.0903121012503762,5.13955743415757e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0450397129880266,0.00289892381311301,-0.0507216036617281,-0.0393578223143251,5.70023787378485e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAXX,Protein PAXX,39736,-0.0751885326176874,0.00483534163619847,-0.0846658022246364,-0.0657112630107384,5.88423130924417e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0604158697396056,0.00389134294646321,-0.0680429019146735,-0.0527888375645377,6.78040301123012e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0315610026420392,0.00203292139854628,0.0275764767008885,0.0355455285831899,6.88646955349388e-54
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.11187895888934,0.00723667417999264,-0.126062840282126,-0.0976950774965547,2.33278642862133e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0591673062795842,0.00383373775572626,-0.0666814322808077,-0.0516531802783607,2.77638407441637e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFM,Afamin,39979,-0.0324957553941285,0.00210839527931376,-0.0366282101415834,-0.0283633006466735,4.62527695614012e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100P,Protein S100-P,41900,-0.08558606544327,0.00555721357788648,-0.0964782040559275,-0.0746939268306125,4.63077059965681e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0877333562755223,0.00569775183931466,-0.098900949880579,-0.0765657626704656,4.70338281672402e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POSTN,Periostin,39966,0.0607658483619853,0.00394520370343944,0.053033249103244,0.0684984476207266,5.39718014747523e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KITLG,Kit ligand,42145,0.0610399534844589,0.00397084166185924,0.0532571038272148,0.068822803141703,7.04276376319924e-53
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.103402324723592,0.00675694970632811,-0.116645946147995,-0.0901587032991889,1.99398830865534e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UMOD,Uromodulin,42274,0.0855496447433684,0.00559093012407482,0.0745914217001818,0.0965078677865551,2.02965599400318e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.177598470825636,0.0116138337782734,-0.200361585031052,-0.15483535662022,2.42019814819666e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0484388137355205,0.003170056264607,-0.0546521240141502,-0.0422255034568908,2.81215435547141e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLN,Promotilin,42119,-0.141540864670131,0.00928407684051291,-0.159737655277537,-0.123344074062726,4.77257519475966e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.150511239296955,0.00988424964363325,-0.169884368598477,-0.131138109995434,6.27090877350099e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.115364668550822,0.00758606246720296,-0.13023335098654,-0.100495986115105,8.52639080280675e-52
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.070920122329728,0.00466331534400317,-0.0800602204039742,-0.0617800242554818,1.040960116488e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0699320665605963,0.00460535930908293,-0.0789585708063989,-0.0609055623147938,1.19067033737743e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0498988031112008,0.00329403322132598,-0.0563551082249997,-0.0434424979974019,2.06081528881732e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0621930630076493,0.00410880331517456,0.0541398085099072,0.0702463175053914,2.4485583255714e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0561985281274201,0.00371602309488975,-0.063481933393404,-0.0489151228614361,3.04416241027921e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0606452165877056,0.00401187121242405,-0.0685084841640567,-0.0527819490113544,3.30183243489035e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO3,Beta-enolase,39638,-0.0993342018959316,0.00656809574745846,-0.11220766956095,-0.086460734230913,3.6717267610153e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EZR,Ezrin,42249,-0.0380629037407093,0.00252406764673559,-0.043010076328311,-0.0331157311531075,5.64292644479108e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.0606088078872165,0.00402256445117988,0.0527245815629039,0.068493034211529,8.2326656350934e-51
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC1,Stanniocalcin-1,42249,-0.071233315544445,0.00475827718182129,-0.0805595388208147,-0.0619070922680753,2.87103861177935e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0921892832116071,0.00615890940394825,-0.104260745643346,-0.0801178207798685,3.04221919882409e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0882039844493957,0.00590462391952564,0.0766309215671254,0.0997770473316659,5.72135922585576e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0899732758683708,0.00604155372090313,-0.101814721161341,-0.0781318305754007,9.2170696354803e-50
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBKS,Ribokinase,41830,-0.0764222948995705,0.00514155645083247,-0.0864997455432021,-0.0663448442559389,1.4245866576307e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM2,Paralemmin-2,39929,-0.0601756628377317,0.00405048994054473,-0.0681146231211994,-0.052236702554264,1.84529114918142e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0296031366575105,0.00199803300231787,0.0256869919729675,0.0335192813420536,2.7975579156706e-49
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHR,Growth hormone receptor,39736,-0.0435987937441155,0.00295811864065626,-0.0493967062798018,-0.0378008812084293,1.04519123672256e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAST,Gastrin,39929,-0.201173600887346,0.0136745067416342,-0.227975634100949,-0.174371567673743,1.52186463901253e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0555501656321574,0.00378105084514668,-0.0629610252886449,-0.0481393059756699,1.74845683017938e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.192720552554875,0.013127686043667,-0.218450817200462,-0.166990287909288,2.03403973523668e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0584243681750144,0.00398305186857401,-0.0662311498374195,-0.0506175865126094,2.41140903809533e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0602798423495892,0.00411352088266217,-0.0683423432796071,-0.0522173414195714,2.96955762954078e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0791170740653396,0.00539672813511678,-0.0896946612101685,-0.0685394869205107,3.28243194545977e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0353506247020352,0.00241750064635605,-0.0400889259688931,-0.0306123234351774,4.67105300383451e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0561853748244353,0.0038544386681274,-0.063740074613965,-0.0486306750349056,9.07164191195814e-48
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH17,Protocadherin-17,42145,-0.0566592858042552,0.00390133216781013,-0.0643058968531631,-0.0490126747553474,1.96601522802665e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0683427585735406,0.0047068380122734,-0.0775681610775964,-0.0591173560694847,2.06093946017711e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0565165086122221,0.00389821514307467,-0.0641570102926485,-0.0488760069317958,2.80108588392231e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.043821003101605,0.00302861115796145,-0.0497570809712095,-0.0378849252320006,4.27030995669983e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD209,CD209 antigen,42171,0.0586359113561425,0.00405818512139928,0.0506818685181999,0.0665899541940851,5.6904761778861e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0708542792447679,0.0049045773406134,-0.0804672508323702,-0.0612413076571657,5.84465418302981e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0480379916623604,0.00333356183430078,0.0415042104671308,0.0545717728575899,9.81922855646894e-47
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.101157720118281,0.00702126400302355,-0.114919397564208,-0.0873960426723552,1.03469646070029e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0588173526098172,0.00408883043005547,-0.066831460252726,-0.0508032449669085,1.4292285499139e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.130510782160972,0.00908446033694378,-0.148316324421382,-0.112705239900562,2.19811589873142e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0410256832051303,0.00285964915117535,-0.0466305955414339,-0.0354207708688266,2.44653034223327e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.125338168354645,0.00874359731911882,-0.142475619100118,-0.108200717609172,3.34993068759417e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0889408491376316,0.00622278670068001,-0.101137511070964,-0.0767441872042988,5.26569288619761e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCXR,L-xylulose reductase,42181,-0.0805709879985492,0.00564266653847992,-0.0916306144139699,-0.0695113615831286,6.36803552862517e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0665648396878743,0.00466854061140724,-0.0757151792862324,-0.0574145000895161,9.9161416274954e-46
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0433648303979627,0.003045882093137,-0.0493347593005112,-0.0373949014954142,1.32758379029092e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0552790463192735,0.00388666676881878,-0.0628969131861583,-0.0476611794523887,1.39999843775427e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COLEC12,Collectin-12,42123,-0.040430029244798,0.0028489122198544,-0.0460138971957126,-0.0348461612938833,2.19250783771487e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCOF1,Treacle protein,39958,-0.0481619209269643,0.00339296643800615,-0.0548121351454564,-0.0415117067084723,2.41297682105663e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0432644322057669,0.00305368096010317,-0.0492496468875691,-0.0372792175239647,3.09520624987132e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVR,Poliovirus receptor,42249,-0.0549994244018415,0.00388759027479453,-0.0626191013404388,-0.0473797474632443,4.03518657850303e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUMB,Protein numb homolog,39657,-0.124112297281844,0.00878773334856744,-0.141336254645037,-0.106888339918652,6.6925803355183e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0895387801723838,0.00634942824294419,-0.101983659528554,-0.0770939008162131,7.6489509591137e-45
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0623808909388636,0.00443333898542904,-0.0710702353503045,-0.0536915465274227,1.17372213478399e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0709585266006625,0.00504441760404647,-0.0808455851045936,-0.0610714680967314,1.44086049209365e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0841049106545823,0.00599204152621317,-0.0958493120459601,-0.0723605092632044,2.19980493224259e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0611017183242369,0.00435960445969864,-0.0696465430652462,-0.0525568935832275,2.9358734738109e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C19orf12,Protein C19orf12,41839,-0.0972736375327391,0.00694596534184618,-0.110887729602758,-0.0836595454627206,3.03253351768268e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.0985179152356844,0.0070344246763342,-0.112305387601299,-0.0847304428700694,3.37912693562124e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.063950503672354,0.00457188456171206,-0.0729113974133096,-0.0549896099313983,3.76330705676302e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0512612736661812,0.00366534915760239,-0.0584453580150819,-0.0440771893172805,3.9197766337017e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HJV,Hemojuvelin,39934,-0.0617402150548987,0.00441359707978389,-0.0703908653312751,-0.0530895647785223,4.25123189525416e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSS,Cathepsin S,39358,-0.0353777816489268,0.00252924792453628,-0.040335107581018,-0.0304204557168357,4.51751199491482e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.133207166569465,0.00953735986833428,-0.1519003919114,-0.11451394122753,5.7313320567902e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.045871304564322,0.00328589462782902,-0.0523116580348669,-0.0394309510937771,6.44887335088022e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0854647277783713,0.00612706427836453,-0.0974737737639658,-0.0734556817927768,6.45322100132344e-44
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.164734487197002,0.0118849789092126,-0.188029045859059,-0.141439928534945,2.17473460619822e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0749750809612151,0.00541522768810458,-0.0855889272299001,-0.0643612346925301,2.66663468772954e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0482089208599892,0.00348354362616413,0.0413811753527075,0.0550366663672709,2.89423887122892e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0854166512390977,0.00617649882725348,-0.0975225889405145,-0.0733107135376809,3.33922247759906e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHISA5,Protein shisa-5,39966,-0.037493758680618,0.00271112361603924,-0.0428075609680549,-0.0321799563931811,3.77518965138598e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0931007463864802,0.00673735418435722,0.07989553218514,0.10630596058782,3.87092503890468e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0367554633931011,0.00266279918355222,-0.0419745497928635,-0.0315363769933388,5.40867621170989e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.0669454953544165,0.00485707044490746,-0.0764653534264352,-0.0574256372823979,7.12552632148889e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.041730482517621,0.00303303975416556,-0.0476752404357855,-0.0357857245994564,8.77257093208223e-43
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFC1,Cryptic protein,41843,-0.0685548517583132,0.00498654689343509,-0.078328483669446,-0.0587812198471804,1.02896861949653e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.087440517009465,0.00636284955521836,-0.099911702137693,-0.074969331881237,1.27466422164543e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0432300134652081,0.00314733041151755,-0.0493987810717825,-0.0370612458586337,1.36509647653774e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0742151023098274,0.00540901580474304,-0.0848167732871238,-0.0636134313325311,1.70388229432958e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0324246247055827,0.00236535760943177,-0.037060725620069,-0.0277885237910964,1.73476464613699e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD83,CD83 antigen,42119,-0.049185153500879,0.00359301909570789,-0.0562274709284665,-0.0421428360732915,2.26065282857488e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0606941249743245,0.00443558853867037,-0.0693878785101184,-0.0520003714385306,2.43852545469496e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD27,CD27 antigen,42181,-0.0607696016034413,0.00444651042855909,-0.0694847620434172,-0.0520544411634655,3.04929194838655e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.064974744721394,0.0047552351364668,-0.0742950055888689,-0.055654483853919,3.15772563338343e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SBSN,Suprabasin,39954,0.0507174013918164,0.00371146029871676,0.0434429392063316,0.0579918635773012,3.53620651273218e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0677686229200609,0.0049744003107193,-0.0775184475290707,-0.058018798311051,5.53803209060982e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BECN1,Beclin-1,39638,-0.0847325694923588,0.00622284319240665,-0.0969293421494758,-0.0725357968352417,6.96996012898447e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0471685351069546,0.0034671737208459,-0.0539641955998126,-0.0403728746140967,7.11077639926099e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL11,Eotaxin,42296,-0.0529143649227205,0.00389235227169555,-0.0605433753752437,-0.0452853544701972,8.06792578570572e-42
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN4,CCN family member 4,42262,-0.0551778936545411,0.00407417266036402,-0.0631632720688546,-0.0471925152402276,1.60764637170019e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.038932877843849,0.00287732328162564,-0.0445724314758352,-0.0332933242118627,1.9055451904466e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0508156864974698,0.00375561214846924,-0.0581766863084695,-0.0434546866864701,1.91779903118016e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.070776256566393,0.00523676446713807,-0.0810403149219836,-0.0605121982108024,2.33837309335168e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0593580239847835,0.00439746218759704,-0.0679770498724737,-0.0507389980970933,2.94560413445076e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0547882181436313,0.0040683790978677,-0.062762241175452,-0.0468141951118106,4.49584281732405e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOA,Elongin-A,42070,-0.0754007988440693,0.00560329218988003,-0.0863832515362341,-0.0644183461519044,5.18709838555892e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0923780404253447,0.00686950768680058,-0.105842275491474,-0.0789138053592155,5.83389902310447e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.113343612336906,0.00843208136937579,-0.129870491820883,-0.0968167328529295,7.18254687941317e-41
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0998591370633948,0.00744761202085175,-0.114456456624264,-0.0852618175025253,1.10569905991894e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0597715991645337,0.00446138841681743,-0.0685159204614959,-0.0510272778675716,1.14086974619256e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0948041125225085,0.00707910961180388,-0.108679167361644,-0.0809290576833729,1.21396849779508e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.0376475522347481,0.00281316051465686,-0.0431613468434755,-0.0321337576260206,1.38002381734925e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0397749433807782,0.00297251802011298,-0.0456010787001996,-0.0339488080613567,1.40742198300162e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0900735508048844,0.00673442561880977,-0.103273025017752,-0.0768740765920172,1.51768583148439e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0436751923177564,0.003265595052738,-0.0500757586211229,-0.0372746260143899,1.54796287807166e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0477097443005682,0.00356771078117999,-0.054702457431681,-0.0407170311694554,1.57632729132228e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0309135219621042,0.00231114509751457,-0.0354433663532328,-0.0263836775709756,1.71767401474807e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0415781116850533,0.00311437522376167,-0.0476822871236261,-0.0354739362464804,2.37235280948408e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0527310931596356,0.00395362838610002,-0.0604802047963917,-0.0449819815228796,2.87351298642553e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0404153691849836,0.00303134472944628,-0.0463568048546983,-0.0344739335152689,3.04655820566856e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0389334949154546,0.00293405462968164,-0.0446842419896306,-0.0331827478412786,6.19293919355729e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD248,Endosialin,39966,0.0561553672852575,0.00423210782763715,0.0478604359430887,0.0644502986274263,6.94076812078123e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFI,Complement factor I,39979,-0.026894972156548,0.00203017849466993,-0.0308741220061011,-0.0229158223069949,9.17325291779067e-40
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH17,Cadherin-17,42145,-0.0940889617201407,0.00711376570683719,-0.108031942505542,-0.0801459809347398,1.08957233635412e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0596981406964027,0.00451726739505155,-0.0685519847907038,-0.0508442966021017,1.25519016469063e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0275231943990618,0.00208467657062632,-0.0316091604774894,-0.0234372283206342,1.48976312338834e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0858017162490341,0.00650183521546496,-0.0985453132713454,-0.0730581192267228,1.79636257972975e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0537993044099852,0.00411488132058431,-0.0618644717983304,-0.04573413702164,7.91756009429019e-39
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0338201632386908,0.0025912676890634,-0.0388990479092551,-0.0287412785681266,1.17793827769081e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.0855520490096418,0.00656101389056321,-0.0984116362351457,-0.0726924617841379,1.40594100641332e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0369250394383826,0.00283773040174378,-0.0424869910258004,-0.0313630878509648,1.7714744699966e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0216264027622825,0.00166260864330888,0.0183676898213971,0.0248851157031679,1.8724905006901e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP7,Matrilysin,41881,-0.0701956497717085,0.00539949953918953,-0.08077866886852,-0.059612630674897,2.08740393434842e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTR,Transthyretin,39862,-0.0337566426956985,0.00259644454318506,-0.0388456740003412,-0.0286676113910558,2.27645252374737e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.123824840507006,0.00953220883605529,-0.142507969825675,-0.105141711188338,2.354676692254e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.080947862759857,0.0062341889420822,-0.0931668730863381,-0.0687288524333759,2.53867846195853e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0841668655492137,0.00648463829826523,-0.0968767566138135,-0.0714569744846139,2.99803810169889e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0835913536301284,0.00644763279666597,-0.0962287139115937,-0.0709539933486631,3.27883511736016e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.066704835642916,0.00514824312450226,-0.0767953921669405,-0.0566142791188916,3.62725686050658e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.115027442316907,0.00888142775648062,-0.132435040719609,-0.0976198439142047,4.3650434005861e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0374994714906992,0.00289887357318654,-0.0431812636941448,-0.0318176792872536,4.7484268794445e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0565945868049473,0.00437815433348878,-0.0651757692985853,-0.0480134043113093,5.39599328973778e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.0850501784220849,0.00658305645604588,-0.0979529690759349,-0.072147387768235,5.91968671456781e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0784888377555853,0.00609053073108924,-0.0904262779885202,-0.0665513975226504,8.87092060562242e-38
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.057842688369001,0.00450525326320383,-0.0666729847648806,-0.0490123919731215,1.63728290005937e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0592522988653353,0.00462414917051807,0.0501889664911198,0.0683156312395507,2.26796585966934e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0576809707828419,0.00450631186378035,-0.0665133420358514,-0.0488485995298324,2.69810115148066e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.1299540388031,0.0101485320318713,-0.149845161585568,-0.110062916020633,2.82274307763154e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.070115922526929,0.00549486075905653,-0.0808858496146798,-0.0593459954391782,4.51702876517285e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.068849102861412,0.00540178345018326,-0.0794365984237712,-0.0582616072990528,5.40803014706764e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.111206291014737,0.00872542640303277,-0.128308126764681,-0.094104455264793,5.42954354332589e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0359016891338415,0.00281786291111875,0.0303786778280487,0.0414247004396342,5.72044652372826e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSN,Gelsolin,39943,0.02528676388768,0.00198537126622525,0.0213954362058785,0.0291780915694815,6.62703472869836e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0498562607293541,0.00392315349019935,-0.0575456415701448,-0.0421668798885634,8.70648488947127e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0846086855137577,0.0066587664364708,-0.0976598677292405,-0.071557503298275,8.80201474611018e-37
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.146317513020473,0.0115197885379356,-0.168896298554827,-0.12373872748612,1.0338369736833e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0507259632286152,0.00399756578593568,-0.0585611921690491,-0.0428907342881813,1.09215027968362e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0476261656910233,0.00375537863017025,-0.0549867078061569,-0.0402656235758896,1.20049083338999e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.081404958340524,0.00642736921376311,-0.0940026019994997,-0.0688073146815483,1.49465508703679e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.126712570246605,0.0100058001424704,-0.146323938525847,-0.107101201967364,1.6557796335745e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.0361210253087095,0.00285651651192257,-0.0417197976720777,-0.0305222529453413,1.90980166254514e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.11278269040216,0.00892058504492034,-0.130267037090203,-0.0952983437141157,1.98100881022353e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.118310589227562,0.00936284183919997,-0.136661759232394,-0.0999594192227306,2.15130894518831e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.115690981632127,0.00915819915438424,-0.13364105197472,-0.097740911289534,2.25120090460087e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.144063667176365,0.0114024021753768,-0.166412375440104,-0.121714958912627,2.3949752322931e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.0757588259565699,0.00600556007163348,-0.0875297236969716,-0.0639879282161683,2.79272315541136e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0303198594810524,0.00240414288361821,-0.0350319795329441,-0.0256077394291607,2.92383029568296e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH9,Myosin-9,39966,-0.149809299822764,0.0118861279556545,-0.173106110615847,-0.126512489029681,3.51550202312484e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0875343057290274,0.00695050923109916,-0.101157303821982,-0.073911307636073,3.65150258067754e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0743059850991379,0.00590220589875391,-0.0858743086606955,-0.0627376615375802,3.82785567022246e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPE,Carboxypeptidase E,42134,0.0513024073081425,0.00407607660649833,0.0433132971594058,0.0592915174568793,4.00569915325216e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0661956944407133,0.00526703746597715,-0.0765190878740286,-0.0558723010073981,5.03728855325389e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAB2,Stabilin-2,39966,-0.036934504849732,0.00294016327030416,-0.0426972248595282,-0.0311717848399358,5.91377147099618e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0602234798782575,0.00479919560901619,-0.0696299032719293,-0.0508170564845858,6.43713136827047e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNCA,Alpha-synuclein,39736,-0.155211353059483,0.0123663070974648,-0.179449314970514,-0.130973391148452,6.85149588653038e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0407458162441496,0.00324930365043968,0.0343771810892878,0.0471144513990114,7.14521713859845e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSE,Cathepsin E,39736,-0.069741940315327,0.00556397855288851,-0.0806473382789885,-0.0588365423516655,8.42416676286492e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORT1,Sortilin,42129,-0.0497947992678523,0.00397660324975754,-0.0575889416373771,-0.0420006568983275,8.94026604657091e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD48,CD48 antigen,42166,-0.0401164623948299,0.00320574195834453,-0.0463997166331851,-0.0338332081564746,9.86498275123312e-36
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSG,Basigin,42284,-0.027202270757775,0.00217785468684891,-0.0314708659439988,-0.0229336755715511,1.3170116892241e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0813142640048334,0.00651997950900532,0.068535104167183,0.0940934238424838,1.674160405426e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0506402273199186,0.00406254498516925,-0.0586028154908503,-0.0426776391489868,1.97424343697453e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.063620290543537,0.00512156861574277,-0.0736585650303928,-0.0535820160566812,3.07212087730358e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN8,Septin-8,39906,-0.0424204700987153,0.00341405153772157,-0.0491120111126495,-0.035728929084781,3.23531993280947e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0824741876192902,0.00664924627567846,-0.0955067103196199,-0.0694416649189604,3.91793146375803e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0394775371612442,0.00318456469028473,-0.0457192839542023,-0.0332357903682861,4.59445161089399e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH15,Cadherin-15,42230,-0.089117645580089,0.00720014062357672,-0.103229921202299,-0.0750053699578787,5.35263357381927e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.13057689756361,0.0105470937941766,-0.151249201400196,-0.109904593727023,5.62010184696272e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0539160953786036,0.00435760974465732,-0.0624570104781319,-0.0453751802790752,5.64680620758361e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0596773154194175,0.00482519902130434,-0.069134705501174,-0.050219925337661,6.60962334985133e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.041771831666358,0.0033811241837276,-0.0483988350664641,-0.0351448282662519,7.22997487943923e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.102970866886645,0.00834214484399893,-0.119321470780883,-0.0866202629924071,8.84208099316426e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0874526071376235,0.0070865725082359,-0.101342289253766,-0.0735629250214811,9.30331472741701e-35
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0827111088350074,0.00671056417344399,-0.0958638146149576,-0.0695584030550572,1.02321853530545e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0510499382152882,0.00414328111983704,-0.0591707692101688,-0.0429291072204076,1.07996587849688e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSZ,Cathepsin Z,42168,-0.041423511517717,0.00336619601747567,-0.0480212557119693,-0.0348257673234647,1.2903835226512e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0491073212515696,0.00399878980988246,-0.0569449492789392,-0.0412696932242,1.76020459788356e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA4,Kallistatin,39802,-0.0300732391342567,0.00245207600669318,-0.0348793081073753,-0.0252671701611381,2.33547789583218e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.0483042060888248,0.00394523557699873,-0.0560368678197423,-0.0405715443579073,2.75849369862417e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PENK,Proenkephalin-A,39736,-0.0398435443529748,0.00325253997449047,-0.0462185227029761,-0.0334685660029735,2.79196992143767e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0959454692767114,0.00784606483928907,-0.111323756361718,-0.0805671821917048,3.34822905690863e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0491784160186431,0.00402422033359618,-0.0570658878724916,-0.0412909441647946,3.65147555215424e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0964962112078057,0.00790385074377778,-0.11198775866561,-0.0810046637500013,4.19738391211352e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18,Interleukin-18,42069,-0.0563653484339217,0.00461752904857878,-0.0654157053691361,-0.0473149914987072,4.32690155616166e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0655175546604582,0.00536586742272083,-0.076034654808991,-0.0550004545119254,4.5620539995926e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.100241080244863,0.00821974504191867,-0.116351780527024,-0.0841303799627027,5.39105186577934e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0300445008724338,0.00246778635968121,-0.0348813621374089,-0.0252076396074586,6.89135667467948e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0370290948243932,0.00304495451235118,-0.0429972056686016,-0.0310609839801849,7.52127870708968e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.123917736983061,0.0101913589983513,-0.14389280061983,-0.103942673346293,7.71915377902628e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0299803212608152,0.00246822933926865,-0.0348180507657817,-0.0251425917558486,8.94413804307457e-34
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0328877340838825,0.00271337440215367,-0.0382059479121037,-0.0275695202556613,1.23019071677318e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.0457738865774106,0.00377452545932991,-0.0531719564776972,-0.038375816677124,1.2455509708737e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0641702794053266,0.00531197076628287,-0.0745817421072411,-0.0537588167034122,1.98738075456285e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.0251949861001558,0.00208959500585722,-0.029290592311636,-0.0210993798886756,2.63161446315112e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0527786751996556,0.0043781188555125,-0.0613597881564601,-0.0441975622428511,2.75815376821993e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0644556730944114,0.00535493263489397,-0.0749513410588036,-0.0539600051300193,3.36447245290639e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0434438193240987,0.00361045326421419,-0.0505203077219585,-0.0363673309262389,3.53507921630621e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.031150112562701,0.00259006704059962,-0.0362266439622762,-0.0260735811631257,3.79263246129142e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.10218641002572,0.00849783895300357,-0.118842174373607,-0.0855306456778329,3.86064091116486e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0441276203914228,0.00367081481205037,-0.0513224174230416,-0.0369328233598041,4.04069021630732e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.105930641496676,0.00883991691008487,-0.123256878640442,-0.0886044043529095,6.3789594451334e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD302,CD302 antigen,42070,-0.0388629134046277,0.00324911397541274,-0.0452311767964367,-0.0324946500128188,8.3290401689082e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0622860878671096,0.00520499590633858,-0.0724878798435332,-0.052084295890686,8.56309171210964e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOE,Apolipoprotein E,39979,-0.0873873455591624,0.00730892454060206,-0.101712837658742,-0.0730618534595823,9.4580519698764e-33
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.0711171783636268,0.00596502709572767,-0.082808631471253,-0.0594257252560006,1.31389685650946e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0489497183884915,0.00410720908721752,-0.0569998481994378,-0.0408995885775451,1.39944283114215e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0910842587245982,0.0076445188420769,-0.106067515655069,-0.0761010017941275,1.45059826693562e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.070801659805679,0.00594702132526366,-0.0824578216031957,-0.0591454980081622,1.60432125176197e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0487423553381309,0.00409394666035673,-0.0567664907924301,-0.0407182198838317,1.74132269317596e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0718604648982865,0.00604661698301318,-0.0837118341849924,-0.0600090956115807,2.22247642896083e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.087754680982151,0.00739006843320687,-0.102239215111236,-0.0732701468530656,2.33399757258453e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0641722972277225,0.00540173921137994,-0.0747597060820272,-0.0535848883734178,2.34146948999477e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0568330964077375,0.00478469403418565,-0.0662110967147414,-0.0474550961007336,2.39499828701983e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFF1,Trefoil factor 1,42084,-0.0994902154481346,0.00838249080708089,-0.115919897430013,-0.0830605334662561,2.48987824539288e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0502104954118462,0.00423097633044182,-0.0585032090195122,-0.0419177818041803,2.52109334635771e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.034553937486982,0.00291530172807925,-0.0402679288740173,-0.0288399460999466,2.99849008041323e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0435167987355309,0.00367216269314309,-0.0507142376140914,-0.0363193598569705,3.08813786431228e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0589873382601091,0.00498116057804605,-0.0687504129930794,-0.0492242635271388,3.41295324086939e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.124205145548636,0.0104834183897143,-0.144752645592476,-0.103657645504795,3.42170039518606e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0504107912932711,0.00425954296627519,-0.0587594955071705,-0.0420620870793718,3.98223511968019e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.058480309173334,0.00494790292767205,-0.0681781989115713,-0.0487824194350968,4.50119740944677e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0498064876083627,0.00421859477105542,-0.0580749333596313,-0.041538041857094,5.18928273665871e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTDH,Protein LYRIC,39657,-0.11813859271845,0.0100088271103776,-0.13775589385479,-0.0985212915821096,5.82608416823819e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA9,Serpin A9,42025,-0.0889262472033911,0.00754197064916092,-0.103708509675746,-0.0741439847310357,6.2529415655537e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0526139176217374,0.00446704800104883,-0.0613693317037931,-0.0438585035396817,7.23412043526934e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDK,Midkine,42129,-0.0628624729603709,0.00533761571482242,-0.0733241997614228,-0.0524007461593189,7.31527438089589e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.080047104530473,0.00679693881218727,-0.09336910460236,-0.0667251044585859,7.39964288369298e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0491246301542972,0.00417795943873801,-0.0573134306542237,-0.0409358296543707,9.81322001439686e-32
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0506285118127057,0.00430768244096369,-0.0590715693969945,-0.0421854542284169,1.04785146295797e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0380358218356445,0.00323807028419863,-0.0443824395926738,-0.0316892040786152,1.12404774196752e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.104006049375484,0.00886659178088106,-0.121384569266011,-0.0866275294849571,1.28091897777243e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0357254564457528,0.00304779562474149,-0.0416991358702462,-0.0297517770212595,1.50055398661727e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0808062304505095,0.00689748799023264,-0.0943253069113655,-0.0672871539896536,1.6166736373405e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.0564138255286449,0.00482229244972067,-0.0658655187300975,-0.0469621323271924,1.83725240727677e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0403925934309942,0.00345621076203188,-0.0471667665245766,-0.0336184203374117,2.09914423925588e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0764971575428976,0.00655094649359637,-0.0893370126703465,-0.0636573024154487,2.35394685128221e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0665794196327682,0.00570443276763518,-0.0777601078573332,-0.0553987314082033,2.5166942258406e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.074581202441528,0.00639165197038192,-0.0871088403034765,-0.0620535645795794,2.62659039339121e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0601159241793844,0.00515197861206526,-0.0702138022590323,-0.0500180460997365,2.62695697608713e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.057368858632019,0.00492242705093639,-0.0670168156518543,-0.0477209016121837,3.05317885080883e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.101896561161453,0.00876028773809742,-0.119066725128124,-0.084726397194782,4.27350163654454e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0445983362721727,0.00384016576279481,-0.0521250611672505,-0.0370716113770949,4.93734287056778e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0698844780738192,0.00602842705475221,-0.0817001951011335,-0.0580687610465049,6.29546165353435e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.10215553909612,0.00881309601673461,-0.11942920728892,-0.08488187090332,6.89508734989514e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0850431340814637,0.00734113233230418,-0.0994317534527799,-0.0706545147101475,6.96776612283014e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.050268919564295,0.00433965501920566,-0.0587746434019381,-0.0417631957266519,6.96819008911477e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAYN,Layilin,41997,-0.0431558657064894,0.00372574602690129,-0.0504583279192159,-0.0358534034937628,7.03912838066409e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.111516551247399,0.00963863748685273,-0.13040828072163,-0.0926248217731672,8.19347516277162e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.034672248751324,0.00300001967939927,-0.0405522873229466,-0.0287922101797015,9.44661206714827e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMD,Osteomodulin,42185,0.0494967413738041,0.00428360322471628,0.0411008790533602,0.057892603694248,9.70320742974427e-31
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.102346820615284,0.00887933010972679,-0.119750307630348,-0.0849433336002192,1.34959514495423e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCA,Calcitonin,41997,-0.0833366000041091,0.00723025532689002,-0.0975079004448136,-0.0691652995634047,1.35859007226511e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0556898812625992,0.00484689195781807,-0.0651897894999226,-0.0461899730252758,2.05309088587489e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0513918672753435,0.00447988211419825,-0.060172436219172,-0.0426112983315149,2.53437932923964e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.0752478331680417,0.00656492745117567,-0.088115090972346,-0.0623805753637374,2.99864580406317e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.0667405728440142,0.00583296152965154,-0.0781731774421312,-0.0553079682458972,3.56013093734664e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0361808598129691,0.00316597247472256,-0.0423861658634253,-0.0299755537625129,4.15319871795022e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINH1,Serpin H1,39757,-0.154867660702105,0.0135549101631327,-0.181435284621845,-0.128300036782365,4.59694251776603e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0378383352985126,0.00331689275263116,-0.0443394450936696,-0.0313372255033555,5.62822155177065e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COCH,Cochlin,39958,-0.0548718980432291,0.00481590394718373,-0.0643110697797092,-0.045432726306749,6.51778797025716e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0764565539428291,0.00671518572037905,-0.089618317954772,-0.0632947899308861,7.16608726405367e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0361782038498333,0.00318057562222566,-0.0424121320693956,-0.029944275630271,7.61321849897902e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSL,Cathepsin L1,42145,-0.0290550747488192,0.00255585533178546,-0.0340645511991187,-0.0240455982985196,8.23331404260998e-30
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0815197613015992,0.00720015739337793,-0.09563206979262,-0.0674074528105785,1.48684610681535e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0914010805195014,0.0080849217811232,-0.107247527210503,-0.0755546338284999,1.77839322750849e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0334027134065166,0.00296065538759311,-0.0392055979661991,-0.027599828846834,2.16798534337756e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0826424715013992,0.00732785737942557,-0.0970050719650733,-0.0682798710377251,2.4195445043769e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0689056417606589,0.00612363295628734,-0.0809079623549821,-0.0569033211663357,3.05879193791483e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0389130752187514,0.00346733056427169,-0.0457090431247239,-0.0321171073127789,4.22475923475632e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB2,Lamin-B2,39929,-0.0337314586061764,0.00300829780841457,-0.039627722310669,-0.0278351949016838,5.01570923786697e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0878826131834235,0.00785144593067802,-0.103271447207552,-0.0724937791592946,6.31526261037399e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.113994041748587,0.0102033550612686,-0.133992617668673,-0.0939954658285004,7.43292125712406e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.077396231333015,0.00693288424349897,-0.090984684450273,-0.0638077782157571,8.25930818625107e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.110354752469911,0.00989135716928417,-0.129741812521708,-0.0909676924181137,8.83801540577055e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.1469149379343,0.0131653550568118,-0.172719033845651,-0.121110842022949,9.1950021399476e-29
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0469803684965145,0.00421541698779767,-0.055242585792598,-0.0387181512004311,1.00755890447479e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0853898001967635,0.00765857586585368,-0.100400608893837,-0.0703789914996903,1.01577722350686e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0404029546084339,0.00362581128883556,-0.0475095447345516,-0.0332963644823162,1.03086498148437e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.10061483062174,0.00903244337603608,-0.118318419638771,-0.0829112416047096,1.07292330573406e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0985865506660236,0.00885857649804429,-0.11594936060219,-0.0812237407298567,1.20927112993091e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0316636873422833,0.002848504842276,-0.0372467568331443,-0.0260806178514224,1.39257836309589e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.0563543152777455,0.00507063258788553,-0.0662927551500011,-0.0464158754054899,1.43491642691963e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.0443373930332907,0.00399460193996562,-0.0521668128356233,-0.0365079732309581,1.68820055576233e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0360484925157195,0.00324961941150405,-0.0424177465622675,-0.0296792384691716,1.79246309906659e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSTB,Cystatin-B,41959,-0.0502580286166524,0.00453135050589161,-0.0591394756082,-0.0413765816251048,1.8429201652198e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0318463467115389,0.00287319320804806,-0.0374778053993131,-0.0262148880237647,1.98255656425064e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0387596857910803,0.00349985127345936,-0.0456193942870607,-0.0318999772951,2.19876628155228e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0865274025116007,0.00782569341672837,-0.101865761608388,-0.0711890434148131,2.68569020691738e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0663628894677961,0.00600118011109538,-0.0781252024855431,-0.0546005764500492,2.80218743853404e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM1,Isthmin-1,42119,-0.0455244115812434,0.00412111487581047,-0.053601796737832,-0.0374470264246549,3.00616847846804e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.0294277034430895,0.00266430211349525,0.0242056713006388,0.0346497355855402,3.04351667053544e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA2,Annexin A2,39492,-0.0817345044317857,0.00739605675554299,-0.09623077567265,-0.0672382331909215,3.05894156628508e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A4,Protein S100-A4,42181,-0.0644473788362844,0.00584562608444372,-0.075904805961794,-0.0529899517107747,3.8154875603553e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0275607699200448,0.00250267237192626,-0.0324660077690203,-0.0226555320710693,4.37520203698128e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0763995908401444,0.00693924755072822,-0.0900005160395717,-0.0627986656407171,4.53725757334758e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0538858320741417,0.00489496646722191,-0.0634799663498967,-0.0442916977983868,4.8688838132417e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0875254725687576,0.00797395199833617,-0.103154418485497,-0.0718965266520187,6.50676881382243e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0426359855483814,0.00388811357431952,-0.0502566881540477,-0.0350152829427152,7.35899827520975e-28
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0695645779844728,0.00636547589855223,-0.0820409107456352,-0.0570882452233104,1.10673126921488e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0372094821480389,0.00340477454088052,-0.0438828402481647,-0.0305361240479131,1.16490260414649e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0598027606346319,0.00547571228786368,-0.0705351567188447,-0.0490703645504191,1.18994493123484e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0757759950110109,0.00694745518305126,-0.0893930071697914,-0.0621589828522305,1.47059730694101e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.0234962661493392,0.00215526529658054,-0.0277205861306371,-0.0192719461680414,1.48287010263351e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0662907970869805,0.0060902929147323,-0.0782277711998558,-0.0543538229741052,1.77265814906786e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0380055092033602,0.0034987906931047,-0.0448631389618454,-0.0311478794448749,2.25094957987663e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD160,CD160 antigen,42296,-0.054904675993231,0.00505866385376705,-0.0648196571466144,-0.0449896948398476,2.47708905721517e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTBDN,Retbindin,42070,-0.033943178230785,0.0031294574017115,-0.0400769147381395,-0.0278094417234304,2.69109770228684e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.0370298750433188,0.00341584278642461,-0.043724926904711,-0.0303348231819266,2.8580130328659e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAG1,Dystroglycan,42185,-0.0536928102581759,0.00495579785057709,-0.063406174045307,-0.0439794464710448,3.05828068665416e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0682581914975562,0.00630460229456856,0.0559011710002019,0.0806152119949106,3.31501459497462e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.125352804663147,0.0115736607656553,-0.148037179763831,-0.102668429562463,3.34254521681322e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSC2,Desmocollin-2,41984,-0.039662804757933,0.00366429992167555,-0.0468448326044171,-0.032480776911449,3.42941842866369e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0879739702891543,0.00814068917911916,-0.103929721080228,-0.0720182194980807,4.11948880283364e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0532915441839584,0.00493159476477062,-0.0629574699229088,-0.043625618445008,4.14403562099323e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0440359529077455,0.00407490232667623,-0.0520227614680309,-0.0360491443474601,4.15537864172929e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBIN,Erbin,42070,-0.115590321747493,0.0106989435363134,-0.136560251078667,-0.0946203924163186,4.26008191581859e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0475554692135538,0.0044017643127182,-0.0561829272664814,-0.0389280111606261,4.26709198232579e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0352714447628174,0.0032659759390068,-0.0416727576032707,-0.028870131922364,4.45455057501893e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0621214921529343,0.00575497079825254,-0.0734012349175093,-0.0508417493883594,4.74085413404859e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0383053157864971,0.00355142442358518,-0.0452661076567241,-0.0313445239162702,5.16278092547835e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.158957204517011,0.0147446855885986,-0.187856788270665,-0.130057620763358,5.74193003446625e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0378860053877806,0.00351726602265309,-0.0447798467921807,-0.0309921639833806,6.05238212025999e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0872577193710859,0.00812258999050245,-0.103177995752471,-0.0713374429897011,8.72390176258533e-27
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0412529816917401,0.00384970318879862,-0.0487983999417854,-0.0337075634416948,1.15069300850726e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.117086388257533,0.0109329801842901,-0.138515029418742,-0.0956577470963244,1.23212996267614e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0272695048603062,0.00254928342089677,-0.0322661003652639,-0.0222729093553485,1.34455260327716e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMN,Protein amnionless,41913,-0.0526968613362198,0.00492917724238096,-0.0623580487312865,-0.0430356739411531,1.44052322692637e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0412862347504227,0.00386953824119847,0.0337019397976737,0.0488705297031717,1.88669432925454e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0458679825086764,0.00431071719662336,-0.0543169882140582,-0.0374189768032947,2.5840823964903e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0627504497610122,0.0059088655537419,-0.0743318262463463,-0.0511690732756781,3.07672313173198e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSF,Cathepsin F,42181,-0.0446747890183654,0.00420818995695359,-0.0529228413339944,-0.0364267367027363,3.17609767791992e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0689462087082596,0.00649699014387921,-0.0816803093902629,-0.0562121080262563,3.32038979588436e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0551911070756051,0.00520534160276842,-0.0653935766170312,-0.044988637534179,3.66316558903733e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.0452523629640984,0.0042671948273431,-0.0536160648256908,-0.0368886611025059,3.79016675214411e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.11766359412375,0.0111027530884402,-0.139424990177093,-0.0959021980704075,3.86744435710373e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0317103239776377,0.00299840411755228,-0.0375871960480402,-0.0258334519072352,4.87476543283024e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0585934625165679,0.00554432199535917,-0.0694603336274718,-0.0477265914056639,5.2949536466859e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0384759397121194,0.0036398506184024,-0.0456100469241882,-0.0313418325000507,5.41761797729831e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0995923255960974,0.00942347101106795,-0.118062328777791,-0.0811223224144042,5.50774276123474e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0925886811350618,0.00876395866870538,-0.109766040125724,-0.0754113221443992,5.51775884461164e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.104806878039276,0.00992956270892033,-0.12426882094876,-0.0853449351297926,6.09715673346604e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0262283930415338,0.00248710576055014,-0.0311031203322121,-0.0213536657508555,6.70024842706722e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0262983523049751,0.00249585085359202,-0.0311902199780155,-0.0214064846319348,7.37352899052468e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0574272750335401,0.00545136268064616,-0.0681119458876066,-0.0467426041794737,7.53900740482721e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0729635910384849,0.00694005295609668,-0.0865660948324344,-0.0593610872445354,9.40437079121663e-26
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0585736230105651,0.00558622067162154,-0.0695226155269433,-0.0476246304941868,1.26976099951985e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKB,Creatine kinase B-type,39966,0.0631123514267871,0.00602068748037023,0.0513118039652614,0.0749128988883127,1.35883931485277e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0631865714779592,0.00603613145125679,-0.0750173891224225,-0.0513557538334959,1.5116947808969e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOST,Sclerostin,42129,-0.04233901827417,0.00404654072027876,-0.0502702380859164,-0.0344077984624236,1.59838872429985e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.125756165282854,0.0120139837627043,-0.149303573457755,-0.102208757107954,1.59945447928319e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0552101574160589,0.00527667969547488,-0.0655524496191896,-0.0448678652129281,1.66846110395341e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.0585023938839076,0.00560465913321595,-0.0694875257850109,-0.0475172619828044,2.07473793109924e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.0260878658192352,0.00250158155494118,-0.03099096566692,-0.0211847659715505,2.29129360836979e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.070691527788587,0.00678652960275608,-0.083993125809989,-0.0573899297671851,2.71436150177257e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0797339845047924,0.00765583272340496,-0.0947394166426661,-0.0647285523669187,2.77915485157394e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0398634370873886,0.00383872427027064,-0.047387336657119,-0.0323395375176581,3.62783220108216e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0333791674652989,0.00321314765877039,-0.0396769368764889,-0.027081398054109,3.65171838620424e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0663695984534952,0.00640599462922697,-0.0789253479267801,-0.0538138489802104,4.65135870027922e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCA2A,Guanylin,42083,-0.0380347679011859,0.00367161781442578,-0.0452311388174605,-0.0308383969849114,4.72283455760932e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RETN,Resistin,42105,-0.0463417523306865,0.00447651294134163,-0.0551157176957161,-0.0375677869656569,5.07296802728034e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0684687366062754,0.00661408505848288,-0.0814323433209018,-0.0555051298916489,5.29905850332337e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.0839635436459861,0.00811480262327563,-0.0998685567876063,-0.0680585305043659,5.34919696202787e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.034151861016073,0.00330438806411058,-0.0406284616217297,-0.0276752604104162,6.0683943965297e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.147970280806835,0.0143187356015519,-0.176035002585877,-0.119905559027793,6.12641255253201e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGN,Mimecan,42137,-0.0465848138880844,0.00451164709901142,-0.0554276422021468,-0.037741985574022,6.68765311496918e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.133685784931622,0.0129425694580199,-0.159053221069341,-0.108318348793903,6.75102650714428e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0935264195456973,0.009061287885499,-0.111286543801275,-0.0757662952901193,6.96609655580723e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0582740464965071,0.0056445423541825,-0.0693373495107048,-0.0472107434823094,7.07641686536375e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0537885358374608,0.0052126141355739,-0.0640052595431856,-0.0435718121317359,7.15881382255544e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0330622444299438,0.00320436695925012,-0.039342803670074,-0.0267816851898135,7.53639686189782e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0301014022949688,0.00291974103252855,-0.0358240947187248,-0.0243787098712129,7.91378741491538e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.0492536689575883,0.00478017963601974,-0.058622821044187,-0.0398845168709896,8.72500424592017e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.048757218793617,0.00473698529856426,-0.058041709978803,-0.0394727276084311,9.37083655318936e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FETUB,Fetuin-B,42199,-0.0345835187187889,0.00336061360212703,-0.0411703213789579,-0.0279967160586199,9.55138816358857e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0738413775744563,0.00717550613069699,-0.0879053695906224,-0.0597773855582902,9.55192188272383e-25
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.063100409591451,0.00614795497335719,-0.0751504013392311,-0.0510504178436709,1.26267829472293e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0316039930625726,0.00308130806311923,-0.0376433568662863,-0.0255646292588589,1.35917465927e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POF1B,Protein POF1B,39657,-0.04894417425821,0.0047767277899642,-0.0583065607265398,-0.0395817877898801,1.58124460087896e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.0784069872400992,0.00766454513204994,0.0633844787812814,0.0934294956989171,1.8613994900744e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TALDO1,Transaldolase,39948,-0.0473973753516749,0.00463481720611737,-0.056481617075665,-0.0383131336276849,1.92823908482412e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0476000091572494,0.00465488079907371,-0.0567235755234339,-0.0384764427910649,1.93983643170915e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0602371235698239,0.00589450546663464,-0.0717903542844278,-0.04868389285522,2.00258879449946e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NADK,NAD kinase,42145,-0.0583044772445288,0.00571426085365235,-0.0695044285176874,-0.0471045259713702,2.34676806755037e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0842308360459653,0.00825636134471516,-0.100413304281607,-0.0680483678103236,2.39161371714064e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0982539807958698,0.00964192825025475,-0.117152160166369,-0.0793558014253705,2.68229019681797e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0826005400336711,0.00810628797849348,-0.0984888644715183,-0.0667122155958238,2.80548370856985e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0824786292442631,0.00810209824646546,-0.0983587418073354,-0.0665985166811908,2.98393500792672e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0285761108351283,0.00281009756852586,-0.034083902069439,-0.0230683196008176,3.33203464915409e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAN,Brevican core protein,42016,0.036591428399704,0.00359928779556172,0.029536824320403,0.043646032479005,3.43075575914647e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSM,Oncostatin-M,42051,-0.0732846221352766,0.00721462854129848,-0.0874252940762217,-0.0591439501943316,3.7394786186782e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0427400666535741,0.0042060604636125,-0.0509839451622546,-0.0344961881448936,3.75158919221427e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0522816651156659,0.00515028691228325,-0.0623762274637411,-0.0421871027675907,4.14922571337436e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0364939946370176,0.00359762598922958,-0.0435453415759076,-0.0294426476981276,4.30482027484888e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0725675497772501,0.00715846964029676,-0.0865981502722318,-0.0585369492822685,4.77905915702074e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0878876248737248,0.00867665616916588,-0.10489387096529,-0.0708813787821597,4.99018110842926e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0565800422713419,0.00558824965867716,-0.0675330116023491,-0.0456270729403347,5.47176462146433e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN1,Ficolin-1,39978,-0.0593168046308194,0.00586248457188414,-0.0708072743917123,-0.0478263348699265,5.80358716261683e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.0877569522134126,0.00867782961180115,-0.104765498252543,-0.0707484061742823,5.90196007978493e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0358848260326177,0.00354795635045429,-0.0428388204795081,-0.0289308315857273,6.03766621511947e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0556174288236659,0.00550475816450978,-0.0664067548261051,-0.0448281028212267,6.48976595631276e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0284731879265079,0.00281833350960468,-0.033997121605333,-0.0229492542476827,6.51965408800911e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0915616969747002,0.00906770907832541,-0.109334406768218,-0.0737889871811823,7.14595703718897e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD63,CD63 antigen,41992,-0.0530847974849806,0.00525908687072635,-0.0633926077516042,-0.0427769872183569,7.15432738890644e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.115466334248965,0.0114401743876136,-0.137889076048687,-0.0930435924492421,7.47832544377831e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0252516054662921,0.0025074960794538,-0.0301662977820216,-0.0203369131505627,9.05244146045693e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0914242081933506,0.00907945049714467,-0.109219931167754,-0.073628485218947,9.14936791902682e-24
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0384140284473706,0.0038225246821387,-0.0459061768243624,-0.0309218800703787,1.16119874548353e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0744268816449002,0.00742315544662077,-0.088976266320277,-0.0598774969695235,1.41282906175993e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0955180034586091,0.00954352166737962,-0.114223305926673,-0.076812700990545,1.68541922828724e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0615170691514053,0.00616503028971564,-0.0736005285192479,-0.0494336097835626,2.2922282361815e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0404248351473414,0.00405436711905334,-0.048371394700686,-0.0324782755939969,2.47500890651091e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.042798320830455,0.00429125074766018,-0.0512091722958689,-0.034387469365041,2.48408765425042e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON1,Spondin-1,42144,-0.0339644311898987,0.00340754263988902,-0.0406432147640812,-0.0272856476157162,2.54635825708517e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0314616081906801,0.00315961646336657,-0.0376544564588786,-0.0252687599224816,2.92211660245491e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0452516154684643,0.00454693350635549,-0.054163605140921,-0.0363396257960075,3.07268572061418e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0984431313232064,0.00991284427948172,-0.117872306110991,-0.0790139565354222,3.66508655598497e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.11160116230089,0.0112344865637182,-0.133620755965778,-0.0895815686360024,3.68950629268536e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0539939740188866,0.00544241903530699,-0.0646611153280883,-0.0433268327096849,4.03971829430747e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0536268891233708,0.00541071084930115,-0.064231882388001,-0.0430218958587405,4.4719191842251e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.0321285216524729,0.00324559208697007,-0.0384898821429342,-0.0257671611620116,5.01654229297343e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.106658560177991,0.0107719254724853,-0.127771534104062,-0.0855455862519193,5.08361310425119e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXIN1,Axin-1,42119,-0.0997533888393844,0.0100806685339386,-0.119511499165904,-0.0799952785128647,5.21263596965113e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0550592221253278,0.00557007566076773,-0.0659765704204326,-0.0441418738302231,5.81744908857632e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0295873221546373,0.00299509646464687,-0.0354577112253452,-0.0237169330839294,6.16603113706788e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0201956029551322,0.00204894064997246,-0.0242115266290782,-0.0161796792811861,7.64790968094077e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0432048700609435,0.0043833605298617,-0.0517962566994724,-0.0346134834224145,7.65514798615707e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0315702756950491,0.00320616946293606,-0.0378543678424038,-0.0252861835476944,8.44201865049927e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.026722793360763,0.00271631509139252,0.0213988157816336,0.0320467709398923,9.22302123638761e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0905445281525657,0.00920358101828267,-0.1085835469484,-0.0725055093567317,9.52860478780301e-23
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.025058127301594,0.00254971231508777,-0.030055563439166,-0.020060691164022,1.01728015106411e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0746588309849758,0.0075950474904297,-0.089545124066218,-0.0597725379037336,1.03150472922604e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGRN,Neugrin,39929,-0.0231450789266079,0.00235535914019923,-0.0277615828413984,-0.0185285750118174,1.0661611556583e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.04936347271129,0.00502705207818743,-0.0592164947845374,-0.0395104506380426,1.14208863513587e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0501090802876816,0.00511218493118037,-0.0601289627527952,-0.0400891978225681,1.36586171501212e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0225891420843661,0.00230761698979751,0.018066212784363,0.0271120713843692,1.4966743146309e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.0678457343744048,0.00693440408417053,-0.0814371663793791,-0.0542543023694306,1.56404514763111e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0583786403383993,0.0059682746986944,-0.0700764587478404,-0.0466808219289583,1.61148349603335e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0853398720169826,0.00872180992992301,-0.102434619479632,-0.0682451245543335,1.61484471526199e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0635480536985686,0.00649919048384519,-0.0762864670469052,-0.050809640350232,1.72944328744967e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0740110643966022,0.00758529409116768,-0.0888782408152909,-0.0591438879779136,2.04049530784087e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0525833781707335,0.00539541327832581,-0.0631583881962521,-0.0420083681452149,2.28278479165383e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0282456895559679,0.00289757467714257,-0.0339249359231673,-0.0225664431887684,2.30504434436911e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPPK1,Epiplakin,39638,-0.07563292371048,0.007779091281491,-0.0908799426222024,-0.0603859047987576,2.9665702500457e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0381579733136733,0.0039286039742426,-0.0458580371031888,-0.0304579095241578,3.15034676451697e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.101429922787933,0.0104487582399401,-0.121909488938216,-0.0809503566376508,3.31440978992151e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCHE,Cholinesterase,39806,-0.0274224387878203,0.00282805709078747,-0.0329654306857637,-0.0218794468898768,3.80967347974067e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0524919497896685,0.00541580743118513,-0.0631069323547913,-0.0418769672245456,3.97543795826726e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.105282016841107,0.0108688815594732,-0.126585024697675,-0.0839790089845398,4.05836866072515e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN3,Ataxin-3,39929,-0.0621257993045465,0.0064155573435501,-0.0747002916979047,-0.0495513069111883,4.31075964418648e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRN,Progranulin,42077,-0.0253489619808776,0.00261978950775247,-0.0304837494160724,-0.0202141745456827,4.50092458278778e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0743952343112411,0.00768762873540418,-0.0894629866326333,-0.0593274819898489,4.58427676205828e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN1,Perilipin-1,41839,-0.0342599469784403,0.00354318339600513,-0.0412045864346104,-0.0273153075222703,4.81744908566867e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTN,Pleiotrophin,41900,-0.0502413466310131,0.00519832666832527,-0.0604300669009307,-0.0400526263610956,5.02114871302914e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0760213602643846,0.00787167740647197,-0.0914498479810697,-0.0605928725476996,5.54533919669046e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0255576908682465,0.00264866814743386,-0.0307490804372169,-0.0203663012992762,5.81446124187811e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0491050771924503,0.00508894021776479,-0.0590794000192693,-0.0391307543656313,5.82137296755943e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR,GMP reductase 1,42296,-0.0479682325326645,0.00497524846203597,-0.057719719518255,-0.038216745547074,6.27683662044398e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0395092162303141,0.00409787532733689,-0.0475410518718944,-0.0314773805887338,6.31782661119466e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.126271960149199,0.01310043462855,-0.151948812021157,-0.100595108277241,6.44596292992543e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.0511861047947319,0.00531563050861363,0.0407674689978491,0.0616047405916146,7.062930305236e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0564668534118014,0.00586952580821582,-0.0679711239959044,-0.0449625828276984,7.70790531497757e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH3,Cadherin-3,42249,-0.0369352794225463,0.00384475379612564,-0.0444709968629526,-0.0293995619821401,8.78170863994443e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0798501088852933,0.0083102924098614,-0.0961382820086216,-0.0635619357619649,8.95125322724359e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0298865058770598,0.0031141969678027,-0.0359903319339531,-0.0237826798201665,9.69940355034439e-22
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.0378008209222498,0.00394068738863931,-0.0455245682039828,-0.0300770736405167,1.01120129305954e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN5,CCN family member 5,42137,-0.0380013851735827,0.00396220252501377,-0.0457673021226096,-0.0302354682245557,1.02287232022209e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0558451402775484,0.00582400689521174,-0.0672601937921634,-0.0444300867629333,1.04335160260066e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.0277560516579801,0.0028995434135229,-0.033439156748485,-0.0220729465674752,1.22022164298372e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADD1,Alpha-adducin,39736,-0.0702108404416674,0.00733402163683562,-0.0845855228498652,-0.0558361580334696,1.25407521806658e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.086516998322069,0.00905237393503047,-0.104259651234729,-0.0687743454094093,1.41296989593665e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS8,Galectin-8,42249,-0.0606607982431441,0.00635116249551567,-0.0731090767343548,-0.0482125197519334,1.4980308246922e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0944905418383411,0.00989644644994245,-0.113887576880228,-0.0750935067964539,1.54894652206922e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0565395776849785,0.00592159104374902,-0.0681458961307266,-0.0449332592392304,1.55045948367219e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.051926664301331,0.00544054161509913,0.0412632027357367,0.0625901258669253,1.60006265556836e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFH,Complement factor H,39418,-0.0235594764460654,0.00246798455210348,-0.0283967261681882,-0.0187222267239426,1.63764517100505e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACAN,Aggrecan core protein,41994,0.0272854865803217,0.00286078833763026,0.0216783414385664,0.032892631722077,1.70798841536875e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0217467147395217,0.0022808447699637,-0.0262171704886506,-0.0172762589903928,1.81104218401318e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0621351060403981,0.00652384604227329,-0.0749218442832537,-0.0493483677975424,1.998306917402e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0281137173255358,0.00295290331762604,-0.0339014078280828,-0.0223260268229887,2.00479277871828e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.0294417859677776,0.00309793376528976,-0.0355137361477455,-0.0233698357878096,2.35701026606409e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0394466263952354,0.00415258862601779,-0.0475857001022303,-0.0313075526882406,2.45804686088307e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREH,Trehalase,39966,-0.0749871823924885,0.00789991653681648,-0.0904710188046488,-0.0595033459803282,2.71375466019134e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0672875172207309,0.00709439279826604,-0.0811925271053323,-0.0533825073361294,2.83402891650606e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0621741782021944,0.00656098874909716,-0.0750337161504248,-0.049314640253964,3.06070224039937e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0456162606485994,0.00481447344282319,-0.0550526285965328,-0.0361798927006659,3.21656632180064e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.055424459569804,0.00585768083858962,-0.0669055140134396,-0.0439434051261683,3.52230370505063e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0537730597494717,0.00568718976167009,-0.064919951682345,-0.0426261678165983,3.87099234279518e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0409903154117456,0.00433756319375492,-0.0494919392715052,-0.0324886915519859,4.04933052977004e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0696375444193038,0.00736913765901989,-0.0840810542309828,-0.0551940346076248,4.07491561559187e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL32,Interleukin-32,42119,0.043762900777684,0.00464416159825293,0.0346603440451082,0.0528654575102597,5.0752036893131e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.031599892576303,0.00335566799207091,-0.038177001840762,-0.0250227833118441,5.3917094672619e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0483629811070863,0.0051444167855115,-0.0584460380066888,-0.0382799242074838,6.46639269259788e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0439003981102693,0.0046704682434401,-0.0530545158674119,-0.0347462803531267,6.55592313592697e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0656847617799345,0.00698958489197215,-0.0793843481681999,-0.0519851753916691,6.64915958876515e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0425459942395016,0.00452930252708413,-0.0514234271925864,-0.0336685612864167,6.73554483078557e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3,Galectin-3,42196,-0.0290130159160836,0.00309078880805333,-0.0350709619798681,-0.0229550698522991,7.14403679702855e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0464319171081672,0.00494638597659835,-0.0561268336223,-0.0367370005940345,7.14733893906515e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELP,P-selectin,42217,-0.0546585638336188,0.00583201748876067,-0.0660893181115897,-0.0432278095556479,8.20944365220121e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0575523274894595,0.00614489507476174,-0.0695963218359925,-0.0455083331429265,8.96386541497419e-21
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.0227674072515955,0.00243476733311383,-0.0275395512244986,-0.0179952632786924,1.03068550991647e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0957860630032421,0.0102594138848531,-0.115894514217554,-0.0756776117889301,1.14991657489555e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0308001295711729,0.00329799745806752,-0.0372642045889852,-0.0243360545533606,1.15837977425296e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0217808320950753,0.00233315796815675,-0.0263538217126625,-0.0172078424774881,1.19401545599542e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0501725486429604,0.00538490966514975,-0.0607269715866539,-0.0396181256992669,1.3742284635739e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPO,Myeloperoxidase,42137,-0.0437495218179929,0.0046958217491195,-0.0529533324462671,-0.0345457111897186,1.38300525350273e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.109789551090676,0.0117880399943438,-0.13289410947959,-0.0866849927017619,1.42144073270705e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0875420120970338,0.00942002866903613,-0.106005268288345,-0.069078755905723,1.73124909082723e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.088494520836222,0.00955898182346677,-0.107230125210217,-0.0697589164622271,2.47278483645456e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.048092743176542,0.00519781818067874,-0.0582804668106724,-0.0379050195424117,2.52543149775917e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0922177817341419,0.00996773372815607,-0.111754539841328,-0.072681023626956,2.53492069605773e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0533778863414253,0.00577749323601321,-0.0647017730840112,-0.0420539995988394,2.85098544144656e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0435335117401178,0.00471082836683834,-0.0527667353391209,-0.0343002881411146,2.87983460173928e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0815803436636102,0.00883161273175738,-0.0988903046178547,-0.0642703827093658,2.97742821489313e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0583789401866215,0.00632631338571859,-0.0707785144226299,-0.045979365950613,3.16570429056947e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0809020338861487,0.00878519386937959,-0.0981210138701327,-0.0636830539021647,3.87249906536419e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0772675359572651,0.00840485090956818,-0.0937410437400187,-0.0607940281745114,4.36271332702464e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0289642841066984,0.003155757571763,-0.0351495689473538,-0.0227789992660429,5.00851546685875e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NBN,Nibrin,41913,-0.0520654617215732,0.00567766792000971,-0.0631936908447922,-0.0409372325983542,5.40485815254851e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.04972033782278,0.00542868448540348,-0.0603605594141708,-0.0390801162313891,5.9816500853985e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0280914762312682,0.00306699368589484,-0.0341027838556221,-0.0220801686069143,6.12536161508274e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0310892329454628,0.00339927983885198,-0.0377518214296127,-0.024426644461313,6.73953375383274e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0644948534271556,0.00707242657269481,-0.0783568095096374,-0.0506328973446738,8.86533229205741e-20
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0693102004998609,0.00761979784408395,-0.0842450042742654,-0.0543753967254563,1.06795356980754e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0452527038024053,0.00497658495469307,-0.0550068103136037,-0.0354985972912069,1.09796598654485e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNST,Consortin,42145,-0.103489108248324,0.0113908788356215,-0.125815230766142,-0.0811629857305062,1.17607452797907e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN3,CCN family member 3,42299,-0.0322298906059379,0.0035484049971393,-0.039184764400331,-0.0252750168115449,1.19974020662929e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0665896182117906,0.00734477771300507,-0.0809853825292805,-0.0521938538943006,1.39866843811161e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.0326638198575737,0.0036032056214107,-0.0397261028755387,-0.0256015368396087,1.45144208022455e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0954499397281562,0.0105458379414002,-0.116119782093301,-0.0747800973630117,1.60700791216426e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0249639057437723,0.00275963116234218,-0.0303727828219629,-0.0195550286655816,1.68086895358698e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLIN3,Perilipin-3,42145,-0.0404336952893592,0.00448207249273444,-0.0492185573751187,-0.0316488332035997,2.10744831671432e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0760047787008078,0.00843501566986705,-0.0925374094137472,-0.0594721479878684,2.32021195545492e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0512814473225568,0.00570041778451076,-0.0624542661801979,-0.0401086284649157,2.71053506615671e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0467860498549029,0.00520220246503731,-0.056982366686376,-0.0365897330234297,2.77439435675595e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GET3,ATPase GET3,39958,-0.0510573433805374,0.00568117909677386,-0.0621924544102142,-0.0399222323508607,2.93860817638659e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP10,Caspase-10,41839,-0.0668394627556745,0.00744953272141056,-0.0814405468896392,-0.0522383786217098,3.2900878128222e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A14,Protein S100-A14,39934,-0.0489383251407088,0.00545402779602469,-0.0596282196209172,-0.0382484306605004,3.34217759558949e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0319476398793815,0.00356055370178189,-0.038926325134874,-0.024968954623889,3.36092769951492e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0559149534451861,0.00623431731054551,-0.0681342153738553,-0.0436956915165169,3.39042023820667e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0684858140386464,0.00764581231148226,-0.0834716061691517,-0.0535000219081412,3.84471750135973e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGN,Secretagogin,41913,-0.0415599481644952,0.00464155504732747,-0.0506573960572571,-0.0324625002717334,3.88184471250653e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCN2,CCN family member 2,42146,-0.0528390555552678,0.0059039760820741,-0.0644108486761331,-0.0412672624344026,4.02097799811343e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0459002111242475,0.00513853973158229,-0.0559717489981488,-0.0358286732503462,4.82713124277196e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.025654560342551,0.00287262227213263,-0.031284899995931,-0.0200242206891711,4.88272588288505e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.069685250633391,0.00780293305194763,-0.0849789994152083,-0.0543915018515736,4.9056676853996e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.050987977013613,0.00571959876294369,-0.0621983905889826,-0.0397775634382434,5.66007927392842e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0720470308446508,0.00809090472853741,-0.0879052041125841,-0.0561888575767175,6.04307496811292e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0992101541802154,0.0111722971181157,-0.121107856531722,-0.0773124518287086,7.51394668273664e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.106735274164592,0.0120184307660984,-0.130291398466145,-0.0831791498630391,7.62589473573642e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0591854939216588,0.00666813257830044,-0.0722550337751277,-0.0461159540681899,7.80260872539316e-19
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0786029851704241,0.00888599566269585,-0.096019536669308,-0.0611864336715402,1.0438591234055e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0559008374678901,0.00632005963872516,-0.0682881543597914,-0.0435135205759887,1.05065176262206e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.037515152871617,0.00424217727492571,-0.0458298203304714,-0.0292004854127626,1.06602981543788e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0562487968760129,0.00637522992627003,-0.0687442475315021,-0.0437533462205236,1.24925226920229e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0715282686763593,0.00810714039133582,-0.0874182638433775,-0.0556382735093411,1.28179258661405e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0438401972420266,0.00497491398753861,-0.0535910286576022,-0.0340893658264509,1.37447319351796e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSA,Arylsulfatase A,42137,-0.041514877354192,0.00471114213120426,-0.0507487159313524,-0.0322810387770317,1.37670139264636e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0907672950445411,0.0103119207066758,-0.110978659629626,-0.0705559304594566,1.50666168595389e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN2,Matrilin-2,42144,-0.0272628241834271,0.00309833453771954,-0.0333355598773574,-0.0211900884894968,1.54308081940901e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDN1,Endothelin-1,39638,-0.0271668430981611,0.00308775096231596,-0.0332188349843004,-0.0211148512120218,1.59601624437325e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.0247914764216589,0.00282059372952888,-0.0303198401315355,-0.0192631127117823,1.68207287061579e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR2,Complement receptor type 2,42217,-0.0428979142407477,0.00488068071858338,-0.0524640484491711,-0.0333317800323242,1.68279494276546e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.074971638854197,0.00854245886498541,-0.0917148582295684,-0.0582284194788256,1.93004066632134e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0579179251938212,0.00660851625290645,-0.0708706170495179,-0.0449652333381246,2.15127368570849e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.0366648854976647,0.0041849037485107,-0.0448672968447457,-0.0284624741505837,2.15890299130607e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0800102207885575,0.00913442978527175,-0.0979137031676901,-0.0621067384094248,2.24555685664396e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZN,Kazrin,39930,-0.09664809613869,0.011043203323038,-0.118292774651844,-0.0750034176255356,2.39621674219225e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0286832300521855,0.00327835989214786,-0.0351088154407953,-0.0222576446635757,2.44933228669588e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0177064519768115,0.002024491085412,-0.021674454504219,-0.013738449449404,2.46699233722559e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00841048151771551,0.000961952688171879,0.00652505424889863,0.0102959087865324,2.52850529733812e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0577833943545934,0.00661224146008099,-0.0707433876163521,-0.0448234010928346,2.63541946834336e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK14,Kallikrein-14,42262,0.0422959503454577,0.00484393618725612,0.0328018354184357,0.0517900652724797,2.79614418145964e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB8,Serpin B8,42296,-0.0533095090972507,0.00611235947755283,-0.0652897336732542,-0.0413292845212472,3.05594559025847e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0585350696204206,0.00670955051159173,-0.0716857886231404,-0.0453843506177009,3.05622068469971e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNA4,Plexin-A4,42119,-0.0733198734090375,0.00840973743835101,-0.0898029587882055,-0.0568367880298695,3.14589745445549e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0712248805580284,0.00818434685910287,-0.08726620040187,-0.0551835607141868,3.69211694407331e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LARP1,La-related protein 1,39919,-0.057007660020665,0.00655790793260472,-0.0698611595685702,-0.0441541604727597,4.01671385777411e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0288196990928768,0.00331647049943536,-0.0353199812717701,-0.0223194169139835,4.04323875338418e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0807713474298008,0.00929262103307623,-0.0989848846546302,-0.0625578102049714,4.05071503850022e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0227562295577318,0.00262754287877397,0.0176062455153348,0.0279062136001288,5.20976392839317e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.102097253403857,0.0118155324244031,-0.125255696955687,-0.078938809852027,6.1955367297983e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6,Interleukin-6,42070,-0.0674947831125142,0.00781226090455565,-0.0828068144854433,-0.0521827517395852,6.27056039616484e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPN,Asporin,39958,0.0252525087068725,0.00292517496202937,0.0195191657812949,0.03098585163245,6.78254116743402e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0384553306790889,0.00445979251592963,-0.047196524010311,-0.0297141373478668,7.25224453772237e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0484641539025931,0.00562150447551353,-0.0594823026745996,-0.0374460051305866,7.35157026463075e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0568938730972441,0.006597526308735,-0.0698250246623647,-0.0439627215321235,7.38516336813781e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0756165669893953,0.00876928822966364,-0.092804371919536,-0.0584287620592546,7.39600367708554e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAN,Neurocan core protein,42249,0.0337385228298238,0.00391378370326189,0.0260675067714305,0.0414095388882171,7.39713756448354e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0358088111614189,0.0041590150880544,0.0276571415888322,0.0439604807340055,8.1107022346431e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM3,Dynamin-3,39934,-0.050012089166671,0.00580796912526405,-0.0613957086521885,-0.0386284696811534,8.20272300192132e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0822443697250799,0.00957027464746525,0.063486631416048,0.101002108034112,9.36181638975382e-18
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0626713691779223,0.00730909128034379,-0.0769971880873961,-0.0483455502684485,1.10467990442717e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0375622114678032,0.00438131187456852,-0.0461495827419576,-0.0289748401936489,1.11298761302963e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0346200467167193,0.00404077589735671,0.0267001259579002,0.0425399674755385,1.1684805523851e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.0209284597955435,0.00244348207807931,-0.0257176846685789,-0.016139234922508,1.22406647133926e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0530849456401566,0.00621784975072479,-0.0652719311515772,-0.040897960128736,1.51891983343218e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0276167072120646,0.00323574140273673,0.0212746540627006,0.0339587603614286,1.54891910281369e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.0229030419179905,0.00268782248516425,-0.0281711739889124,-0.0176349098470685,1.74888632333107e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0470020534384913,0.00551568875367202,-0.0578128033956884,-0.0361913034812941,1.77744716122812e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0521209394124853,0.00613068043012708,-0.0641370730555344,-0.0401048057694362,2.06180035577499e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.0654384253403363,0.00770221901487599,-0.0805347746094932,-0.0503420760711793,2.16452184610864e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.020413915565456,0.00240514126746356,-0.0251279924496845,-0.0156998386812274,2.32906761368067e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC1,Syndecan-1,42145,-0.0359517379993242,0.00423686555262334,-0.0442559944824659,-0.0276474815161824,2.36994195003109e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0701772765273934,0.00828018100098096,-0.0864064312893161,-0.0539481217654707,2.64133667998999e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL19,Interleukin-19,41756,-0.0650934597498596,0.00768273821926559,-0.0801516266596202,-0.0500352928400991,2.65082003041167e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0238120692772376,0.00281435330044226,0.0182959368083708,0.0293282017461044,2.92232035161642e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0545667407975647,0.00645238210856545,-0.0672134097303529,-0.0419200718647764,3.03284339015586e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0270111082326159,0.00319767810010349,-0.0332785573088187,-0.0207436591564131,3.35018444271838e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPOCK1,Testican-1,42016,0.0230171688736978,0.0027265016874146,0.0176732255663652,0.0283611121810304,3.43664982965283e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.0441719085141793,0.00523616447312073,-0.054434790881496,-0.0339090261468627,3.61389387179712e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0562150381077238,0.00666208392549926,-0.0692727226017023,-0.0431573536137452,3.61789336922244e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.0195142241675597,0.00231443375934656,-0.0240505143358789,-0.0149779339992404,3.75280577803785e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAB2,Disabled homolog 2,42262,-0.0974667391257975,0.0115917810442183,-0.120186629972465,-0.0747468482791297,4.57011486714172e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADA,Adenosine deaminase,42296,-0.0312168792042698,0.00371376124272641,-0.0384958512400135,-0.023937907168526,4.66818022907074e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0782107631368247,0.00931156997557423,-0.0964614402889502,-0.0599600859846992,4.93693228252742e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0498168068014675,0.00593249650283346,-0.0614444999470211,-0.0381891136559139,5.02065044783714e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0207344997376052,0.00246963534362055,-0.0255749850111015,-0.015894014464109,5.10291786112842e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0607793746549687,0.00724392830530123,-0.0749774741333591,-0.0465812751765783,5.41956335642067e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0508387408308685,0.00605901646158836,-0.0627144130955817,-0.0389630685661554,5.42068436640231e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0445621967972626,0.00531357445429024,-0.0549768027276715,-0.0341475908668538,5.6014460766539e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.041302436218152,0.00492651127947907,-0.050958398325931,-0.0316464741103731,5.73429403540112e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0392367737899127,0.00468262662652719,-0.048414721977906,-0.0300588256019194,5.86089083018741e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.0510044510139743,0.00608992351491415,-0.062940701103206,-0.0390682009247426,6.06249162553716e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0430721560017696,0.00515249033044584,-0.0531710370494435,-0.0329732749540958,7.03516806532311e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0635756214144226,0.00760763533996676,-0.0784865866807575,-0.0486646561480878,7.06729414068398e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0606052601382479,0.00725318177598359,-0.0748214964191757,-0.04638902385732,7.13544030860962e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.050005310141315,0.00598567708137893,-0.0617372372208177,-0.0382733830618123,7.35693813141312e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0548379969219681,0.00657277179560283,-0.0677206296413496,-0.0419553642025865,7.93238441210863e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.108126168141525,0.0129683097351015,-0.133544055222324,-0.0827082810607259,8.29953690586081e-17
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0522301354724504,0.00628114880949826,-0.064541187139067,-0.0399190838058338,1.0004257106775e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0468813576878758,0.00563864512040807,-0.0579331021238756,-0.0358296132518759,1.01242850870155e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0444724915495803,0.0053543562090996,-0.0549670297194155,-0.0339779533797451,1.10570894279943e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.06628799625516,0.00798179859400735,-0.0819323214994144,-0.0506436710109056,1.11252979291371e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD7,T-cell antigen CD7,39636,-0.0390703942173336,0.00471220276859722,-0.0483063116437842,-0.0298344767908831,1.24981216005683e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0416046927007923,0.00502358006145507,-0.0514509096212442,-0.0317584757803404,1.34849679934338e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0388347746211768,0.00469108350348228,-0.0480292982880021,-0.0296402509543516,1.39166760690173e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0682255599980567,0.00824559374813244,-0.0843869237443963,-0.0520641962517172,1.43795657645793e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI2,Serpin I2,39930,-0.0503536751024204,0.00608611290400147,-0.0622824563942632,-0.0384248938105775,1.4458020401686e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASAH1,Acid ceramidase,39876,-0.041101950974538,0.00496965505086565,-0.0508424748742347,-0.0313614270748414,1.48258217803162e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0607795068413047,0.00734993721244465,-0.0751853837776962,-0.0463736299049132,1.49664627877086e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK2,Docking protein 2,42145,-0.106146994897227,0.0128571455980902,-0.131347000269484,-0.0809469895249704,1.64655917261284e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0758648979808348,0.00921155326596941,-0.0939195423821348,-0.0578102535795347,1.98399612402915e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.06827227421738,0.00829923415455691,-0.0845387731603115,-0.0520057752744484,2.10940494511845e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0283227787495605,0.00344393781199572,0.0215726606380489,0.0350728968610721,2.14723224758937e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.0232392111461026,0.00282638976605714,-0.0287789350875746,-0.0176994872046306,2.22124832352727e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEPR,Leptin receptor,42145,0.0270313816170945,0.00329037316647787,0.0205822502107979,0.0334805130233911,2.30713547800666e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.095259024219523,0.01159827768154,-0.117991648475341,-0.0725263999637046,2.38973147645391e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0616751098625179,0.00752165510390737,-0.0764175538661763,-0.0469326658588595,2.67004350505749e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15,Interleukin-15,42119,-0.0282186011317014,0.00344414470729564,-0.0349691247580008,-0.0214680775054019,2.77058087098122e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAL,Galanin peptides,42185,0.0569332989001936,0.00696712090618261,0.0432777419240757,0.0705888558763115,3.30764511730254e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0212535908246474,0.00260231963132439,-0.0263541373020432,-0.0161530443472516,3.43383566523548e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0321419898552787,0.00393513976710661,-0.0398548637988077,-0.0244291159117498,3.47807124634716e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0430757272112672,0.00527687630571031,-0.0534184047704594,-0.032733049652075,3.62248675332831e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS1,Galectin-1,42145,-0.029900859330106,0.00366408948459574,-0.0370824747199136,-0.0227192439402983,3.62837871454366e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0543892589963203,0.00667252343502256,-0.0674674049289646,-0.0413111130636761,3.91821957876981e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0551519811574062,0.00676635210086133,-0.0684140312750944,-0.041889931039718,3.92427408890428e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.0550644352878575,0.00676141439611349,-0.0683168075042399,-0.041812063071475,4.22743647496097e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0390363486584037,0.00479602436918779,-0.0484365564220117,-0.0296361408947956,4.31997204355065e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0486100949778546,0.00598291701541962,-0.0603366123280771,-0.0368835776276322,4.87354880286757e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.046521976544451,0.00572829263311754,-0.0577494301053614,-0.0352945229835407,5.01000054135712e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0289583529003001,0.00356615934096,-0.0359480252085817,-0.0219686805920185,5.13063551836789e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0816063453768561,0.0100580389550918,-0.101320101728836,-0.0618925890248761,5.34724597944735e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSB,Cathepsin B,42153,0.0430368996088458,0.00530489252733734,0.0326393102552646,0.0534344889624269,5.37491092253502e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA10,Annexin A10,41839,-0.0691479318724913,0.00855180588890567,-0.0859094714147464,-0.0523863923302362,6.71120737342275e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0613983557462381,0.00760027669955314,-0.0762948980773623,-0.046501813415114,7.11299134415101e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0461853214077334,0.00572436345969494,-0.0574050737887355,-0.0349655690267313,7.86592076789672e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0261321485456458,0.00324012193688971,-0.0324827875419496,-0.019781509549342,8.08025461650911e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0470298766620481,0.00583419106330879,-0.0584648911461333,-0.0355948621779629,8.34109657686202e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0439987826724087,0.00546073609556155,-0.0547018254197094,-0.0332957399251081,8.46415840141334e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0560781206042158,0.00695976543815859,-0.0697192608630067,-0.042436980345425,8.56891070933493e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0457242467298781,0.00568165143811114,-0.056860283548576,-0.0345882099111803,9.29256334560936e-16
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0936083887880916,0.0116640261491145,-0.116469880040356,-0.0707468975358272,1.09580640965742e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.0369514213721053,0.00460439763652162,-0.0459760407396877,-0.0279268020045229,1.11566559637456e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0575807823469135,0.00717739230037047,-0.0716484712556396,-0.0435130934381874,1.12080905840725e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN2,Centrin-2,41839,-0.0570553467082208,0.00711636781137127,-0.0710034276185085,-0.0431072657979331,1.16945945845915e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0644172161407969,0.00803509863020042,-0.0801660094559897,-0.0486684228256041,1.17379855879782e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.0310725421240608,0.00387781492374166,-0.0386730593745944,-0.0234720248735271,1.22970429225212e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL8,Interleukin-8,42035,-0.0567771021164475,0.00709714887431651,-0.0706875139101078,-0.0428666903227871,1.34571426488842e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.0911890112388088,0.011414145006522,-0.113560735451592,-0.0688172870260257,1.49050107155581e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0650206529723217,0.00814834614378951,-0.0809914114141492,-0.0490498945304943,1.61313659234231e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0724058714142792,0.0090840666095517,-0.0902106419690006,-0.0546011008595579,1.7298884294981e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.060734012723175,0.00763020670343882,-0.0756892178619151,-0.0457788075844349,1.86053274411412e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO3,R-spondin-3,42262,-0.0233428926611052,0.00293989371680063,-0.0291050843460344,-0.0175807009761759,2.17801395394908e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0358731842847805,0.00451695700977871,-0.0447264200239468,-0.0270199485456143,2.18260543727554e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0441394048086895,0.00555989702067872,-0.0550368029692197,-0.0332420066481592,2.19985267464929e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.021339650956592,0.00269110149982341,-0.0266142098962459,-0.0160650920169381,2.40836319410392e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0266020618322053,0.00335639577735509,-0.0331805975558212,-0.0200235261085893,2.44359983750303e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0792776679353939,0.0100154166703826,-0.0989078846093438,-0.0596474512614441,2.65217923258149e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0572028449053621,0.00724397685125397,-0.0714010395338199,-0.0430046502769043,3.08681898017053e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0347635808794259,0.00440674783356796,0.0261263551256327,0.0434008066332191,3.28546370424678e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.023699736757771,0.00300516352496215,-0.0295898572666968,-0.0178096162488452,3.35313188145563e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0337291547726729,0.00427657558594387,-0.0421112429211229,-0.0253470666242229,3.38052743336742e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCTN3,Tectonic-3,39958,-0.0252021356136158,0.00319827940277565,-0.0314707632430561,-0.0189335079841755,3.57506285649733e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.0252341030188488,0.00320396073706062,-0.0315138660634876,-0.0189543399742099,3.63719396495696e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0274448761513733,0.00348533053295136,-0.0342761239959579,-0.0206136283067886,3.73632457167585e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.0432158656491112,0.00549348775284001,0.0324486296535448,0.0539831016446776,3.91504514177099e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.0384101638025509,0.00488533195998498,-0.0479854144441214,-0.0288349131609803,4.05136805124907e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0573210757210669,0.00730381528633451,-0.0716365536822825,-0.0430055977598513,4.61409618877731e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.032476952619476,0.00413870709476891,-0.0405888185252231,-0.024365086713729,4.65225378953392e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0623445856028074,0.00796161075719786,-0.0779493426869152,-0.0467398285186996,5.29788154231571e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0471748587056684,0.00602710807777854,-0.0589879905381143,-0.0353617268732224,5.36460541159906e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0458894415087391,0.00586452806205676,-0.0573839165103703,-0.0343949665071078,5.53102224701583e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL4,Myosin light chain 4,39638,-0.0424235823983176,0.00542150569767947,-0.0530497335657694,-0.0317974312308658,5.53751861446285e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0777301597746787,0.00993936032571388,-0.0972113060130779,-0.0582490135362795,5.65903512027331e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0541943677437409,0.00693220972798,-0.0677814988105817,-0.0406072366769001,5.8527328850174e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0891644652158369,0.0114072247293916,-0.111522625685444,-0.0668063047462294,5.91199145075428e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0300170486313053,0.00384055789972255,-0.0375445421147615,-0.0224895551478491,5.95652780864894e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNG,Interferon gamma,41913,-0.0932105233729437,0.0119407949239897,-0.116614481423964,-0.0698065653219238,6.33960921357623e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.120026427471047,0.0153862187072261,-0.150183416137211,-0.0898694388048844,6.68563272566573e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.0247873967689408,0.00318497665602408,-0.031029951014748,-0.0185448425231336,7.62534919967311e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.036305461515578,0.00467251815801837,-0.0454635971052939,-0.027147325925862,8.54464837338002e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0590516294604593,0.00760093381836468,-0.0739494597444541,-0.0441537991764646,8.60574806968607e-15
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPSE,Heparanase,39866,-0.0777055676133733,0.0100327234595823,-0.0973697055941546,-0.0580414296325919,1.03598725036918e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.0289490899473591,0.00373867754799828,-0.0362768979414357,-0.0216212819532825,1.03858961428777e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2,Complement C2,42199,-0.0183022063610741,0.00236488577657098,-0.0229373824831532,-0.013667030238995,1.07119081018019e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.0443784361175946,0.00573597908045575,-0.0556209551152879,-0.0331359171199013,1.10548625176617e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0405264665357865,0.0052402854745811,-0.0507974260659655,-0.0302555070056076,1.13598764327583e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0331134022557214,0.00428515003225099,-0.0415122963189334,-0.0247145081925095,1.18955053020661e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0551619934734036,0.00714077608581725,-0.0691579146016054,-0.0411660723452017,1.21516827707117e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALCAM,CD166 antigen,42310,-0.015882695095087,0.00205783978292508,-0.0199160610696201,-0.0118493291205538,1.2617795695158e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.0224010940307911,0.00290283213389403,-0.0280906450132234,-0.0167115430483588,1.29116516405938e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0538493302226587,0.0069884876549323,-0.067546766026326,-0.0401518944189914,1.39339203287269e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH7,Protocadherin-7,39930,-0.0283329983519679,0.00367630141661454,-0.0355385491285324,-0.0211274475754034,1.39638032182134e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0311804936160894,0.00404787000878087,-0.0391143188332999,-0.0232466683988789,1.4239789732389e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.0576472605423129,0.00748448625423788,-0.0723168536006191,-0.0429776674840066,1.42909364242022e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0448595527695608,0.00582761743255502,-0.0562816829373686,-0.033437422601753,1.48050958171046e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0580640290606186,0.00754467160014784,-0.0728515853969083,-0.0432764727243288,1.50216403171108e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0446771494540949,0.00580443862542878,-0.0560538491599353,-0.0333004497482545,1.5074823457148e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0304345718517959,0.00395910738112547,-0.0381944223188018,-0.02267472138479,1.6319039031635e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0608663974994968,0.0079207647096589,-0.0763910963304283,-0.0453416986685654,1.64324806860388e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0642072583865711,0.00835666145304888,-0.0805863148345469,-0.0478282019385953,1.68077765644347e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0360506856863852,0.00469941510457637,0.0268398320814155,0.0452615392913549,1.84183004772184e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0827347162862674,0.0108184386382698,-0.103938856017276,-0.0615305765552586,2.21839431813648e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0431894218032249,0.00565035863832914,-0.05426412473435,-0.0321147188720998,2.25325977221086e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.04860995994219,0.00636241122283633,-0.0610802859389493,-0.0361396339454308,2.31412238198731e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0546664654289441,0.00715986549384612,-0.0686998017968825,-0.0406331290610057,2.43726847587671e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX8,Syntaxin-8,42119,-0.0381839919523257,0.00500396176906926,-0.0479917570197015,-0.02837622688495,2.48975690718922e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0324974555940174,0.00426401571548406,-0.0408549263963662,-0.0241399847916686,2.711257601689e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0797745975721048,0.0104695363974092,-0.100294888911027,-0.0592543062331827,2.74500051351313e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.0338094942201383,0.00444148359851582,-0.0425148020732293,-0.0251041863670473,2.87017982199038e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMPR2,GMP reductase 2,39736,-0.053244492421967,0.00699914217142639,-0.0669628110779628,-0.0395261737659713,3.02461120060191e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0607949252113957,0.00799438046256428,-0.0764639109180217,-0.0451259395047697,3.08121278975402e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0659319250995845,0.00868212154403759,-0.0829488833258982,-0.0489149668732708,3.34524128104406e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.027891757044331,0.00368036674222189,-0.0351052758590859,-0.0206782382295761,3.71901281834475e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0322616797494414,0.00425746664814309,-0.0406063143798018,-0.0239170451190809,3.74792118495782e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0865662100009,0.0114356467026929,-0.108980077538178,-0.0641523424636218,3.97671551491912e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0232611183496251,0.00307537874536786,-0.0292888606905461,-0.0172333760087041,4.17148442822005e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0344249508716342,0.00455323817204478,-0.0433492976888419,-0.0255006040544264,4.27767817203489e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0426652888014054,0.00564435130443743,-0.0537282173581028,-0.0316023602447081,4.32943979660201e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0392759595725971,0.00520415422708243,0.0290758172875156,0.0494761018576787,4.79195558705093e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0354935697904826,0.00470699319726204,-0.0447192764571162,-0.026267863123849,4.97686907681503e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0353616613348145,0.00469239383904804,-0.0445587532593487,-0.0261645694102804,5.15256371101368e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0604572245849972,0.008025303598526,-0.0761868196381082,-0.0447276295318863,5.25986347227453e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0612355581474657,0.00812928407835649,-0.0771689549410444,-0.045302161353887,5.28549074573149e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0598116490167885,0.00794155428577898,-0.0753770954169153,-0.0442462026166617,5.33419542607884e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0463396871683252,0.00616116806252933,-0.0584155765708827,-0.0342637977657678,5.83532138167467e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0524454671934515,0.0069784291248895,-0.0661231882782349,-0.0387677461086681,6.10240668347315e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.0356847386967598,0.0047551037518735,-0.0450047420504319,-0.0263647353430878,6.55229161849433e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0380457559629562,0.00506877830721867,-0.0479805614451048,-0.0281109504808077,6.55832817478944e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0604240826626053,0.00805609366605741,-0.0762140262480778,-0.0446341390771327,6.83652610163436e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0335258130398356,0.00447160609265939,0.0247614650982232,0.042290160981448,6.91129730596971e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.0260653561033472,0.00347621386682362,-0.0328787352823215,-0.0192519769243729,6.9614125779873e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.021540794450888,0.00287373258961561,-0.0271733103265346,-0.0159082785752414,6.9954795359487e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0235119767433232,0.00313833490209505,0.0173608403352169,0.0296631131514295,7.20900947695399e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPO,Lactoperoxidase,41647,-0.0481218046702576,0.0064317403046575,-0.0607280156673863,-0.0355155936731288,7.79257852398085e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0508740852975075,0.00681557862265639,-0.0642326193979141,-0.037515551197101,8.99842985592978e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0378346237801285,0.00507353303493901,-0.0477787485286089,-0.027890499031648,9.4789843412382e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0403846348998725,0.00541672619024043,-0.0510014182327438,-0.0297678515670013,9.49922572991955e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0258118193772655,0.00346226911411563,-0.0325978668409322,-0.0190257719135989,9.62629925034792e-14
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0369246741115275,0.00495715483467548,-0.0466406975874915,-0.0272086506355636,1.01064496516006e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0761134286711239,0.0102217256920412,-0.0961480110275248,-0.0560788463147231,1.03182595044766e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAP,Prosaposin,39886,-0.0223262801013373,0.00299894760375687,-0.0282042174047007,-0.0164483427979738,1.04232582946058e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP3,Stromelysin-1,42137,0.0386224030068515,0.00519354388074226,0.0284430570005966,0.0488017490131063,1.09502389795753e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0396771366864165,0.00533414885167032,-0.0501320684356904,-0.0292222049371427,1.09522935195943e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0316442806887679,0.00425686989044382,-0.0399877456740378,-0.0233008157034981,1.11879758656002e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0803773259796396,0.0108192090996647,-0.101582975814982,-0.0591716761442968,1.1716975768985e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0442363467135136,0.00596468145500058,-0.0559271223653148,-0.0325455710617125,1.29174208884879e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGMN,Legumain,42185,-0.0281695260861835,0.00380080620564559,-0.0356191062492488,-0.0207199459231182,1.32292817396602e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0513433575449394,0.00693051963343534,-0.0649271760264726,-0.0377595390634061,1.35519276266146e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.09902659004169,0.0133675157169889,-0.125226920846988,-0.0728262592363917,1.35773572058638e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0253329994233873,0.00342352497817126,-0.032043108380603,-0.0186228904661717,1.44445274776683e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0452006978403401,0.00610769395586071,-0.0571717779938271,-0.0332296176868531,1.4515544950234e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0285453334741718,0.00385985367396722,-0.0361106466751475,-0.020980020273196,1.49368320363154e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX4,Syntaxin-4,42070,-0.045658249059807,0.00617466871953057,-0.0577605997500869,-0.033555898369527,1.50381280723801e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0231082521234318,0.00312510051334015,-0.0292334491295785,-0.0169830551172851,1.52061932372965e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0803890514700114,0.0108819482587321,-0.101717670057126,-0.0590604328828966,1.58482274238873e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0606805508992268,0.00822143040807698,0.044566547299396,0.0767945544990577,1.66519766704123e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.102225056672014,0.0138496526187265,-0.129370375804718,-0.0750797375393104,1.68321023351528e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.0199656642987037,0.00270617499885844,-0.0252697672964662,-0.0146615613009412,1.70263537786881e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0115239715246595,0.00156263692458425,0.00846120315247437,0.0145867398968446,1.76189860684424e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.034338489065392,0.00465799175077914,-0.0434681528969191,-0.0252088252338649,1.78124037741058e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.0167042634307052,0.00226588999077341,-0.0211454078126211,-0.0122631190487893,1.79722618689266e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0338956308454337,0.00460256640024425,-0.0429166609899124,-0.024874600700955,1.88122510230745e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.0368069721020566,0.0049986035748614,-0.0466042351087849,-0.0270097090953282,1.89801949524596e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0707520309699038,0.00961563709823724,-0.0895986796824488,-0.0519053822573588,1.99530226859812e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPL,Periplakin,39657,-0.025025685511924,0.00340195448289084,-0.03169351629839,-0.018357854725458,2.02516893645696e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0210048270335386,0.00285937485937997,0.0154004523091538,0.0266092017579233,2.18283535014038e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0343453403918844,0.00467681150600818,0.0251787898401084,0.0435118909436605,2.19551198202735e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0278138318560878,0.00378734363991225,-0.0352370253903158,-0.0203906383218598,2.19599576280636e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0806128124427357,0.0109802075186996,-0.102134019179387,-0.0590916057060844,2.23128217357796e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0419827909519365,0.00572073827048676,-0.0531954379620906,-0.0307701439417825,2.30388054995826e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0350510741220632,0.00479139907074936,-0.0444422163007319,-0.0256599319433945,2.7396465684645e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0279666331671313,0.00382400209521601,-0.0354616772737546,-0.0204715890605079,2.75137601965707e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0387924556247981,0.00530974177790722,-0.0491995495094962,-0.0283853617400999,2.9068822654901e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0436440132413228,0.00598883640476998,-0.055382132594672,-0.0319058938879736,3.37190534475145e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.031744903934402,0.00435680999164398,-0.0402842515180242,-0.0232055563507798,3.40354681664807e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0168636116225674,0.00231647944535921,-0.0214039113354714,-0.0123233119096633,3.52458185092738e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0370292013951057,0.00508898468464833,-0.0470036113770165,-0.027054791413195,3.65590897440705e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0315916655349479,0.00434387564031872,-0.0401056617899726,-0.0230776692799232,3.71567811141077e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0273754856120022,0.00376569886783332,-0.0347562553929555,-0.0199947158310489,3.84437736239752e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0407917586768392,0.00561422619671762,-0.0517956420224057,-0.0297878753312727,3.91273156332814e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C8B,Complement component C8 beta chain,39979,0.023027185600286,0.00317720968643662,0.0167998546148703,0.0292545165857018,4.516368419633e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0399797578131996,0.00551762004879283,-0.0507942931088336,-0.0291652225175657,4.57729358431098e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0278039970588668,0.00383828408887726,-0.0353270338730663,-0.0202809602446674,4.64383006453694e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.0403450998586753,0.00557657960857768,-0.0512751958914876,-0.0294150038258631,4.97350744375258e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0224818939375489,0.00311180523856864,-0.0285810322051434,-0.0163827556699543,5.35219824167373e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0292002642370938,0.00404779968624189,-0.0371339516221279,-0.0212665768520597,5.72820541453551e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.0215969549598938,0.00299417372370814,-0.0274655354583617,-0.0157283744614258,5.82065230172052e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLVRB,Flavin reductase,42137,-0.0479563462219288,0.00665995270965482,-0.0610098535328522,-0.0349028389110054,6.30632708820718e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0213647284314053,0.00296815531949294,0.0155471440051991,0.0271823128576115,6.42881726651349e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0418833697133951,0.00582243206412528,-0.0532953365590806,-0.0304714028677095,6.65146670340556e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0627646828212542,0.00872926888345267,-0.0798740498328214,-0.0456553158096869,6.82239688955342e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0333675544829671,0.00464154697622602,-0.0424649865563701,-0.0242701224095641,6.87493889889638e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0606213077404924,0.0084357375319085,-0.0771553533030331,-0.0440872621779517,7.00791399301735e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0382490004294762,0.00532395326535064,-0.0486839488295635,-0.027814052029389,7.11365877745399e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EREG,Proepiregulin,41997,-0.0601080304076704,0.00837515772235036,-0.0765233395434771,-0.0436927212718637,7.50387379691765e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0630046217173426,0.00880233286550009,-0.0802571941337228,-0.0457520493009625,8.62617367342495e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.0186154727630783,0.00260074794098225,-0.0237129387274035,-0.0135180067987531,8.72269950705979e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0500385875759941,0.006994923032649,-0.0637486367199862,-0.0363285384320021,8.9945111364865e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.0341319939272305,0.00477247247297466,-0.0434860399742609,-0.0247779478802002,9.10266943525599e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0295428032045649,0.00413530398733861,-0.0376479990197486,-0.0214376073893812,9.61715902560958e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0298876809100466,0.00418715648404664,-0.038094507618778,-0.0216808542013151,9.96575712559781e-13
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0205484772631633,0.00287924618053952,-0.0261917997770207,-0.0149051547493058,1.01542669475051e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0723412974711933,0.0101534533467782,-0.0922420660308785,-0.0524405289115081,1.09560609888514e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0537155207806317,0.0075485774936873,-0.0685107326682588,-0.0389203088930045,1.17836423517165e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMB,RGM domain family member B,42249,-0.020850940661624,0.00293089609590249,-0.0265954970095929,-0.0151063843136552,1.18185732052015e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0637874450155487,0.00896879634070973,-0.0813662858433398,-0.0462086041877576,1.19961992336296e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0460428147408211,0.00647744348460169,-0.0587386039706404,-0.0333470255110018,1.24635479664426e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.0202732880000213,0.00285286576585464,-0.0258649049010964,-0.0146816710989462,1.25133718852691e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD1,Polycystin-1,39958,-0.0203327576524358,0.00286223363264218,-0.0259427355724145,-0.0147227797324571,1.28623961283459e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASC3,Protein CASC3,39649,-0.0322907601896404,0.0045459991221029,-0.041200918468962,-0.0233806019103187,1.29476102634936e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0274322525897336,0.00386390974499196,-0.0350055156899179,-0.0198589894895494,1.32592733238999e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0319592761394628,0.00450271590615596,0.0231339529633971,0.0407845993155284,1.33054272059434e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0572890090199552,0.00807827156217278,-0.0731224212818138,-0.0414555967580965,1.40318633671906e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0254292044305714,0.0035898212557824,-0.0324652540919049,-0.0183931547692379,1.47309285140895e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.0226750967029106,0.00320122326432538,-0.0289494943009883,-0.0164006991048328,1.47703116732666e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0339067557946617,0.00478775835125032,-0.0432907621631123,-0.024522749426211,1.49130398893537e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0389312401442693,0.00550431031793959,-0.0497196883674309,-0.0281427919211077,1.60850946060404e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0512981795586771,0.0072548892651161,-0.0655177625183046,-0.0370785965990495,1.63219449509191e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0248939911470534,0.00352260894788617,0.0179896776091965,0.0317983046849103,1.66090843185863e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0712263437896711,0.0100931056461257,-0.0910088308560776,-0.0514438567232647,1.78579513784318e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAD,Chondroadherin,39736,0.0348768581058717,0.00494138424132742,0.02519174499287,0.0445619712188735,1.78812133946297e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0263228893005965,0.00372992887642474,-0.033633549898389,-0.019012228702804,1.79808164204618e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2,Brorin,41973,-0.0301518758879438,0.00427430389897241,-0.0385295115299297,-0.0217742402459578,1.82110866221369e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0243992210449788,0.00345919423722008,-0.0311792417499301,-0.0176192003400274,1.83066111553517e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.0176807827016812,0.00250679514885479,0.0127674642099258,0.0225941011934366,1.83367497179311e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0618044276956435,0.00876285570100412,-0.0789796248696116,-0.0446292305216755,1.85726056862383e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI3,Elafin,41966,-0.0414166690725408,0.00587688493925607,-0.0529353635534827,-0.0298979745915989,1.91249664732541e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0396691429468734,0.0056284480281091,0.0286373848117796,0.0507009010819673,1.92031551006944e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AZU1,Azurocidin,41751,-0.055465429906918,0.00787471653309709,-0.0708998743117883,-0.0400309855020477,1.9681799507202e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0517619334429345,0.00734969074473221,-0.0661673273026096,-0.0373565395832594,1.9767984107051e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.02803133508321,0.00398122221543408,-0.0358345306254608,-0.0202281395409592,2.00229965794816e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0894278913962571,0.0127000440926729,-0.114319977817896,-0.0645358049746183,2.01491221511544e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.049293750405237,0.00700362899339183,-0.063020863232285,-0.0355666375781891,2.06189598172411e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.0181753628965602,0.00258301048545691,-0.0232380634480558,-0.0131126623450647,2.06491434321084e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.037008964427989,0.00526114721528195,-0.0473208129699416,-0.0266971158860364,2.11850985243164e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0748818507489438,0.0106486184394469,-0.0957531428902598,-0.0540105586076278,2.132639775865e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0297584840862952,0.00423244898762244,0.0214628840705552,0.0380540841020352,2.15009537911451e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0497079826586011,0.00707973959210889,-0.0635842722591346,-0.0358316930580677,2.30517795344747e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0578845605589609,0.00824864259389421,-0.0740519000429935,-0.0417172210749282,2.367771325045e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0438244792235301,0.0062568545740428,-0.056087914188654,-0.0315610442584062,2.62405507706579e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0480037501037726,0.00685714595067852,-0.0614437561671025,-0.0345637440404427,2.69687239832386e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.0215459559757057,0.00308067862581305,-0.0275840860822993,-0.0155078258691122,2.7991132272506e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0306419974952746,0.00438286579954929,-0.0392324144623912,-0.022051580528158,2.8810801490458e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0207158931365993,0.00296681933370015,-0.0265308590306516,-0.014900927242547,3.06674796768117e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0400976584226865,0.00574947402507847,-0.0513666275118403,-0.0288286893335327,3.25420658632124e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.029930805117174,0.00429467444179831,-0.0383483670230987,-0.0215132432112493,3.33349813782104e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0386865902437688,0.00555402604329045,-0.0495724812886181,-0.0278006991989195,3.45847607309134e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.048203485844544,0.00692977472723691,-0.0617858443099283,-0.0346211273791596,3.66179083336172e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0350720747354976,0.00504136506515334,-0.0449531502631981,-0.0251909992077971,3.67012019304599e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0405492916606592,0.00584253672762559,-0.0520006636468053,-0.029097919674513,4.13001347911123e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0621581988287789,0.00896587902887611,-0.0797313217253761,-0.0445850759321818,4.35775685203138e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0380450490747237,0.00549464893869886,-0.0488145609945734,-0.0272755371548739,4.62773508759571e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0492994829310581,0.0071275128592298,-0.0632694081351485,-0.0353295577269677,4.82533937476148e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0901426274231396,0.0130363726182697,-0.115693917754948,-0.0645913370913311,4.95468108747896e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRKL,Crk-like protein,42143,-0.0762201594356507,0.0110373023507193,-0.0978532720430604,-0.0545870468282409,5.21886736387572e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDA,Cytidine deaminase,39946,-0.0346046772029608,0.00501464920286765,-0.0444333896405814,-0.0247759647653402,5.44969012397429e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0297399320561523,0.00431190801346959,-0.0381912717625527,-0.021288592349752,5.54094850616181e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.0255368764086461,0.00370274663041997,-0.0327942598042692,-0.0182794930130229,5.5582193787728e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLG4,Disks large homolog 4,39929,-0.0523622738017524,0.00759524361732989,-0.067248951291719,-0.0374755963117858,5.70929353989544e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0149950250182813,0.0021762362130798,-0.0192604479959177,-0.0107296020406449,5.81293415285797e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.0751781045453887,0.0109111128838283,-0.0965638857976922,-0.0537923232930853,5.82420194122809e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0316648920563291,0.00459504416167212,-0.0406711786132065,-0.0226586054994518,5.83776276222608e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0356389384213483,0.00517454224192156,-0.0457810412155146,-0.025496835627182,5.99217794635265e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0675682013790402,0.00981154721927069,-0.0867988339288108,-0.0483375688292697,6.01653503657859e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.0193471520087484,0.00281177777357209,-0.0248582364449497,-0.0138360675725471,6.21587700114882e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0277596975894219,0.0040394890958881,-0.0356770962173625,-0.0198422989614812,6.60532744539614e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0574923110858253,0.00837807611890801,0.0410712818927656,0.073913340278885,7.07393642547796e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0624138378282749,0.00911500603631419,-0.0802792496594507,-0.0445484259970991,7.84789458387866e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0467747018361118,0.00683260972505901,-0.0601666168972274,-0.0333827867749961,7.93984362599998e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0664143944694742,0.00971425463268968,-0.085454333549546,-0.0473744553894024,8.45130949531243e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0260135892578813,0.00380881886161807,-0.0334788742266528,-0.0185483042891099,8.86482507675177e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAT,Catalase,39827,-0.0376034858192686,0.0055108272712915,-0.048404707271,-0.0268022643675373,9.3380054083934e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0338593052623913,0.00496335775244189,-0.0435874864571774,-0.0241311240676052,9.37677446030141e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0234093510869407,0.00343235516618099,-0.0301367672126555,-0.016681934961226,9.47915373737793e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.033007544890315,0.00484261767768647,-0.0424990755385805,-0.0235160142420495,9.75037464352862e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0404547036921176,0.0059355529097259,-0.0520883873951804,-0.0288210199890548,9.7894468855787e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0273020730674128,0.00400641220281524,-0.0351546409849307,-0.019449505149895,9.86209024812478e-12
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID1,Nidogen-1,42189,-0.0257019535981601,0.00377287498567905,-0.033096788570091,-0.0183071186262291,1.00092982366687e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.019377435200214,0.00284766431094955,-0.0249588572496751,-0.0137960131507528,1.06356332477977e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0398963740131102,0.00587652679337228,-0.0514143665281199,-0.0283783814981005,1.18651472989786e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0382753813152513,0.00564101077654775,-0.0493317624372849,-0.0272190001932177,1.21706519390126e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0675581316467671,0.00995839710207838,-0.0870765899668407,-0.0480396733266934,1.22683702519207e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0626452399880701,0.00924016655374922,-0.0807559664334186,-0.0445345135427216,1.26601778081146e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0474182947468801,0.00699981492804045,-0.0611379320058394,-0.0336986574879208,1.31271333055428e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0245169815817572,0.00363227649693643,0.0173977196477618,0.0316362435157526,1.54130052569183e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.0193016921372526,0.00286115222544398,0.0136938337753824,0.0249095504991228,1.58000054466374e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPF,Centromere protein F,39757,-0.0383923128416561,0.00569260982337446,-0.04954982809547,-0.0272347975878421,1.61436705632102e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0872914029532699,0.0129511237742972,-0.112675605550892,-0.0619072003556475,1.64929770593515e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0244505126706419,0.00362752400714905,-0.031560459724654,-0.0173405656166298,1.65882030629961e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0566055391882422,0.00840065418183316,-0.0730708213846352,-0.0401402569918493,1.66871180182005e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0625175796159989,0.00927929642755762,-0.0807050006140118,-0.044330158617986,1.69351331536468e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD276,CD276 antigen,42123,-0.0253149897480582,0.00375939214879416,-0.0326833983596947,-0.0179465811364216,1.71963962681154e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.0109092953647774,0.00162048163385019,0.00773315136243105,0.0140854393671238,1.75237309034154e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR2,Folate receptor beta,42249,-0.0204248487055089,0.00303775318626903,-0.0263788449505962,-0.0144708524604216,1.84249522127178e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.0225736919160263,0.00335879582627024,-0.029156931735516,-0.0159904520965367,1.89676132592593e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLB1,Beta-galactosidase,42016,-0.0302450612922015,0.00450390432126895,-0.0390727137618887,-0.0214174088225144,1.95238124204164e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0437173220611953,0.00651022674161424,-0.0564773664747592,-0.0309572776476314,1.95269395035075e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST5,Cystatin-D,41846,-0.0394335631184341,0.00587472281620921,-0.0509480198382042,-0.0279191063986641,1.99227179366505e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0420538201957174,0.0062697499598722,0.0297651102743679,0.0543425301170669,2.06077184228738e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0297408779066572,0.00446254904332497,-0.0384874740315741,-0.0209942817817402,2.78129399926603e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0387153032629999,0.00581405877069209,-0.0501108584535564,-0.0273197480724434,2.86558394255469e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.032727669935168,0.00491744318593963,-0.0423658585796097,-0.0230894812907263,2.93470129955778e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0426310918490708,0.00640867539147491,-0.0551920956163616,-0.03007008808178,3.02704690888496e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.0169445153780976,0.00255149335719073,-0.0219454423581914,-0.0119435883980038,3.23471592153099e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STC2,Stanniocalcin-2,42113,-0.0166762954442336,0.0025114783442903,-0.0215987929990426,-0.0117537978894246,3.25599623475233e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.046664946250353,0.00702699223023064,-0.0604378510216051,-0.032892041479101,3.26220392827495e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN5,Contactin-5,42170,0.0256885917022254,0.00387156514401037,0.018100324019965,0.0332768593844857,3.3636722642305e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0528222989828968,0.00796288788691773,-0.0684295592412555,-0.037215038724538,3.42607945476174e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.063441675927351,0.00957011259160856,-0.0821990966069038,-0.0446842552477982,3.50457051649051e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0173980557145563,0.00262450855213414,-0.0225420924767392,-0.0122540189523734,3.50562113354766e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0217872596037159,0.00328829105852411,-0.0282323100784231,-0.0153422091290086,3.5887749641094e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0344247497661237,0.00520576283615592,-0.0446280449249893,-0.0242214546072581,3.9120072835915e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0424932671908655,0.00642514248808952,-0.055086546467521,-0.0298999879142101,3.92440255052831e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0260192762543891,0.00394252535730214,-0.0337466259547013,-0.018291926554077,4.30989722738366e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0358548678552994,0.00543720255089468,-0.046511784855053,-0.0251979508555459,4.43302254872326e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0202934561616526,0.00307858877916588,-0.0263274901688177,-0.0142594221544874,4.54150164269145e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0348493930772186,0.00529275153642636,-0.0452231860886142,-0.0244756000658229,4.73692701095088e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0466393375495216,0.00708432950869075,-0.0605246233865555,-0.0327540517124877,4.80630390032628e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0745312892436499,0.0113375011476574,-0.0967527914930584,-0.0523097869942413,5.11711880341737e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0205593169535461,0.00312777031469026,-0.026689746770339,-0.0144288871367532,5.1417846540476e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0236759702776798,0.00360395486046873,-0.0307397218041985,-0.0166122187511611,5.23504549210612e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.0183251061165939,0.00278956188010665,-0.023792647401603,-0.0128575648315849,5.24534645359004e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.0147459668890074,0.00224490763631923,-0.0191459858561931,-0.0103459479218217,5.26450476554197e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0384849609659204,0.00586745036448044,-0.049985163680302,-0.0269847582515387,5.60983565060403e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7,Complement component C7,39722,-0.0229749638333029,0.00350299612607365,-0.0298408362404073,-0.0161090914261986,5.67011238754246e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0231502107610987,0.00353160034309273,-0.0300721474335605,-0.0162282740886369,5.76419106768827e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0249436648383615,0.00381080312304839,-0.0324128389595364,-0.0174744907171867,6.19354806963213e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0249855857151423,0.00381964849800529,-0.0324720967712327,-0.017499074659052,6.31847971196558e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0416335409636091,0.0063668206090506,-0.0541125093573483,-0.02915457256987,6.41434741869362e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0320004757714469,0.00489417554301769,-0.0415930598357616,-0.0224078917071322,6.44163272200923e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.01136467387166,0.00173807415988072,-0.0147712992250262,-0.00795804851829377,6.47301130986576e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.0485750709125282,0.00743618807954018,-0.0631499995484269,-0.0340001422766294,6.70947356858988e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0235154600810342,0.00360678536456067,-0.0305847593955731,-0.0164461607664953,7.29371445367437e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0156088592630165,0.0023959848175081,-0.0203049895053324,-0.0109127290207007,7.54322594486616e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.0114139127603786,0.00175190903105232,-0.0148476544612411,-0.00798017105951606,7.56919402080408e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.042343773637987,0.00650533617427188,-0.0550942325395599,-0.0295933147364141,7.83359947362421e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0356339999173355,0.00547541639993142,-0.0463658160612011,-0.0249021837734699,7.89010304478741e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0588327218221237,0.00907858660881689,-0.0766267515754048,-0.0410386920688426,9.53610132394592e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0326202742189378,0.00503469148503684,-0.04248826952961,-0.0227522789082656,9.54719933426969e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.042627922642152,0.00658350147094191,-0.0555315855251981,-0.0297242597591058,9.87557261711139e-11
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100G,Protein S100-G,39934,0.0333932737364872,0.00516024635011953,0.0232791908902529,0.0435073565827215,1.01200009783547e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0403653242183489,0.00625649067422305,-0.0526280459398261,-0.0281026024968717,1.14329260354353e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0300675065631121,0.00466927138730847,-0.0392192784822367,-0.0209157346439875,1.24034442663202e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPT,Dermatopontin,42310,-0.0170947618356328,0.00265636853494311,-0.0223012441641213,-0.0118882795071443,1.27252946906686e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.0181516502319786,0.00282358460831953,-0.0236858760642849,-0.0126174243996724,1.33960665475455e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.011820402893159,0.00183907617030916,-0.015424992186965,-0.00821581359935306,1.34188279340089e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0489322086150419,0.00761932611134977,-0.0638660877932875,-0.0339983294367964,1.38961640097742e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0458833673994353,0.00714527454715051,-0.0598881055118503,-0.0318786292870203,1.3954811374984e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0283627082147461,0.0044169473456599,-0.0370199250122395,-0.0197054914172527,1.40658247711245e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0395079299936765,0.00615363063708436,-0.0515690460423619,-0.0274468139449912,1.41613551245148e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0291796418489815,0.00454709642202597,-0.0380919508361524,-0.0202673328618106,1.44487776489177e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.0149122092408367,0.00232642057861563,-0.0194719935749233,-0.0103524249067501,1.50409987294217e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0599295498444277,0.00935950779923196,-0.0782741851309223,-0.0415849145579331,1.58310019870899e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK11,Kallikrein-11,42062,-0.0215889773943566,0.00337526101663148,-0.0282044889869543,-0.0149734658017589,1.64514622223857e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.0155710645586911,0.00243937897062651,-0.020352247341119,-0.0107898817762631,1.79003840679408e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0624080768614771,0.00977971556307355,-0.0815763193651012,-0.0432398343578529,1.81267919682736e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.030362567125879,0.00475967234462701,-0.0396915249213479,-0.0210336093304101,1.84021828244393e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IST1,IST1 homolog,39850,-0.0660585270357149,0.0103810863589153,-0.0864054562991889,-0.0457115977722408,2.05066423728469e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0447260185740818,0.00703594062482985,-0.0585164621987483,-0.0309355749494153,2.1261287943043e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0354943868471659,0.00558469032231935,-0.0464403798789118,-0.02454839381542,2.14336689948191e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.0190049105493342,0.00298997121884013,-0.0248652541382609,-0.0131445669604076,2.14698093500118e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.0240316384961371,0.00378242851247582,-0.0314451983805897,-0.0166180786116845,2.1854895239141e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0267418548638351,0.00420978469986492,-0.0349930328755704,-0.0184906768520999,2.18827425899287e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0314477537481951,0.00495337412075514,-0.0411563670248752,-0.021739140471515,2.24028162770865e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MILR1,Allergin-1,41913,-0.0339649458901524,0.00535242939958789,-0.0444557075133446,-0.0234741842669601,2.28579870107518e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.048696914201139,0.00767968603706728,-0.0637490988337909,-0.0336447295684872,2.37183645769718e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDK2,Protein sidekick-2,39736,-0.026244898333194,0.00414723478074901,-0.0343734785034621,-0.0181163181629259,2.57417914773051e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0263167147825505,0.0041625139674362,-0.0344752421587255,-0.0181581874063756,2.65824433153467e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0373219910533433,0.00590554576831818,-0.048896860759247,-0.0257471213474397,2.71808279870882e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17C,Interleukin-17C,41913,-0.0467925846954664,0.00741823917962004,-0.0613323334875217,-0.0322528359034112,2.92030341640329e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0606523146878577,0.00961556824217556,-0.0794988284425218,-0.0418058009331937,2.94010350190566e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.0583271960339385,0.00924860119059227,-0.0764544543674993,-0.0401999377003776,2.95872993108622e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0372716114592737,0.00591309006093339,-0.0488612679787031,-0.0256819549398443,3.0070296724342e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0675183465045403,0.010715229589772,-0.0885201965004934,-0.0465164965085873,3.04531714378869e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.031241960587204,0.00495918439775881,-0.0409619620068112,-0.0215219591675967,3.07458590944611e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.033129820036187,0.00526586499340644,-0.0434509154232636,-0.0228087246491104,3.24460206602413e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0849246729237505,0.0135248659245356,-0.11143341013584,-0.0584159357116607,3.50820998978659e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0428253121478972,0.0068301042297693,-0.056212316438245,-0.0294383078575493,3.739554932755e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MBL2,Mannose-binding protein C,39826,0.0725624375913288,0.0115908176061005,0.0498444350833719,0.0952804400992857,3.98165356432848e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRAXIN,Draxin,42016,-0.027822838630347,0.00444504627102691,-0.0365351293215598,-0.0191105479391343,3.9850525039251e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0386342827613637,0.00617506290339728,-0.0507374060520224,-0.0265311594707051,4.08166193375338e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0296134960393563,0.00473860502178206,-0.0389011618820491,-0.0203258301966635,4.26810303468671e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0606319016978441,0.00970597750860381,-0.0796556176147076,-0.0416081857809806,4.31271152799611e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.0213619417720001,0.00342383117373302,-0.0280726508725168,-0.0146512326714834,4.53075672357242e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0679662540945154,0.0109160696846019,-0.0893617506763351,-0.0465707575126958,4.91894969695094e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0228135771116377,0.00367410224997644,-0.0300148175215915,-0.0156123367016839,5.51478325683371e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0498535760183216,0.00803200309192624,-0.065596302078497,-0.0341108499581461,5.56285458914277e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0382874077397417,0.00617185039817268,-0.0503842345201602,-0.0261905809593233,5.68243322530789e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH12,Protocadherin-12,39934,-0.0166809031635791,0.00269017026093628,-0.0219536368750142,-0.011408169452144,5.81737022409436e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0484717701000266,0.00781742762646608,-0.0637939282479001,-0.0331496119521531,5.82868698205759e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.036208087520627,0.0058436687389962,-0.0476616782490595,-0.0247544967921944,5.9881867206526e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBD,Thrombomodulin,42145,-0.0191572646942102,0.00309742547606561,-0.0252282186272988,-0.0130863107611216,6.39291906953127e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST7,Cystatin-F,42148,-0.0611302178144985,0.00988658381009787,-0.0805079220822904,-0.0417525135467067,6.4640056688384e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0429278634415312,0.00696202449950081,-0.0565734314605528,-0.0292822954225096,7.25007033723582e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMS,Spermine synthase,39586,-0.0417955746631357,0.00677999129833144,-0.0550843576078653,-0.0285067917184061,7.31660559094925e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F10,Coagulation factor X,39990,-0.0188376378143649,0.00305672958091776,-0.0248288277929637,-0.0128464478357661,7.39422763159154e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0581296154263845,0.00943280744261102,-0.0766179180139022,-0.0396413128388669,7.40347398186161e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.0394352551813478,0.00640157732496007,-0.0519823467382695,-0.026888163624426,7.46677379697431e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0438549941646841,0.00712104510558245,-0.0578122425716257,-0.0298977457577425,7.55111324314822e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.0221957041017026,0.0036188941995363,-0.0292887367327938,-0.0151026714706115,8.84601627593758e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.030570754758927,0.00498709191494275,-0.0403454549122148,-0.0207960546056392,9.08163253680017e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN4,Nectin-4,42181,-0.0215539186856517,0.00351917676101018,-0.0284515051372317,-0.0146563322340718,9.33587965612153e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0381518038081614,0.00623011891910924,-0.0503628368896155,-0.0259407707267073,9.38865969541748e-10
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0228030453136678,0.00373150710677717,-0.0301167992429511,-0.0154892913843846,1.01807737222337e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CETN3,Centrin-3,39930,-0.0506187043383513,0.00829717023074009,-0.0668811579906019,-0.0343562506861007,1.09039124572e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.056958561438273,0.00933750528908283,-0.0752600718048753,-0.0386570510716706,1.09536640091588e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.038197635377073,0.0062701362938344,-0.0504871025129884,-0.0259081682411576,1.15130703441776e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX7,Syntaxin-7,39657,-0.0315222194188759,0.00517500602005853,-0.0416652312181906,-0.0213792076195612,1.15763010940738e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEXN,Nexilin,39990,-0.0448028980282748,0.00735634809955156,-0.0592213403033958,-0.0303844557531537,1.16281417761263e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0443766009618981,0.00728631490268066,-0.0586577781711522,-0.030095423752644,1.16397763442562e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRELP,Prolargin,42123,-0.0149135430424756,0.00245103706564903,-0.0197175756911477,-0.0101095103938035,1.19947285514565e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.0537580056550075,0.00885939985572093,-0.0711224293722205,-0.0363935819377945,1.33802549171357e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.0188477979566685,0.0031090187128831,-0.0249414746339194,-0.0127541212794177,1.3777779411465e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0714676292480772,0.0117889107467013,-0.0945738943116117,-0.0483613641845427,1.37786494482248e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0207536316329121,0.00342655724999918,0.0140375794229138,0.0274696838429105,1.4345932543127e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0428535770592081,0.0070867474139603,-0.0567436019905703,-0.0289635521278459,1.52376169634718e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0757254243215607,0.0125271924992081,-0.100278721620009,-0.0511721270231129,1.54222141894768e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.0349818573642315,0.00579735707785759,-0.0463446772368324,-0.0236190374916306,1.64005470404516e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0272747066045411,0.00452127941682182,0.0184129989475704,0.0361364142615119,1.66597882336251e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0372881396620586,0.00618496923935319,-0.0494106793711909,-0.0251655999529264,1.6944489508572e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGA4,Pepsin A-4,39990,-0.04765436260356,0.00790411021907618,-0.0631464186329493,-0.0321623065741707,1.70024955408794e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0363901001365886,0.00603866939129065,-0.0482258921435182,-0.0245543081296589,1.7233898196344e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAX,Protein max,41839,-0.0669418610388527,0.0111099311807467,-0.0887173261531161,-0.0451663959245892,1.73161936024212e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0147076282370473,0.00244281323088995,-0.0194955421695916,-0.00991971430450297,1.78018458196113e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0550081563725982,0.00913676195213116,-0.0729162097987753,-0.0371001029464211,1.78333979096602e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA12,Serpin A12,41751,-0.0682661307205242,0.0113565594153084,-0.0905249871745287,-0.0460072742665196,1.89073829355861e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10,Interleukin-10,41913,-0.0483814262403775,0.00804921461207999,-0.0641578868800543,-0.0326049656007008,1.8955137490825e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMH,Granzyme H,41900,-0.0494900229514325,0.00823406132969419,-0.0656287831576331,-0.0333512627452319,1.89905114013376e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD226,CD226 antigen,39657,-0.026989662860496,0.00449183778495773,-0.0357936649190132,-0.0181856608019789,1.93026031187386e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.044997711631322,0.00751708857003981,-0.0597312052286001,-0.030264218034044,2.20358872181014e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.0196816655251753,0.00328939026972697,-0.0261288704538402,-0.0132344605965105,2.2417412958073e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0367147101792897,0.00614252601978312,-0.0487540611780646,-0.0246753591805147,2.32857032015121e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKD2,Polycystin-2,39575,-0.0368492583462405,0.00616830656914002,-0.048939139221755,-0.0247593774707261,2.387372060618e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0521997783477175,0.00874967217139645,-0.0693491358036545,-0.0350504208917804,2.49365980367569e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.024522241108318,0.00411599383371204,-0.0325895890223936,-0.0164548931942424,2.62009445579194e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0261768646267126,0.0043958482881125,0.0175610019820121,0.034792727271413,2.67986102177105e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0215295629224495,0.0036182625677021,-0.0286213575551456,-0.0144377682897534,2.75618292500153e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0753001464503043,0.012656672521778,-0.100107224592989,-0.0504930683076194,2.77009865582352e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.0167480689014794,0.00282183147281995,-0.0222788585882065,-0.0112172792147523,3.02337927883794e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0371383751665679,0.00626677117627771,-0.0494212466720722,-0.0248555036610635,3.1895268892363e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0512910999496925,0.00865664525000719,-0.0682581246397066,-0.0343240752596784,3.19786663015762e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0547442030142521,0.00925550640713691,-0.0728849955722404,-0.0366034104562638,3.41964610858971e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0228435413765868,0.00386372128825329,-0.0304164351015633,-0.0152706476516104,3.45640518429108e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DMD,Dystrophin,39638,-0.0319034853583618,0.00541831193417555,-0.0425233767493459,-0.0212835939673778,4.02076350993229e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.0144383273623526,0.00245338230678016,-0.0192469566836417,-0.00962969804106348,4.07343225733098e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0288501803015435,0.00491060368811895,-0.0384749635302566,-0.0192253970728303,4.34828560129623e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL34,Interleukin-34,41814,-0.0224481458393861,0.00382598829926509,-0.0299470829059457,-0.0149492087728265,4.53611218452554e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A12,Protein S100-A12,41910,-0.0451127940324338,0.00769426189321754,-0.0601935473431402,-0.0300320407217274,4.64869506275491e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRL,Prolactin,42249,-0.0450956650937564,0.00769777192737597,-0.0601832980714133,-0.0300080321160994,4.78475190792936e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB1,Calbindin,42070,-0.0277684415369158,0.00474067028715613,-0.0370601552997419,-0.0184767277740898,4.80873466265815e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0568661594039839,0.00971136116657397,-0.0759004272904689,-0.0378318915174989,4.86417340372321e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.040763356639288,0.00696423941465034,-0.0544132658920027,-0.0271134473865734,4.95796838096899e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.025278402372381,0.00432183081681797,-0.0337491907733442,-0.0168076139714177,5.06122320315459e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0150652246742702,0.00257655741705498,0.0100151721368424,0.0201152772116979,5.14160026819528e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.0186404104984707,0.00318856524054998,-0.0248899983699486,-0.0123908226269927,5.1510579325829e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.024153927238873,0.00413395994076241,-0.0322564887227674,-0.0160513657549787,5.27408693510556e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0244756618138146,0.00418982926916161,-0.0326877271813713,-0.0162635964462578,5.31176692717003e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK10,Kallikrein-10,42138,-0.0249418070081165,0.00428150099462423,-0.03333354895758,-0.016550065058653,5.82420278992389e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0276158031950889,0.00474202492233247,-0.0369101720428605,-0.0183214343473172,5.89188668164435e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TWF2,Twinfilin-2,39966,-0.0521354529843663,0.00896034397808566,-0.0696977271814142,-0.0345731787873185,6.09930355996869e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.0554755683446926,0.00954237297533531,-0.0741786193763498,-0.0367725173130354,6.27922046636214e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0514020028109869,0.00884406345946157,-0.0687363671915315,-0.0340676384304422,6.31329312730267e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.0261162009683275,0.00449386200356623,-0.0349241704953173,-0.0173082314413377,6.33009564558627e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0378179510444092,0.00651489551859241,-0.0505871462608503,-0.025048755827968,6.58564743360675e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0240673043409415,0.00415127715942004,-0.0322038075734048,-0.0159308011084782,6.90803476833416e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0549463511450387,0.0095020876448325,-0.0735704429289104,-0.036322259361167,7.52346470151085e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0399847727251615,0.00691518066172601,-0.0535385268221444,-0.0264310186281785,7.57532829587157e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0319607960446132,0.00552782593857904,-0.0427953348842282,-0.0211262572049983,7.59084669222583e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0479398064814399,0.00829362889854551,-0.0641953191225891,-0.0316842938402907,7.62181470879592e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.0139735675084125,0.00241745848305234,-0.0187117861351951,-0.00923534888162995,7.65440783493101e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0662322969153638,0.0114798454206362,-0.0887327939398107,-0.0437317998909169,8.165408174913e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0324085013431289,0.00562898328276255,-0.0434413085773436,-0.0213756941089143,8.76201061657781e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0240230346358246,0.00417735738517231,-0.0322106551107623,-0.0158354141608868,9.11690826477658e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0287600481272604,0.00500586770973879,-0.0385715488383485,-0.0189485474161724,9.41351498262519e-09
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.0196490102343787,0.00342937380532282,-0.0263705828928114,-0.012927437575946,1.02809391984924e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0260558443437986,0.00456000553088881,-0.0349934551843406,-0.0171182335032565,1.13136952819319e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASN,Vasorin,41975,0.0164200807082123,0.00287446880002343,0.0107861218601664,0.0220540395562583,1.13774413956377e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0477556405986329,0.00836935616142503,-0.0641595786750259,-0.0313517025222398,1.18118256982659e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0286688425860534,0.00502487127313993,-0.0385175902814077,-0.0188200948906992,1.18549930959924e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELOB,Elongin-B,39575,-0.0235780080822868,0.00413445680775484,-0.0316815434254863,-0.0154744727390874,1.20895225538623e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,-0.012897884962327,0.00226609157809646,-0.017339424455396,-0.00845634546925792,1.28389920389753e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0238992873977035,0.00420169160520924,-0.0321346029439136,-0.0156639718514933,1.31709814976637e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0187853235206258,0.00330357283663618,0.0123103207608189,0.0252603262804327,1.32453268179171e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0277064075249287,0.00487376240103226,0.0181538332189054,0.0372589818309519,1.33640311825612e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0445760848284564,0.00784050418516981,-0.0599434730313892,-0.0292086966255236,1.33814877898309e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.0373723301234921,0.00658666208967568,-0.0502821878192564,-0.0244624724277278,1.42971598999247e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPART,Spartin,39736,-0.046518516631864,0.00820328725580402,-0.0625969596532399,-0.0304400736104881,1.45742167926754e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0396281805852705,0.00699895095454788,-0.0533461244561843,-0.0259102367143566,1.52651358851563e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALB2,Calretinin,41839,-0.0174074034263931,0.00308005080822591,-0.0234443030105158,-0.0113705038422703,1.62183595070325e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0258666921229734,0.00458295258016391,-0.0348492791800947,-0.0168841050658522,1.70131983932237e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.0257029273414177,0.00455478782806415,-0.0346303114844234,-0.0167755431984119,1.71070758666394e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0487625180271427,0.0086450503536611,-0.0657068167203184,-0.0318182193339669,1.72936815187764e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0270702893691481,0.00479925913886474,0.0176637414569732,0.036476837281323,1.72973295698592e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0362123478827246,0.00643145332555474,-0.0488179964008119,-0.0236066993646373,1.83284791328007e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0497905158678547,0.00884381642062994,-0.0671243960522894,-0.03245663568342,1.84520753922361e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0444796960894286,0.00790674041974686,-0.0599769073121325,-0.0289824848667248,1.88682814137664e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN3,Calsyntenin-3,39929,-0.0178930985958763,0.00318673277127161,-0.0241390948275686,-0.0116471023641839,2.01337100401688e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPARC,SPARC,42181,-0.0410654406473796,0.00731750331429611,-0.0554077471434,-0.0267231341513592,2.0397648618056e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.0192509527190685,0.00343153287808809,-0.0259767571601212,-0.0125251482780159,2.06276127025621e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0387478556523272,0.00691905154536571,-0.052309196681244,-0.0251865146234105,2.18319598279158e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0227374493393287,0.00406479446383544,-0.0307044464884461,-0.0147704521902112,2.27536704035417e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C3,Complement C3,39445,-0.0271222587670963,0.00485138393252944,-0.036630971274854,-0.0176135462593386,2.31728161599851e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNXB,Tenascin-X,42137,0.015286722331487,0.00273476766930524,0.00992657769964872,0.0206468669633253,2.31764397545987e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0371642446051602,0.00664971122712675,-0.0501976786103286,-0.0241308105999918,2.3293976687893e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0497498854609278,0.00891362687871622,-0.0672205941432115,-0.032279176778644,2.43278941853022e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0198676162611814,0.00356197562583217,-0.0268490884878124,-0.0128861440345503,2.4846769587987e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRND,Prion-like protein doppel,39929,-0.0287030541661906,0.00514829742690821,-0.0387937171229307,-0.0186123912094506,2.52830585539075e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0368611826426596,0.00662293436552003,-0.0498421339990788,-0.0238802312862403,2.66019294192365e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0287460312261797,0.00517141011620327,-0.0388819950539381,-0.0186100673984213,2.78028614940532e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0689301752307622,0.0124271316892883,-0.0932873533417673,-0.0445729971197572,2.96487221743767e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNN,Tenascin-N,39966,-0.025223857687566,0.00454699922354797,-0.03413597616572,-0.016311739209412,2.96497752728466e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0681362648542742,0.0122879504524013,-0.0922206477409807,-0.0440518819675677,2.99589351147207e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.0168817324292259,0.0030508852254524,-0.0228614674711126,-0.0109019973873392,3.20035830964405e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGN,Biglycan,41820,0.0684593000186768,0.0123787446413326,0.0441969605216649,0.0927216395156886,3.25582347177063e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0279427755933497,0.00505646911262896,-0.0378534550541025,-0.018032096132597,3.34580904645175e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0187454419939363,0.00339338953002255,0.0120943985150921,0.0253964854727805,3.38608492306583e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0620105001859813,0.0112434317366342,-0.0840476263897844,-0.0399733739821782,3.55893801122175e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.0576193298733944,0.0104564874902162,-0.0781140453542181,-0.0371246143925707,3.64640120328077e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PF4,Platelet factor 4,39914,-0.0564247053944719,0.0102592570810058,-0.0765328492732433,-0.0363165615157006,3.88304340347821e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0504392447529595,0.00918059269492998,-0.0684332064350223,-0.0324452830708967,3.9979322572637e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0307151125216373,0.00559074393403431,-0.0416729706323445,-0.01975725441093,4.00361839100764e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0324951269064015,0.00591461231145739,-0.044087767036858,-0.020902486775945,4.01604447431215e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.0209694555424587,0.00382079428011629,0.0134806987534308,0.0284582123314867,4.13314634851907e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCN2,Ficolin-2,42116,-0.0232964380377825,0.00424917237139545,-0.0316248158857176,-0.0149680601898474,4.26682313068469e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0371629181021261,0.00678736033120348,-0.050466144351285,-0.0238596918529673,4.46285623849536e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0384956241686739,0.00704158033120471,-0.0522971216178352,-0.0246941267195127,4.66265558580127e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0281683433122304,0.00515247906694923,-0.0382672022834509,-0.0180694843410099,4.67592799217396e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENR,Density-regulated protein,39657,-0.0331395796504475,0.00606591050671536,-0.0450287642436096,-0.0212503950572854,4.77627576951483e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.039585461682938,0.00727746009149552,-0.0538492834622692,-0.0253216399036068,5.45527277035698e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0229934333947077,0.00423298740062721,-0.031290088699937,-0.0146967780894784,5.68865829858962e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0330789156929686,0.0060918420910955,-0.0450189261915158,-0.0211389051944214,5.73199556829666e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0433458013596403,0.00798524496406968,-0.0589968814892169,-0.0276947212300637,5.81238329416081e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0164089334439102,0.00302788788130721,-0.0223435936912723,-0.0104742731965481,6.10665382025762e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.048353532894745,0.00892396211913885,-0.0658444986482571,-0.0308625671412328,6.13681417283971e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0447468549270492,0.00826288581592964,-0.0609421111262713,-0.0285515987278271,6.2399486480405e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0206416928483777,0.00381856524258285,-0.0281260807238401,-0.0131573049729154,6.59309607567245e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0413231271789658,0.00765289765115445,-0.0563228065752285,-0.0263234477827031,6.79179879487403e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0390403455732172,0.00723310292658774,-0.0532172273093292,-0.0248634638371052,6.8977051946889e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0218838172850162,0.00405722519601059,-0.029835978669197,-0.0139316559008355,7.01459772016846e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX3,Syntaxin-3,39929,-0.0216373160530709,0.00401674582573189,-0.0295101378715054,-0.0137644942346364,7.31673912441574e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0362928146852158,0.00674055722122931,-0.0495043068388252,-0.0230813225316063,7.39910040058826e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0507769487822515,0.00943590648206354,-0.0692713254870961,-0.032282572077407,7.52095817920826e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0406948597891686,0.00756671289544231,-0.0555256170642355,-0.0258641025141016,7.67779141715299e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0669197548824326,0.0124432688831971,-0.0913085618934989,-0.0425309478713663,7.68600094021151e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0512162456130939,0.0095388502022336,-0.0699123920094717,-0.032520099216716,8.06760003504293e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.059315282838292,0.0110498381373707,-0.0809729655875386,-0.0376576000890454,8.12234736009573e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0186204713088918,0.00347029766915974,0.0118186878773387,0.0254222547404449,8.22332616752519e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0364006790193135,0.00679531323926465,-0.0497194929682722,-0.0230818650703548,8.63988918807914e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0785366025418036,0.0146788764399949,-0.107307200364194,-0.0497660047194136,8.92571121805194e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0321070084271799,0.00600305532960772,-0.043872996873211,-0.0203410199811488,9.01529836278655e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0409067632763501,0.00765167868817432,-0.0559040535051718,-0.0259094730475284,9.16025815818533e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0609845886468386,0.0114207852914479,-0.0833693278180766,-0.0385998494756007,9.45646872713528e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0298154107426738,0.00558925036669387,-0.0407703414613938,-0.0188604800239538,9.76961060239438e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FST,Follistatin,42166,0.0272209935099433,0.00510438756695992,0.0172163938787019,0.0372255931411848,9.82279898897104e-08
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0240308770401303,0.00451071058846106,-0.032871869793514,-0.0151898842867467,1.01196498243011e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.056833884092568,0.0106752757672995,-0.077757424596475,-0.035910343588661,1.03215710963019e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP1,Neuropilin-1,42230,0.0152285256732614,0.00286106030285549,0.00962084747966459,0.0208362038668581,1.03866731076082e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.064207316793431,0.0120638502831387,-0.0878524633483829,-0.040562170238479,1.04423851502588e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.0369390359385457,0.00694684786655688,-0.0505548577569972,-0.0233232141200943,1.07272956923496e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0460167209048958,0.0086579246309468,-0.0629862531815515,-0.02904718862824,1.08744368896101e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0379106974720461,0.00713790557928937,-0.0519009924074533,-0.023920402536639,1.10640658798272e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0352278595134284,0.00663320550094949,-0.0482289422952894,-0.0222267767315674,1.10889751864707e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.016502531377294,0.00310819902034381,-0.0225946014571679,-0.0104104612974202,1.11742395443447e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.0486368482916793,0.00917302449651423,-0.0666159763048472,-0.0306577202785114,1.16630194716693e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.0142506141339706,0.00268918518493655,-0.0195214170964462,-0.00897981117149492,1.18107180400409e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0506557670956858,0.00956824199355698,-0.0694095214030574,-0.0319020127883141,1.21421301960616e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0260381468397234,0.00491823744713026,-0.0356778922360988,-0.0163984014433481,1.21450020070208e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPON2,Spondin-2,42070,-0.0193535684369432,0.00365830673737825,-0.0265238496422045,-0.0121832872316818,1.24023273427445e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.0238264731077779,0.00450614434561224,-0.0326585160251779,-0.0149944301903779,1.25924679313595e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0339313873967213,0.00641795848608025,-0.0465105860294386,-0.021352188764004,1.26303897086617e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0431392407738281,0.00816508769457042,0.0271356688924701,0.0591428126551862,1.28799907848495e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.0146637053152965,0.00278182991033449,0.00921131869104093,0.0201160919395521,1.37979549620024e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLNK,B-cell linker protein,39657,-0.0232551539416224,0.00441431862811367,-0.0319072184527252,-0.0146030894305196,1.40419760804266e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA11,Annexin A11,42087,-0.036495586105358,0.00693453029935276,-0.0500872654920894,-0.0229039067186266,1.43991695232714e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROK1,Prokineticin-1,42119,-0.0273986910189801,0.00520635495268463,-0.037603146726242,-0.0171942353117182,1.44244929152938e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0368606064298741,0.00700966304574973,-0.0505995459995435,-0.0231216668602046,1.47845394525085e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.0214119415923169,0.00407383718397768,-0.0293966624729132,-0.0134272207117206,1.49927705159643e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTG,Protogenin,42262,-0.0134775417442224,0.0025737905326793,-0.0185221711882739,-0.00843291230017102,1.66117705939328e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.0194175131486272,0.00370962300955626,-0.0266883742473574,-0.0121466520498969,1.6851890072879e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLGN,Calmegin,39649,-0.0251961751265589,0.00481375785693401,-0.0346311405261496,-0.0157612097269683,1.68739554719844e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.022440595733481,0.00429230267894107,-0.0308535089842055,-0.0140276824827565,1.73820687665687e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0360868955581354,0.00690805070550457,-0.0496266749409243,-0.0225471161753464,1.77800866004512e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0368430297707686,0.00705250122218295,-0.0506659321662472,-0.02302012737529,1.78151073423888e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0559474070884131,0.0107363128740145,-0.0769905803214815,-0.0349042338553448,1.91189948158997e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0164420168978218,0.00315560263394726,-0.0226269980603585,-0.0102570357352852,1.91205501271567e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX2,Sorting nexin-2,39919,-0.0469228295396677,0.00901198178094564,-0.0645863138303211,-0.0292593452490142,1.95582927328085e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.0188779430619809,0.00363342437599868,-0.0259994548389383,-0.0117564312850235,2.07037217816546e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0272446610618972,0.00524437687273428,-0.0375236397324564,-0.016965682391338,2.07733366559718e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0239062190387274,0.00460904573527638,-0.0329399486798691,-0.0148724893975857,2.17746164958032e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0366505929018385,0.00706620541444412,-0.0505003555141489,-0.022800830289528,2.17791881348059e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0408877820317707,0.00788394336465671,-0.0563403110264978,-0.0254352530370435,2.18311049926147e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.0338470230621059,0.00652761752434174,-0.0466411534098158,-0.0210528927143961,2.18888175111143e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THBS4,Thrombospondin-4,42189,-0.0246831170761682,0.00476267846316104,-0.0340179668639639,-0.0153482672883726,2.21934615562517e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0269614985519615,0.00520908933669324,-0.0371713136518802,-0.0167516834520427,2.30851242211669e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.029061175984571,0.00561677449029713,-0.0400700539855534,-0.0180522979835886,2.32382932871128e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.0323280098853878,0.00625081432447527,-0.0445796059613593,-0.0200764138094162,2.35152581529745e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0287611136739098,0.00556301785891747,0.0178575986704315,0.039664628677388,2.37328060782394e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0494497922646281,0.00956742035830474,-0.0682019361669054,-0.0306976483623508,2.40027222942219e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XG,Glycoprotein Xg,42261,-0.0187041284384572,0.00362215212312513,-0.0258035465997825,-0.011604710277132,2.45365602746118e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0342900302311529,0.00664029350394119,-0.0473050054988776,-0.0212750549634282,2.46050801092481e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0631728376632532,0.0122414264040001,-0.0871660334150934,-0.0391796419114129,2.49689038031833e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.0112586733219259,0.00218776741793678,-0.015546697461082,-0.00697064918276983,2.69565080395543e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.0123637592231087,0.00240234018068332,-0.017072345977248,-0.00765517246896936,2.69766818535868e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BOC,Brother of CDO,41900,0.0125132286547848,0.0024335186442996,0.00774353211195757,0.017282925197612,2.75643959431627e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.0164105208822156,0.00319204295722948,-0.0226669250783853,-0.0101541166860458,2.77844914129839e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPBP,Platelet basic protein,39908,-0.0462903257378554,0.00901801415603862,-0.0639656334836911,-0.0286150179920197,2.89749118717265e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0322795251406781,0.00629043826690116,0.0199502661375518,0.0446087841438044,2.9134952396227e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LXN,Latexin,41960,0.0367600430735992,0.00716818838802508,0.02271039383307,0.0508096923141283,2.96587664327941e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.038743497447764,0.00756164106851897,-0.0535643139420611,-0.0239226809534668,3.03830882522046e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0370708171597383,0.00723582927880197,-0.0512530425461901,-0.0228885917732864,3.04482458203679e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A11,Protein S100-A11,42027,-0.0248251510809379,0.0048494018916278,-0.0343299787885284,-0.0153203233733474,3.11045136448542e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.0286919426576226,0.00560667351045293,-0.0396810227381104,-0.0177028625771349,3.13985916118548e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSV,Cathepsin L2,42200,0.0214609267760641,0.00419405488050634,0.0132405792102717,0.0296812743418566,3.14684310002772e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0253738915196123,0.00496284807674705,-0.0351010737500365,-0.015646709289188,3.22786240360635e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0375245614300859,0.00734613176825767,-0.0519229796958709,-0.0231261431643009,3.29952793548209e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.0353605164639217,0.00692605080355219,-0.048935576038884,-0.0217854568889594,3.35387516221851e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0477715483430468,0.00936088650885158,-0.0661188859003959,-0.0294242107856977,3.38292202278119e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0323817954817141,0.00634928042517658,-0.0448263851150602,-0.019937205848368,3.44076095157533e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0125218187650954,0.00245788631129806,0.00770436159495123,0.0173392759352396,3.54219965721697e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0476309230784545,0.00935158933058318,-0.0659600381663975,-0.0293018079905115,3.57588390873857e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0596577090463094,0.0117145428859203,-0.0826182131027133,-0.0366972049899055,3.57980846988562e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0273777316085392,0.0053840747858551,-0.0379305181888152,-0.0168249450282632,3.72730787549387e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.0118865325480306,0.00234436042211001,-0.0164814789753663,-0.00729158612069502,4.02470735022288e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0554722832569557,0.0109467733172078,-0.0769279589586829,-0.0340166075552285,4.09650855945287e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0397347426647978,0.00784228635286809,-0.0551056239164193,-0.0243638614131763,4.11185805173499e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0241574622269861,0.00477645205577853,-0.033519308256312,-0.0147956161976602,4.31172877394191e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0145085613036198,0.00287652065588788,-0.0201465417891601,-0.00887058081807961,4.63467854883982e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17A,Interleukin-17A,41877,-0.0226496234728345,0.00449477614994571,-0.0314593847267281,-0.0138398622189409,4.73879402576614e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0174135405270853,0.00345539973788765,-0.0241861240133451,-0.0106409570408255,4.74105592935019e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.0130434015380413,0.00259250510171986,-0.0181247115374122,-0.00796209153867034,4.95033901986079e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F12,Coagulation factor XII,39979,-0.0217737120708103,0.00434114482644574,-0.0302823559306439,-0.0132650682109766,5.36485773572579e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0457929042032218,0.0091319852764677,-0.0636915953450985,-0.0278942130613451,5.39587784187077e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0164476639810931,0.00328302945922962,-0.0228824017211831,-0.010012926241003,5.52988002073803e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.0212348309410517,0.00423976201782488,-0.0295447644959885,-0.012924897386115,5.56834930637977e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0176729773907987,0.00352895005263818,-0.0245897194939695,-0.0107562352876278,5.58272549587612e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0525395706002246,0.0105048884280914,-0.0731291519192838,-0.0319499892811654,5.77563345692412e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0344978476405957,0.00690313422080286,-0.0480279907133693,-0.0209677045678221,5.88409624852797e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0163396370543227,0.0032735019623458,-0.0227557009005205,-0.00992357320812494,6.08079804328019e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.0134344825392805,0.00269173981603613,-0.0187102925787113,-0.00815867249984972,6.09565810262551e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.051718836950479,0.010380542048094,-0.0720646993647432,-0.0313729745362148,6.37625409385354e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0335049934951247,0.00672831886691965,-0.0466924984742872,-0.0203174885159622,6.46468766109289e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0198430559429635,0.00398702209929676,0.0120284926283419,0.0276576192575852,6.54187246729784e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.0213822527995844,0.00429928182751514,-0.0298088451815141,-0.0129556604176547,6.65737477076775e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0179013678577351,0.00360511400301098,-0.0249673913036366,-0.0108353444118336,6.93430060826578e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.155747586612429,0.0313661166123539,-0.217225175172642,-0.094269998052215,6.93698466316e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP7,Caspase-7,39929,-0.044220415804872,0.00890992709693923,-0.0616838729148729,-0.0267569586948711,7.04038677428423e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0190264025464854,0.00383461345971735,-0.0265422449275314,-0.0115105601654394,7.09093733580155e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0318252986405397,0.00642695502033016,-0.0444221304803868,-0.0192284668006926,7.44185039781249e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.01385921742939,0.00280400552382417,0.00836336660269464,0.0193550682560854,7.79947439984421e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0396457238449446,0.00802176284389928,-0.0553683790189872,-0.023923068670902,7.83601974691555e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0314365470926305,0.00636212625151124,-0.0439063145455925,-0.0189667796396685,7.87636501137429e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0384278804502639,0.00778187861033339,-0.0536803625265173,-0.0231753983740105,8.00201664852448e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0161166546074278,0.00326685976181662,0.00971360947426718,0.0225196997405883,8.19107919001824e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0377204004738374,0.00764956613067511,-0.0527135500899606,-0.0227272508577142,8.2986056216954e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0473918987188479,0.00961222256203473,-0.066231854940436,-0.0285519424972599,8.30669551200538e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0364473716953223,0.00739934708747253,0.0219446514038761,0.0509500919867684,8.50270387779593e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0387830331234109,0.00787404332419975,-0.0542161580388424,-0.0233499082079794,8.51747279732978e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.0181128613637544,0.00368023678578276,-0.0253261254638886,-0.0108995972636202,8.68430069542699e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.0236273319238939,0.00480138133782325,-0.0330380393460275,-0.0142166245017604,8.73605001195122e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.047851641987373,0.00974708255591595,-0.0669559237969683,-0.0287473601777778,9.24552065922814e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.0171359040680054,0.00349289701488715,0.0102898259188266,0.0239819822171842,9.40750616417349e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0221100297347075,0.00450926613697143,-0.0309481913631715,-0.0132718681062435,9.56174954291257e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0244459751649942,0.0049862462944668,-0.0342190179021492,-0.0146729324278393,9.58689548022411e-07
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0211816129786506,0.00433320212070329,-0.0296746891352291,-0.0126885368220722,1.02948663900834e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0273900426545856,0.00561590640912002,-0.0383972192164608,-0.0163828660927104,1.08808637401616e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0297578139427993,0.00611899931094825,-0.0417510525922579,-0.0177645752933407,1.17065493706156e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0563200169004971,0.0115972663726678,-0.0790506589909261,-0.0335893748100682,1.20924440775127e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM3,Paralemmin-3,39575,-0.0388046699122272,0.00799629876593811,-0.0544774154934659,-0.0231319243309886,1.23387922047084e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0174722063016425,0.00360788160197066,0.01040075836178,0.024543654241505,1.29440149802179e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNC,Tenascin,42217,0.0245002870379556,0.00506172502043589,0.0145793059979013,0.03442126807801,1.31063124528641e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0220464092123009,0.00455723640081917,-0.0309785925579065,-0.0131142258666954,1.32848616588298e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNLY,Granulysin,42137,-0.0272928686199777,0.00564576428390632,-0.0383585666164341,-0.0162271706235213,1.3513655732468e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0310953970831564,0.00644913622565489,-0.0437357040854399,-0.0184550900808728,1.4393175669499e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0361870549362219,0.00752532011942948,-0.0509366823703037,-0.0214374275021401,1.53539494636981e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0246962502574882,0.00513777482752237,-0.0347662889194321,-0.0146262115955444,1.55051209077333e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0408543935473308,0.00850373561065823,-0.0575217153442209,-0.0241870717504407,1.56996686295678e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0222498911621655,0.00464317101560903,-0.0313505063527592,-0.0131492759715718,1.66913054970098e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB6,Serpin B6,42216,-0.0293519317185568,0.00612692587968876,-0.0413607064427468,-0.0173431569943668,1.67998222346347e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0247701506242087,0.00517331250662307,-0.0349098431371899,-0.0146304581112274,1.70179252627291e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17D,Interleukin-17D,41913,-0.0170895196665079,0.00356955043235905,-0.0240858385139316,-0.0100932008190841,1.70617761914051e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.00931331857061916,0.00194796970729492,0.00549529794432113,0.0131313391969172,1.76580642131421e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0281216584088397,0.00588324958639314,-0.0396528275981703,-0.0165904892195092,1.77615137608683e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0241540242546551,0.00505927194664707,-0.0340701972700834,-0.0142378512392268,1.82344749553589e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0520509546840991,0.010902653499307,-0.0734201555427407,-0.0306817538254574,1.82360082497614e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.0128253437155466,0.00269038855545259,-0.0180985052842337,-0.00755218214685955,1.88842967847814e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED8,Protein TMED8,39930,-0.0519531959641609,0.0109063205155623,-0.0733295841746631,-0.0305768077536588,1.9254209880223e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0258455809248467,0.00543293241474255,-0.0364941284577421,-0.0151970333919513,1.98777669483958e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NID2,Nidogen-2,42137,-0.0362785908698513,0.00762878858624963,-0.0512310164989006,-0.021326165240802,2.00011121703724e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.0102332315555206,0.00215283968962462,-0.0144527973471848,-0.00601366576385633,2.0258202020771e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0184029009939718,0.00387213517526179,-0.0259922859374849,-0.0108135160504587,2.02826375042197e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0342118799842392,0.00721464849893338,0.0200711689263298,0.0483525910421486,2.13784572996932e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.026641629789069,0.00561956370715213,-0.0376559746550871,-0.0156272849230508,2.15461658269707e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0418554097433504,0.00883547380590349,-0.0591729384029212,-0.0245378810837795,2.18940683915627e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0216282326562498,0.0045657724427179,-0.0305771466439769,-0.0126793186685227,2.19107274416767e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.03150317317476,0.0066520339368002,-0.0445411596908884,-0.0184651866586316,2.20848428779236e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCN15,Lipocalin-15,39934,-0.030316730167741,0.0064030157131267,-0.0428666409654694,-0.0177668193700127,2.21973670014448e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A13,Protein S100-A13,39657,-0.0177803547905422,0.00375717263384991,-0.025144413152888,-0.0104162964281964,2.24657322404288e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.0326281927572432,0.00689735295266691,-0.0461470045444703,-0.0191093809700161,2.26698884423637e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST1,Cystatin-SN,38503,-0.053297431772648,0.0112721289608931,-0.0753908045359984,-0.0312040590092975,2.29590079514897e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTD,Biotinidase,39979,-0.0102011501224771,0.00215918382454289,-0.0144331504185811,-0.00596914982637301,2.33396961433734e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0596823840007071,0.0126349274028444,-0.0844468417102822,-0.034917926291132,2.34533651609989e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0223578832549629,0.00473468518982067,-0.0316378662270114,-0.0130779002829144,2.3616907327606e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0535283740268219,0.0113811615255539,-0.0758354506169077,-0.0312212974367362,2.58648666772934e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0218739317250717,0.00465598482546521,-0.0309996619829835,-0.0127482014671599,2.65879493023135e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN2,Transcobalamin-2,42286,-0.0148728371706384,0.00316613852973052,-0.0210784686889102,-0.00866720565236659,2.65966686981868e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.0172996283871857,0.00368971910004016,-0.0245314778232644,-0.010067778951107,2.77729831165034e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0288675077751173,0.0061569103499872,-0.0409350520610922,-0.0167999634891424,2.77778017978123e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD55,Complement decay-accelerating factor,41714,-0.0129672398083785,0.00276718242639483,-0.0183909173641124,-0.00754356225264463,2.81286943645723e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0203933555286705,0.00435218878407096,-0.0289236455454496,-0.0118630655118914,2.81686611327703e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0346209008735419,0.00738863755408701,-0.0491026304795525,-0.0201391712675314,2.8231685370738e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0200068782344757,0.00427266434570862,-0.0283813003520646,-0.0116324561168868,2.86174002841578e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.042122182643696,0.00899723681009345,-0.0597567667914792,-0.0244875984959129,2.87834017547192e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0302094938670114,0.006452658233513,-0.0428567040046969,-0.017562283729326,2.87873142593829e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0198761293566515,0.00424910735680683,-0.0282043797759929,-0.0115478789373102,2.93444710192147e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.0350544037237595,0.00749465167195349,-0.0497439210007883,-0.0203648864467306,2.94153077745435e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0527415996800218,0.0112897172585446,-0.0748694455067692,-0.0306137538532744,3.02229621155806e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.017872108401632,0.00382617506431132,-0.0253714115276821,-0.0103728052755818,3.03174025940683e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0371793210680829,0.00797623232652937,-0.0528127364280804,-0.0215459057080853,3.17266551933028e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0262412457153026,0.00563289381563442,-0.037281717593946,-0.0152007738366591,3.22025178385928e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0300145269055226,0.00645027865730936,-0.0426570730738489,-0.0173719807371962,3.30492956524617e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.0224480356770343,0.00482724316087343,-0.0319094322723463,-0.0129866390817224,3.34616339090841e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS27,Serine protease 27,42107,-0.0195499494230215,0.00421231636569197,-0.0278060894997777,-0.0112938093462652,3.49751560329182e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.0186886380131782,0.00403573370901997,-0.0265986760828574,-0.0107785999434991,3.6833315521617e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM17,Splicing factor 45,39934,-0.0374331772072176,0.00812069884355463,-0.0533497469405847,-0.0215166074738506,4.07851661907828e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0480679427855541,0.0104309882814518,-0.0685126798171996,-0.0276232057539087,4.10630534630262e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.0180868701393036,0.00392701197558926,-0.0257838136114585,-0.0103899266671486,4.15511657704251e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0229467954006661,0.00498861006946066,-0.032724471136809,-0.0131691196645232,4.27526447354902e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOK1,Docking protein 1,39929,-0.0664919138344874,0.0144683998871866,-0.0948499776133731,-0.0381338500556017,4.36032732759302e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0278527158579816,0.00606861487907968,-0.0397472010209777,-0.0159582306949854,4.48926252010263e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0391022339156226,0.00853033588714718,-0.0558216922544311,-0.0223827755768142,4.61378672937539e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX16,Syntaxin-16,41843,-0.0274169238492785,0.00598400288972563,-0.0391455695131407,-0.0156882781854162,4.65415366140283e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREG1,Protein CREG1,41960,-0.0193769712149522,0.00423103600697212,-0.0276698017886176,-0.0110841406412869,4.69799456158576e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0179423283086449,0.00392207692955595,-0.0256295990905746,-0.0102550575267152,4.81968358553579e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0400419664873489,0.0087617814092304,-0.0572150580494405,-0.0228688749252573,4.91856051642792e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0230205726075098,0.00503725501090805,-0.0328935924288896,-0.0131475527861301,4.9273361316377e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0224407551312845,0.00491034694287212,0.0128164751232552,0.0320650351393139,4.92823945136992e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00965329467689923,0.00211258999970451,-0.0137939710763201,-0.0055126182774784,4.94266169347398e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.0182215629492909,0.00399774432886446,-0.0260571418338652,-0.0103859840647165,5.21046234612246e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX6,Syntaxin-6,41843,-0.0313232001836661,0.00687849861223042,-0.0448050574636377,-0.0178413429036944,5.31592089386658e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.033911759003406,0.00744780366810392,-0.0485094541928897,-0.0193140638139223,5.33810849431663e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH6,Cadherin-6,42145,-0.0185281956195873,0.00408187582460847,-0.0265286722358199,-0.0105277190033547,5.69711855986684e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RP2,Protein XRP2,42070,-0.020244498602172,0.00446369191102266,-0.0289933347477764,-0.0114956624565676,5.79986629362992e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0539415619307178,0.0119108376546579,-0.0772868037338473,-0.0305963201275883,5.98295175411034e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0239847477512165,0.00530499643545623,0.0135869547377223,0.0343825407647107,6.21250636980828e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0273254467596517,0.00606377121213982,-0.0392104383354457,-0.0154404551838576,6.65113926479566e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.0141767563282353,0.00314780136389969,-0.0203464470014787,-0.00800706565499195,6.73338531863464e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP1,Caspase-1,41839,-0.0325108896359938,0.00721905121939908,-0.046660230026016,-0.0183615492459716,6.74194596668842e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0389807830951557,0.00865547644144011,-0.0559455169203783,-0.0220160492699331,6.75014051618762e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.0126977783970128,0.00282085544230268,-0.018226655063926,-0.00716890173009951,6.81795039944459e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0324182499577616,0.00722479083870719,-0.0465788400016277,-0.0182576599138955,7.29340015552663e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.0133343664116796,0.00297670870756045,-0.0191687154784981,-0.00750001734486107,7.54020921356539e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTN3,Myeloblastin,41800,-0.0225574089894887,0.00503784316664206,-0.0324315815961072,-0.0126832363828703,7.61225220653634e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.028111635078665,0.00628236795748596,-0.0404250762753375,-0.0157981938819925,7.72822211632919e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.046758353860246,0.0104533133965368,-0.0672468481174581,-0.026269859603034,7.78805625261902e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.031141162735891,0.00697131779319125,-0.0448049456105459,-0.0174773798612362,7.99547146416431e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0327175432983089,0.00732505806186837,0.0183604294970469,0.0470746570995709,8.01633821017055e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.0297473020584644,0.00666996567839023,0.0166741693288195,0.0428204347881092,8.28175181176729e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0132752135899006,0.00298295015902119,0.00742863127821905,0.0191217959015821,8.65577697076576e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.020547406192867,0.00461936739007556,-0.0296013662774151,-0.011493446108319,8.74589590359856e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0264708487634842,0.00595249873430258,-0.0381377462827173,-0.0148039512442512,8.77688183491551e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCDH1,Protocadherin-1,42264,-0.0095721417611356,0.0021585637127066,-0.0138029266380405,-0.00534135688423066,9.30083073224462e-06
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0240843987922028,0.00545824561702202,-0.0347825602015659,-0.0133862373828396,1.02974869819831e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0515201687005986,0.0116763319124978,0.0286345581521029,0.0744057792490942,1.03252708556953e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.0133867146947572,0.00303511128829437,-0.0193355328198141,-0.0074378965697002,1.03868914725641e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0290199341201854,0.00657995419075004,-0.0419166443340555,-0.0161232239063153,1.04177422888548e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0366111403453279,0.00830344056493125,-0.0528858838525932,-0.0203363968380627,1.04757203227798e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.0134467733883101,0.00305250072253992,-0.0194296748044884,-0.00746387197213187,1.06688382352523e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC3B,Tetranectin,39726,0.00973484149184348,0.00221086473423096,0.00540154661275079,0.0140681363709362,1.07669984578629e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GM2A,Ganglioside GM2 activator,39733,-0.0178553798301048,0.0040555576703748,-0.0258042728640394,-0.00990648679617021,1.07911813959427e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0362340859818585,0.00823714477229815,-0.0523788897355629,-0.0200892822281541,1.0966831746817e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX5,Sorting nexin-5,39638,-0.0137921886423603,0.00313918989229281,-0.0199450008312542,-0.00763937645346636,1.12554875940867e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.0134585753343754,0.0030748383122506,-0.0194852584263866,-0.00743189224236422,1.2140009665834e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0168313062350611,0.00384775563842499,-0.024372907286374,-0.00928970518374807,1.22938393802455e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.0131836454294841,0.00301901002751567,-0.0191009050834148,-0.00726638577555335,1.26980313778995e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFP,Properdin,39979,-0.0108778581662346,0.0024922204107938,-0.0157626101713904,-0.00599310616107872,1.28405667339325e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.0134665650736267,0.00309099045203136,-0.0195249063596081,-0.00740822378764519,1.33190430309997e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1,Integrin beta-1,42167,0.00961464148213704,0.0022104382530546,0.00528218250615002,0.0139471004581241,1.37347935848493e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22,Interleukin-22,39919,-0.0323068331170351,0.00742891181212565,-0.0468675002688014,-0.0177461659652688,1.38083545175738e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGN,Cingulin,39649,-0.0171425384757742,0.00394578743259199,-0.0248762818436545,-0.00940879510789389,1.40829107435688e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0299384703175504,0.00689726614153162,0.0164198286801484,0.0434571119549524,1.43105078803876e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.0125042924740546,0.00288706222444182,-0.0181629344339606,-0.00684565051414864,1.49421037532599e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.0213387852122114,0.00493157843415984,-0.0310046789431646,-0.0116728914812581,1.52283775777334e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0201983132660659,0.00467391184974554,0.0110374460405647,0.0293591804915672,1.56075225210402e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,-0.00729879919000219,0.00168940142689913,-0.0106100259867245,-0.0039875723932799,1.56881178266764e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0181991766596643,0.00421399571496811,-0.0264586082610018,-0.0099397450583268,1.58255135243845e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0210272501466009,0.00486887684733981,-0.030570248767387,-0.0114842515258149,1.58325364310414e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.030101276139954,0.00697112740627028,-0.0437646858562437,-0.0164378664236642,1.587906127823e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIM,Vimentin,41900,-0.0517970246047096,0.0120238636997202,-0.0753637974561611,-0.028230251753258,1.66030801933419e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,-0.0131553866977808,0.00305459555192514,-0.0191423939795541,-0.00716837941600754,1.66865590038373e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.025162672689832,0.00584481477839521,-0.0366185096554866,-0.0137068357241774,1.68327675463362e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.0124090589891864,0.00288804972150221,-0.0180696364433307,-0.00674848153504208,1.74813123691767e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0143766162375679,0.00335015914628464,-0.0209429281642858,-0.00781030431084995,1.79133023750288e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0254435488209104,0.00593044362022804,-0.0370672183165574,-0.0138198793252635,1.79937941814803e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0477776656842113,0.0111527745535611,-0.0696371038091911,-0.0259182275592315,1.8516236463984e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.025293743812875,0.00591240627995143,-0.0368820601215798,-0.0137054275041702,1.90077723410293e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0292433702748155,0.00684037317203953,-0.042650501692013,-0.015836238857618,1.92595842563062e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0272610833579899,0.00638142508921172,-0.0397686765328448,-0.0147534901831349,1.95124218742603e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.0167766730820233,0.00392983680375609,-0.0244791532173853,-0.00907419294666137,1.97637474296184e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.0167929625332818,0.00393985983196475,-0.0245150878039327,-0.00907083726263094,2.03944103272327e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.012234034104613,0.00287557800255191,0.00659790121961123,0.0178701669896147,2.112435209884e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA3,Annexin A3,42224,-0.0309382658523127,0.00727446875999305,-0.0451962246218991,-0.0166803070827263,2.12339206729918e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0219234938185998,0.00515504454349633,-0.0320273811238526,-0.011819606513347,2.12831003411767e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG3,Proteoglycan 3,39966,0.0222147226645134,0.00523645196219668,0.0119512768186079,0.0324781685104189,2.2297055976954e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.0101409734441451,0.00239260902498527,-0.0148304871331162,-0.00545145975517392,2.26532654199993e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.0175514961868537,0.00414161711940955,-0.0256690657408965,-0.00943392663281104,2.27516407501195e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00539871367478288,0.00127406782977597,0.00290154072842198,0.00789588662114378,2.27650678268542e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0394680617183414,0.00932931153129741,-0.0577535123196843,-0.0211826111169984,2.34960607702201e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGB,Secretogranin-1,42210,-0.0187046873427482,0.00442531361496581,-0.0273783020280812,-0.0100310726574152,2.38638860276209e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.056145791191577,0.0133264377014324,-0.0822656090863845,-0.0300259732967694,2.53858889054263e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSPN,Persephin,42119,-0.038127075288036,0.00905548828723702,-0.0558758323310206,-0.0203783182450515,2.56587347797222e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0430525435969776,0.0102515868839358,-0.0631456538894918,-0.0229594333044634,2.69138202014484e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0175880580551502,0.00418803060537303,-0.0257965980416813,-0.00937951806861903,2.69432575218105e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN10,Ataxin-10,41839,-0.0322680928042262,0.00768636484408851,-0.0473333678986397,-0.0172028177098127,2.70927929081563e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0316102601239802,0.00754986749180756,-0.0464080004079231,-0.0168125198400374,2.84665739311472e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.0132548053449448,0.00316933428361321,-0.0194667005408267,-0.00704291014906294,2.90868140396259e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0142928408978995,0.00343101506360955,0.00756805137322478,0.0210176304225742,3.12208752079251e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXN,Thioredoxin,39854,-0.0189152219014644,0.00454090054669197,-0.0278153869729806,-0.0100150568299481,3.12959458787779e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0266591890434224,0.00640915452710986,0.0140972461702871,0.0392211319165577,3.21216202713466e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0415203082726863,0.00999760924702455,-0.0611156223968544,-0.0219249941485181,3.30518023807996e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0325940229569289,0.00784915858089535,-0.0479783737754838,-0.017209672138374,3.31237327134005e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0342054769587652,0.00823837911755636,-0.0503527000291757,-0.0180582538883548,3.32042920856818e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0385208547276547,0.0092803417631615,-0.0567103245834512,-0.0203313848718581,3.33736776032149e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0528960317270883,0.0127515024619722,-0.0778889765525538,-0.0279030869016228,3.37116632379606e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCT,Secretin,39649,-0.0210251456435534,0.00507656579490086,-0.0309752146015591,-0.0110750766855478,3.47444656356685e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0141319947537334,0.0034128154233129,-0.0208211129834267,-0.00744287652404009,3.48506122680643e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0122787488735436,0.00296786862472566,0.00646172636908134,0.0180957713780059,3.5365145664348e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP3,Caspase-3,42310,-0.0380890061931916,0.00921641691618555,-0.0561531833489153,-0.0200248290374679,3.60602660899565e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BGLAP,Osteocalcin,39966,-0.0365702784691505,0.00886383603972051,-0.0539433971070027,-0.0191971598312983,3.7210562215225e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.0114858949099372,0.00278546029368148,-0.0169453970855529,-0.00602639273432149,3.75777322795524e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.012796199740984,0.00310468948573995,-0.0188813911330343,-0.00671100834893374,3.78565307511371e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0190162473586738,0.00461639397722337,-0.0280643795540316,-0.00996811516331602,3.82748529788714e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0307463308511682,0.00748633684842673,-0.0454195510740846,-0.0160731106282518,4.03652894148305e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0360086334207509,0.00876834630819049,-0.0531945921848043,-0.0188226746566976,4.03763721036778e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EGFLAM,Pikachurin,39930,-0.0133872004059144,0.00326242854388701,-0.0197815603519329,-0.00699284045989582,4.09891052254276e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0295503951439773,0.00720497509289558,-0.0436721463260526,-0.0154286439619019,4.13073480995603e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,-0.0157588328572854,0.00384313165825671,-0.0232913709074686,-0.00822629480710226,4.14636806890274e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0113907869382335,0.00278080752499742,0.00594040418923858,0.0168411696872285,4.22380288967544e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.031386930474651,0.00767312304516849,-0.0464262516431813,-0.0163476093061208,4.3293378203264e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0358825106763296,0.00877190987808044,-0.0530754540373673,-0.018689567315292,4.33258655303783e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0364431955864313,0.00893554380087147,-0.0539568614361394,-0.0189295297367232,4.56016191747539e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0100051596731018,0.00245445277321302,0.00519443223760428,0.0148158871085993,4.60125585961941e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0533557909142585,0.0131057288091283,-0.07904301938015,-0.027668562448367,4.71035771489526e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD5L,CD5 antigen-like,39925,-0.0205050277887013,0.00505170772855113,-0.0304063749366615,-0.0106036806407411,4.96084081271457e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0101563682143747,0.00250416167276065,0.00524821133576386,0.0150645250929856,5.02437476264748e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0246685147559578,0.00608362581257211,-0.0365924213485991,-0.0127446081633164,5.04420977034027e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0210452819419243,0.00520099643539159,-0.0312392349552918,-0.0108513289285568,5.23667268583811e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0243013520541543,0.00603889800176372,-0.0361375921376112,-0.0124651119706974,5.75662930154776e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP2,Caspase-2,42119,-0.028717647840295,0.00715832853047151,-0.0427479717600192,-0.0146873239205709,6.05867572927547e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MATN3,Matrilin-3,41992,0.0138487219898667,0.00345200662112912,0.00708278901245363,0.0206146549672798,6.05878554522031e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.0119052420523822,0.00297010108937438,-0.0177266401875559,-0.00608384391720837,6.14743735563243e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0146421233070152,0.00365312415958722,0.00748199995422421,0.0218022466598061,6.16112748335856e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.0242385091966509,0.00605684369720554,-0.0361099228431737,-0.012367095550128,6.31859494451773e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0130784965519617,0.00328427515515345,0.00664131724786095,0.0195156758560625,6.87333870960505e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.0141913492255225,0.00356849616581393,-0.0211856017105178,-0.00719709674052721,7.02059110210772e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0344031674664439,0.00865307333134108,-0.0513631911958724,-0.0174431437370154,7.04997870787902e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0317116776438233,0.00798292920083777,-0.0473582188774653,-0.0160651364101813,7.15179039815264e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0248030713499662,0.00625255289723011,0.0125480676713952,0.0370580750285373,7.32707768282427e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0480088375822854,0.012102652051224,-0.0717300356026844,-0.0242876395618865,7.32916076563124e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.018911402938211,0.00477686843274541,0.00954874081003003,0.028274065066392,7.56728210416796e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0403078217937559,0.0101821063081161,-0.0602647501576635,-0.0203508934298482,7.58217774822875e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0384013313371787,0.00970218578781126,-0.0574176154812887,-0.0193850471930686,7.6051001301877e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0241416585908812,0.00612133222831331,-0.0361394697583753,-0.0121438474233871,8.06735247575968e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0201426541021625,0.00510779730115675,-0.0301539368124297,-0.0101313713918952,8.0781290846972e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0551351027109395,0.0140207596251888,-0.0826157915763096,-0.0276544138455695,8.45265442315397e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0391081387111873,0.00994612983620953,-0.058602553190158,-0.0196137242322167,8.46654109490091e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATXN2,Ataxin-2,39586,-0.0440020358383786,0.0111949048196977,-0.065944049284986,-0.0220600223917711,8.52746188592454e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.011003148522269,0.00280123864522915,0.00551272077761989,0.0164935762669181,8.61760258276558e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0357010018041358,0.00911061932869729,-0.0535578156883824,-0.0178441879198891,8.96018143068468e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.0129958555685028,0.00332211841949876,-0.0195072076707204,-0.00648450346628525,9.2013093398088e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0202426524372867,0.00518221216117107,0.0100855166013914,0.030399788273182,9.43220009496926e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0153823711657993,0.00394002064586433,-0.0231048116316934,-0.00765993069990521,9.51110548603067e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.0164757676497477,0.00422301427635985,-0.024752875631413,-0.00819865966808243,9.60953778925075e-05
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0217825396188216,0.00559843561187882,-0.0327554734181041,-0.0108096058195391,0.000100384177127712
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0139327314888874,0.00358545945817562,-0.0209602320269116,-0.0069052309508632,0.000102436155970651
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0103700409336387,0.00267331878593836,-0.0156097457540779,-0.0051303361131995,0.000105439050344933
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0240549371943906,0.00621839662072865,-0.0362429945710187,-0.0118668798177624,0.000110203147441729
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENAH,Protein enabled homolog,41913,-0.0195147390622775,0.00504696202219986,-0.0294067846257892,-0.00962269349876576,0.000110873956458445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0292610829842875,0.00756885433798473,-0.0440960374867375,-0.0144261284818374,0.000111259943207839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.0152144584076244,0.00394875020869226,-0.0229540088166612,-0.00747490799858755,0.000117332677999293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA5,Annexin A5,41780,-0.0122749814536522,0.00318672726781402,-0.0185209668985677,-0.00602899600873676,0.000117755722424557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.03000126663104,0.00780419318844495,-0.0452974852803921,-0.0147050479816878,0.000121480832724355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBN1,Drebrin,39657,-0.0206804184518197,0.00538726033322938,-0.0312394487049493,-0.0101213881986901,0.00012434451584518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.0157553778479958,0.00410474103409103,-0.0238006702748143,-0.0077100854211774,0.000124565726525372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,-0.0141689312384108,0.00369633835253107,-0.0214137544093717,-0.00692410806744994,0.000127037999152008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0394927100709603,0.0103023794562467,-0.0596853738052038,-0.0193000463367167,0.000127111608541609
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0384456880297538,0.0100371361051351,-0.0581184747958186,-0.0187729012636889,0.000128540690831825
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRP2,Neuropilin-2,42137,0.0112319720087387,0.0029438078919443,0.0054621085405279,0.0170018354769496,0.000136535632360021
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0590124791630053,0.0154769728758262,-0.0893473459996246,-0.028677612326386,0.00013808649407489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0111423008878514,0.00292860003591924,0.00540224481744968,0.0168823569582531,0.000142637868321414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.0234876767568096,0.00617346925819811,-0.0355876765028779,-0.0113876770107413,0.000142650111047472
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK8,Kallikrein-8,41668,-0.0145766288445884,0.00383981082129974,-0.0221026580543359,-0.00705059963484092,0.000147604445517379
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0233475824203104,0.00615766037907427,-0.035416596763296,-0.0112785680773248,0.000150303343532973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN1,Contactin-1,42310,0.0106010290939943,0.00279687236179114,0.00511915926488366,0.0160828989231049,0.000151100252824171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0229798145298364,0.0060637103787469,-0.0348646868721804,-0.0110949421874925,0.000151466266121022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRNN,Cornulin,41749,0.0267103961843202,0.00705797937989673,0.0128767565997226,0.0405440357689178,0.000154748042416923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0251652839155384,0.00666658700520857,-0.0382317944457472,-0.0120987733853296,0.00016094178469054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0234263153086075,0.00621595195534137,-0.0356095811410766,-0.0112430494761384,0.000164932093030062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0220681414657507,0.00586623511832855,-0.0335659622976747,-0.0105703206338268,0.000169482746735992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0255826297349989,0.00680624619063909,-0.0389228722686515,-0.0122423872013463,0.000171678279906799
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.0124357832895866,0.0033175354626049,-0.0189381527962922,-0.00593341378288104,0.000178779017723676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0226890244753496,0.00605765755280011,-0.0345620332788378,-0.0108160156718614,0.000180932890795161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0185460907226922,0.00495159091039272,-0.028251208907062,-0.0088409725383225,0.000180940335445448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0324340438490277,0.00867036605722799,-0.0494279613211945,-0.0154401263768608,0.000184198769420067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.0204998339628199,0.00550210045416149,-0.0312839508529764,-0.00971571707266337,0.00019562841213497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F11,Coagulation factor XI,39822,0.012249502647172,0.00330954496401579,0.00576279451770101,0.0187362107766429,0.000215553894355317
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0148936768353378,0.00403056701844019,0.006993765479195,0.0227935881914805,0.000220608155746093
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCRN1,Secernin-1,42119,-0.0214151796747436,0.00579944927014409,-0.0327821002442261,-0.0100482591052612,0.000222826607018083
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.0129284823814484,0.00350430796566784,-0.0197969259941573,-0.00606003876873939,0.000225744222914446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.0284034389282755,0.00771073048397234,-0.0435164706768613,-0.0132904071796897,0.000230856356162494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.0164216676159439,0.00446395056381888,-0.025171010721029,-0.00767232451085895,0.000235322274548033
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VNN1,Pantetheinase,39990,-0.0284058057211959,0.00772592018067005,-0.0435486092753092,-0.0132630021670826,0.000237367186530169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO2,Roundabout homolog 2,42249,-0.00868599119195858,0.00236930991640916,-0.0133298386281205,-0.00404214375579662,0.00024726752920732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0271443404161753,0.00740668060664851,-0.0416614344052064,-0.0126272464271442,0.000248646835131727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0221636702794936,0.00605556246551633,-0.0340325727119056,-0.0102947678470816,0.000253144719855214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0416413495328717,0.0113954649523017,-0.0639764608393831,-0.0193062382263603,0.00025914786193214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.0214702150526326,0.00590499442734376,-0.0330440041302263,-0.00989642597503878,0.000278225128322483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.0155450416299617,0.00427762296577006,-0.023929182642871,-0.00716090061705241,0.000280285360462687
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0384252497820311,0.010574730348795,-0.0591517212656694,-0.0176987782983929,0.000280636038133679
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.032345729618071,0.00892435146751469,-0.0498374584943998,-0.0148540007417422,0.000290660856613614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.0108979747257015,0.00300749628188066,-0.0167926674381876,-0.0050032820132154,0.000291794986630598
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,-0.0102908459030838,0.00284324229862382,-0.0158636008083865,-0.00471809099778109,0.000296563610537667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00756097922686694,0.00208931584218831,-0.011656038277556,-0.00346592017617784,0.000296966683297328
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0274526110747782,0.00759115020169396,-0.0423312654700983,-0.012573956679458,0.000300026861456286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.0110267227000223,0.00305562157155658,-0.0170157409802732,-0.0050377044197714,0.00030910117761831
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.0080615591338855,0.00224298013875868,0.00366531806191848,0.0124578002058525,0.00032688464103998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELENOP,Selenoprotein P,39979,0.00855567290409296,0.00238053302080057,0.00388982818332384,0.0132215176248621,0.000326996277711215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0224279522643436,0.0062433397845858,-0.0346648982421317,-0.0101910062865554,0.0003292052226363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.00818330171630567,0.00227833612405302,0.00371776291316174,0.0126488405194496,0.000329843642413164
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0423978061543141,0.0118165655048696,-0.0655582745438586,-0.0192373377647697,0.000334678542111226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0250423361041438,0.00698832140135407,-0.0387394460507977,-0.0113452261574898,0.00034029862494139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0278896649899182,0.00778631208881795,-0.0431508366840014,-0.012628493295835,0.000342348345195252
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F3,Tissue factor,42174,0.00981580666563059,0.00274135100023889,0.00444275870516237,0.0151888546260988,0.000343943217593527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0169154356811174,0.00472646715629017,-0.0261793113074461,-0.00765156005478865,0.000346519259590475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_A,,39934,-0.0123491928352288,0.00346651900529014,-0.0191435700855975,-0.00555481558486009,0.000368961669826077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.0148837293114484,0.00417836698558221,-0.0230733286031896,-0.0066941300197073,0.00036920296045562
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0443348355201549,0.0124531169640819,-0.0687429447697555,-0.0199267262705544,0.000372175366475235
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMTN,Smoothelin,39897,-0.0347216775387864,0.00976365019038932,-0.0538584319119494,-0.0155849231656233,0.000377769859782888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0291877956851971,0.00820781930593835,-0.0452751215248362,-0.0131004698455579,0.00037794147087179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSR,Insulin receptor,39657,-0.00643048558259698,0.00180883931859317,-0.00997581064703959,-0.00288516051815436,0.000379507821135351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFD,Complement factor D,39979,-0.00757058861232113,0.00213135983246257,-0.0117480538839478,-0.0033931233406945,0.000383861875330124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0331704999341924,0.00933995511140805,-0.0514768119525522,-0.0148641879158326,0.000384397819693016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0451584338863327,0.0127396647996835,-0.0701281768937124,-0.020188690878953,0.000394370578461382
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0296861264973028,0.00837709774101527,-0.0461052380696927,-0.0132670149249128,0.000395875886760531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0326458718596158,0.00923030269359081,-0.0507372651390538,-0.0145544785801778,0.000406630253447353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0318612130094741,0.009009277293386,-0.0495193965045107,-0.0142030295144376,0.000407142960941374
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SDC4,Syndecan-4,42145,0.0175362568617101,0.0049659384922742,0.00780301741685264,0.0272694963065675,0.000414884495459218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNR,Tenascin-R,42016,0.0154657075507326,0.00438090952990768,0.00687912487211357,0.0240522902293517,0.000416557881801349
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0188178844504454,0.00534912411619442,-0.0293021677181865,-0.00833360118270434,0.000436673709203351
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0178327996310256,0.00509587262325577,-0.0278207099726069,-0.00784488928944425,0.000467727748329428
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0408471886932997,0.0116836595914312,-0.063747161492505,-0.0179472158940945,0.000473666022771152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0271945398698293,0.00778535033865976,-0.0424538265336024,-0.0119352532060562,0.000479113435419909
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM3,Myomesin-3,39736,0.0356810023528068,0.0102360310409824,0.0156183815124813,0.0557436231931322,0.000492513444605033
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN4,Cerebellin-4,42262,-0.0115787584258546,0.00332660094725228,-0.0180988962824691,-0.00505862056924015,0.000501746021806572
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD8,Frizzled-8,39586,-0.0158243015242197,0.00454874156203283,-0.0247398349858041,-0.00690876806263535,0.000505558293145266
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.0149368317768064,0.0042957762594894,-0.0233565532454056,-0.00651711030820714,0.000508821901675121
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,-0.0136953278433673,0.00394302888808881,-0.0214236644640214,-0.00596699122271326,0.000515712477289329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0338201944655486,0.00980332697227115,-0.0530347153312,-0.0146056735998971,0.000562569330625239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CX3CL1,Fractalkine,42016,0.0120282445337542,0.0034962107797986,0.00517567140534894,0.0188808176621594,0.000582696306474223
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.028202764966207,0.00821729698609921,-0.0443086670589615,-0.0120968628734526,0.000600708529714221
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0316029355655953,0.00921058132755278,-0.0496556749675987,-0.0135501961635919,0.000603194544959977
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0314161818033903,0.00916694850026649,-0.0493834008639126,-0.013448962742868,0.000611844691479483
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.0279817756058702,0.00817076874141633,-0.0439964823390462,-0.0119670688726942,0.00061748867418661
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.0108871021930944,0.00318838986022931,-0.0171363463191438,-0.00463785806704494,0.000640976308918345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0133848774934571,0.00392089166285764,0.00569992983425611,0.0210698251526581,0.000643109926312135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN9,Septin-9,42070,-0.0102859714557938,0.00301518128515906,-0.0161957267747056,-0.00437621613688206,0.000648214752247132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CR1,Complement receptor type 1,39970,-0.0127653537347102,0.00374485892681375,-0.0201052772312651,-0.00542543023815522,0.000654835387801442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0137814790635562,0.00404477119209988,0.00585372752704048,0.021709230600072,0.000658140333044747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0173100862395489,0.00508066382381219,-0.0272681873342208,-0.00735198514487702,0.000658971129772659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.0122219264997154,0.00358966184180239,-0.0192576637096481,-0.00518618928978268,0.000664160677379673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.00862883259826256,0.00253673490295284,0.003656832188475,0.0136008330080501,0.000671994025642992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OPTC,Opticin,42070,0.0161502824870671,0.00475862810241405,0.00682337140633554,0.0254771935677986,0.000691047728013998
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.025437816806852,0.00749807649993947,0.0107415868669706,0.0401340467467333,0.000694749082207177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.0144152976159002,0.00425314204686763,-0.0227514560277607,-0.00607913920403965,0.000703064996515781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0233644118207635,0.0069199474625999,-0.0369275088474593,-0.00980131479406768,0.000736561295370179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR15L,Protein GPR15L,39930,-0.0221367682912384,0.00658371234160039,-0.0350408444807752,-0.00923269210170164,0.000775369110040392
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG1,Arginase-1,42015,-0.0177944852100359,0.00529878906550609,-0.0281801117784278,-0.00740885864164391,0.000786651731500438
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0340637593379147,0.0101451537689594,-0.0539482607250752,-0.0141792579507542,0.000788770338624536
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0302341377694327,0.00903413242864077,-0.0479410373295687,-0.0125272382092968,0.000820653374506865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0200554818212881,0.00599427146095929,0.00830670975780788,0.0318042538847683,0.000822788124817608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0140910562462023,0.00421291932693287,-0.0223483781269907,-0.00583373436541384,0.000826383700659128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SELL,L-selectin,39979,0.00819974255272099,0.00245207797748502,0.00339366971685035,0.0130058153885916,0.00082847168833591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0350879773703422,0.0105276527453586,-0.0557221767512451,-0.0144537779894393,0.000862193816578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0336747116403098,0.0101113984837895,-0.0534930526685371,-0.0138563706120824,0.000870121300084553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THPO,Thrombopoietin,41900,0.0135903044493508,0.00408212001476703,0.00558934922040744,0.0215912596782942,0.000873240317151811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0135678722235619,0.00408600197278372,-0.021576436090218,-0.00555930835690585,0.000901238859759029
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0166469486177482,0.0050135031780723,-0.0264734148467699,-0.00682048238872654,0.000901643784163916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.0110132715984009,0.00331687244561501,-0.0175143415918063,-0.00451220160499547,0.000901870240955452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.00899158982277024,0.00271244214127861,0.00367520322586416,0.0143079764196763,0.000919496814407853
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.0108625941405661,0.00328312934756732,-0.0172975276617981,-0.00442766061933419,0.000940604575499214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA1,Annexin A1,39699,-0.0155134002750739,0.00469007057345951,-0.0247059385990545,-0.00632086195109321,0.000943607362594001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0417468622187832,0.0126217279197902,-0.0664854489415719,-0.0170082754959944,0.000943638807726308
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRTN,Neurturin,41913,-0.0171695374548031,0.0051912656619017,-0.0273444181521304,-0.00699465675747575,0.000944193555462846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0254334673739024,0.0077162859654144,-0.0405573878661146,-0.0103095468816902,0.000982946871243569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0304748670362832,0.00924703391891053,-0.0485990535173479,-0.0123506805552186,0.000984504288537963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0427540932613546,0.0129753756689893,-0.0681858295725737,-0.0173223569501355,0.000987251235778375
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.0117012386226237,0.00355471919231046,-0.0186684882395522,-0.00473398900569523,0.000998795765223843
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.00932362391144853,0.00283599288986039,-0.0148821699755749,-0.00376507784732216,0.00101297798073409
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0102133839725043,0.00311069999928728,0.00411641197390127,0.0163103559711074,0.00102856102708571
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00761394090256191,0.00232041187116704,-0.0121619481700493,-0.00306593363507452,0.00103654122567515
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.0202016993764334,0.00618562377521207,-0.0323255219758491,-0.00807787677701776,0.00109444599658547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.051293832152523,0.0157193337682578,-0.0821037263383083,-0.0204839379667377,0.00110472307161929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEO1,Neogenin,39934,-0.00778315282430904,0.00238633286170648,-0.0124603652332537,-0.00310594041536434,0.00111130937441612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.038403360923037,0.0117920850025983,0.0152908743179443,0.0615158475281297,0.0011299274099152
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.0106893041459433,0.00329052280250743,0.00423987945302873,0.0171387288388579,0.00116359538166821
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.0124363432228668,0.00383164258121992,-0.0199463626820578,-0.00492632376367574,0.00117512931968733
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0318910141581685,0.00983191263824781,-0.0511615629291342,-0.0126204653872028,0.00118307557636922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TF,Serotransferrin,39979,-0.00731413178311684,0.00225671023390455,-0.0117372838415698,-0.00289097972466393,0.00119428906577557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0505127251169684,0.0155908675077189,-0.0810708254320975,-0.0199546248018393,0.00119870202342891
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.0204139831568904,0.00630558213873373,-0.0327729241488085,-0.00805504216497229,0.00120891698194941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.0113102523212096,0.00349671073523899,-0.018163805362278,-0.00445669928014118,0.00122131437979522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD84,SLAM family member 5,42119,-0.0107928268910296,0.00333893005083432,-0.0173371297906649,-0.00424852399139439,0.00123040364959494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.0169790011198778,0.00525460409947462,-0.0272780251548481,-0.00667997708490755,0.00123546190347388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FN1,Fibronectin,39979,-0.00923863243143352,0.00286958609118408,-0.0148630211701543,-0.00361424369271272,0.00128774709339859
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.024924153922375,0.0077528003645216,-0.0401196426368373,-0.00972866520791267,0.00130884513900193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0368894785150977,0.0114852882624032,-0.0594006435094079,-0.0143783135207875,0.00132173999255241
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.030854609718036,0.009623770300435,-0.0497171995068886,-0.0119920199291834,0.00134937928493967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0206129879712547,0.00644659838997772,-0.0332483208156111,-0.0079776551268984,0.00139016195798627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB9,Serpin B9,42016,-0.0109700703033623,0.00343454451216401,-0.0177017775472037,-0.00423836305952079,0.00140621234480923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRGN,Neurogranin,39990,-0.0310741804453835,0.00975584242575538,-0.0501956315998641,-0.011952729290903,0.00145050430615449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0187604897948144,0.00590026516892844,-0.0303250095259141,-0.00719597006371467,0.001478748856177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0180850810539661,0.00569281119372871,-0.0292429909936744,-0.00692717111425784,0.00149295267317355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.0208696294740338,0.00659573793124484,-0.0337972758192737,-0.00794198312879394,0.00155905143248463
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.0127112415789596,0.00401775505418181,-0.020586041485156,-0.00483644167276327,0.0015616305152449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0426972783907207,0.0135036222686637,-0.0691643780373015,-0.0162301787441399,0.00157149545358099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,-0.0120079064312632,0.00380273914084635,-0.0194612751473221,-0.00455453771520437,0.00159436647573391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0243751224147982,0.0077418027010739,-0.039549055708903,-0.00920118912069336,0.00164543906158888
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.0152105336253175,0.00483214374231128,-0.0246815353602476,-0.00573953189038739,0.00164941062298803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP10,Stromelysin-2,42124,0.0189961572720897,0.00603857409518658,0.00716055204552402,0.0308317624986554,0.0016599124361222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0276098096601101,0.00879382974246334,-0.0448457159553382,-0.0103739033648819,0.00169502726542309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00911465121403886,0.00291086035859008,-0.0148199375168754,-0.0034093649112023,0.00174434571831858
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0187493932402636,0.00599371798958754,-0.0304970804998552,-0.00700170598067205,0.00176356896394753
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.0119890167954045,0.00383432590389296,-0.0195042955670347,-0.00447373802377429,0.0017720247609009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP9,Caspase-9,39657,-0.0210464506949169,0.00674162924924099,-0.0342600440234292,-0.00783285736640454,0.00180173175181641
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.0157815106468462,0.00506762496775923,-0.0257140555836543,-0.00584896571003816,0.00184849282133135
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0245634206155145,0.00790559063204563,-0.0400583782543239,-0.00906846297670507,0.00189411022123036
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK6,Kallikrein-6,42158,-0.0100386988242937,0.00323731072902434,-0.0163838278531814,-0.00369356979540603,0.0019330455334559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.018049810418001,0.00582441758757763,-0.0294656688896531,-0.0066339519463488,0.00194672683032318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0210328371444565,0.00682005065160654,-0.0344001364216053,-0.00766553786730769,0.00204675789866243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.0339850367548236,0.0110461227544874,-0.0556354373536188,-0.0123346361560283,0.00209853600558548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0244640799864974,0.00796459635808657,-0.0400746888483471,-0.00885347112464777,0.00213433055741673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.0153388438024114,0.00499560291003025,-0.0251302255060707,-0.00554746209875212,0.00214142120646719
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.0180153045630862,0.00587137297522074,-0.0295231955945189,-0.0065074135316536,0.00215691952014771
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFB,Complement factor B,39794,-0.0105611256805139,0.00344885330097581,-0.0173208781504265,-0.00380137321060129,0.00220227844548675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0173714593597676,0.00569208276341569,-0.0285279415760624,-0.00621497714347286,0.00227965468425827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0322614557331876,0.0105845335773186,-0.0530071415447321,-0.0115157699216431,0.00230916026303792
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0134747741959013,0.00442957845060541,0.00479280043271472,0.0221567479590879,0.00235550004395683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.0126629010287844,0.00416458460608093,0.0045003152008658,0.0208254868567031,0.00236651744179333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0380217757939803,0.0125076277734741,-0.0625367262299894,-0.0135068253579711,0.00237117915379175
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JUN,Transcription factor AP-1,41913,-0.015361642709274,0.00505809548324773,-0.0252755098564395,-0.00544777556210843,0.00239375444396829
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.0117167737633648,0.00387829994178417,-0.0193182416492618,-0.00411530587746782,0.00252327334047016
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.0379433761444644,0.0125806490433456,-0.0626014482694218,-0.013285304019507,0.0025659984167202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.0107732111102489,0.00357970150194585,-0.0177894260540628,-0.00375699616643503,0.00262136686004673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00874905134922187,0.00291183456941717,-0.0144562471052795,-0.00304185559316423,0.00266381904227824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAM,Basal cell adhesion molecule,42137,-0.00771509125384786,0.00257018739922608,-0.012752658556331,-0.00267752395136475,0.00268911344870615
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.0122020149561521,0.0040692946181332,-0.0201778324076931,-0.00422619750461101,0.00271764615329057
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.0063803003407434,0.0021364879093606,-0.0105678166430902,-0.00219278403839662,0.00282832974020902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.0103798476642135,0.00347602445237148,-0.0171928555908616,-0.00356683973756536,0.00283159650693608
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.0189625941301224,0.00635400935227385,-0.0314164524605792,-0.00650873579966569,0.00284696500540251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBN2,Fibrillin-2,39649,-0.0188727266081499,0.00633632027433409,-0.0312919143458447,-0.00645353887045505,0.00290292700905995
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0226160070003589,0.00759355640141559,-0.0374993775471335,-0.00773263645358439,0.00290353666380594
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB7,Integrin beta-7,42262,-0.0144005906520393,0.00483612238870645,-0.0238793905339039,-0.00492179077017465,0.00290916173020234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0204129485422564,0.00688511837370701,-0.0339077805547222,-0.00691811652979068,0.00303518459503035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.0122301326079612,0.00412544239050377,-0.0203159996933486,-0.0041442655225738,0.00303644316410997
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.0133298159250616,0.00449983511134948,-0.0221494927433066,-0.00451013910681663,0.00305897524056166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGT,Angiotensinogen,39990,-0.00676981267321534,0.00229874691604499,-0.0112753566286635,-0.00226426871776716,0.00323606288366218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.021852756084406,0.00742314336504817,-0.0364021170799004,-0.00730339508891154,0.00324817178678032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0176474830207498,0.00600386519361352,-0.0294150588002323,-0.00587990724126732,0.00329562969655442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0135937841382578,0.0046327580560032,-0.0226739899280241,-0.00451357834849153,0.00334999573395339
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0213890397417372,0.00731689155120801,-0.0357301471821048,-0.00704793230136946,0.00347093057238285
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.0109106755174104,0.00373671701016022,-0.0182346408573244,-0.00358671017749635,0.00350893835863271
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSD1,Tryptase delta,39934,-0.0112700881115977,0.00386293238804156,-0.0188414355921591,-0.00369874063103623,0.00353547576362217
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD109,CD109 antigen,42137,-0.0104199494650265,0.00357242774620836,-0.0174219078475949,-0.00341799108245808,0.00354257586637436
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0274309797406834,0.00941938415322114,-0.0458929726809968,-0.00896898680036994,0.00359623761345948
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.0152672004257069,0.00524319215048592,-0.0255438570406592,-0.00499054381075445,0.00360054731425923
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,-0.0095978751587266,0.00329831040123173,-0.0160625635451408,-0.00313318677231241,0.00362100961575381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.012797821904265,0.00440543988949424,0.00416315972085632,0.0214324840876737,0.00367981286395168
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0334160099835547,0.0115036368674667,0.0108688817233201,0.0559631382437894,0.00368055479265637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.00975602269721797,0.00335949431665197,0.0031714138365801,0.0163406315578558,0.0036899827276077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.0122674120741345,0.00422696983539898,-0.0205522729515165,-0.00398255119675255,0.00371305069816628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.00671387227292311,0.00231598634431832,0.00217453903805919,0.011253205507787,0.00375160064316008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0183337647898562,0.00633217052165357,-0.0307448190122972,-0.00592271056741521,0.00379499333756396
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0247179020452787,0.00853870858006226,-0.0414537708622007,-0.00798203322835666,0.00380136198465412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIT,Vitrin,39958,-0.0117291097276099,0.00405250638026973,-0.0196720222329386,-0.00378619722228127,0.00380746056617029
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK13,Kallikrein-13,41839,-0.0136082685344692,0.00470664372646496,-0.0228332902383406,-0.0043832468305979,0.0038428894948722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00858169087972493,0.00297132082138566,-0.0144054796896408,-0.00275790206980903,0.00388099455113337
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.00689019358917199,0.00239586964439552,-0.0115860980921872,-0.00219428908615677,0.00403551877751138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.0159221687446554,0.00553805632506505,-0.0267767591417829,-0.00506757834752792,0.00404718741858245
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.0167890331808975,0.00584689396721269,-0.0282489453566344,-0.00532912100516067,0.00409241839089811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.023245874345897,0.008125524741049,-0.039171902838353,-0.00731984585344099,0.00423283401263023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0344763805861014,0.0120557520324485,0.0108471066025023,0.0581056545697006,0.00424753463028539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0119665912681616,0.00420835650752816,0.00371821251340644,0.0202149700229168,0.00446986628665393
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0318880055818909,0.011220804539876,-0.0538807824800479,-0.00989522868373396,0.00449326326549579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.0169743959336064,0.00597408256550315,-0.0286835977619926,-0.00526519410522022,0.00449927084527386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0216171208907713,0.00761899276245529,-0.0365503467051836,-0.00668389507635888,0.0045568457813839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0112914297342699,0.00398496350504157,-0.0191019582041514,-0.00348090126438841,0.00461241184422519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.0103464679478142,0.00365626275884797,-0.0175127429551562,-0.00318019294047218,0.00466600739131543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.0062146900380767,0.00219674250994319,0.00190907471858805,0.0105203053575653,0.00467713735296327
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00719799743143071,0.00254871461576539,0.00220251678453054,0.0121934780783309,0.00474859087675585
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.0100706286720907,0.00356618749979387,0.00308090117249468,0.0170603561716866,0.00475252005619747
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.0106729352595126,0.00378356185570422,-0.0180887164966929,-0.00325715402233236,0.004796450347532
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0143271501453952,0.005085425228223,-0.0242945835927123,-0.00435971669807813,0.00485136273796588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.0274443210224561,0.00978888234538378,-0.0466305304194083,-0.00825811162550385,0.00506180897724378
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0204968209871369,0.00732403072531375,-0.0348519212087519,-0.00614172076552198,0.0051418788836863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0200853284893932,0.0071822185346091,-0.0341624768172271,-0.00600818016155942,0.00517261290931501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.028031537621141,0.010042289708437,-0.0477144254496775,-0.00834864979260456,0.00525796294532154
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.018253073322103,0.00655006404393123,-0.0310911988482082,-0.0054149477959978,0.00533390862411457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD40LG,CD40 ligand,42296,-0.0231455387687666,0.00830701783621111,-0.0394272937277403,-0.00686378380979278,0.0053392886522035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.00936921169554992,0.00336356205161943,0.00277663007437584,0.015961793316724,0.00535187122882563
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.00930783319726167,0.00334676342048571,0.00274817689310968,0.0158674895014137,0.00542599674075224
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.00831370551355582,0.00298994071037334,-0.0141739893058876,-0.00245342172122408,0.00543403744727795
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NENF,Neudesin,39919,-0.0329009664413772,0.0118657467027919,-0.0561578299788493,-0.00964410290390515,0.00556725862440569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0149423592612755,0.00540104974881507,-0.025528416768953,-0.00435630175359793,0.00567443177133981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH5,Cadherin-5,42310,0.00878615294503359,0.00318203492183777,0.00254936449823156,0.0150229413918356,0.00576705369783325
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.0155363876567276,0.00564315243961098,-0.0265969664383651,-0.00447580887509008,0.00591072866240545
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.0118604626850641,0.00430990190381799,0.00341305495358088,0.0203078704165474,0.00593430855426177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.0295289862118546,0.0107454395861116,-0.0505900478006334,-0.00846792462307581,0.00600485516048878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOSB,Protein fosB,41839,-0.0110684972576524,0.00403238208640923,-0.0189719661470144,-0.00316502836829028,0.00606104203533132
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.0202987174040001,0.00741198760060444,-0.0348262131011848,-0.00577122170681541,0.00617916854042474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0162181484449859,0.00593329928147338,0.00458888185329811,0.0278474150366737,0.00627637922380636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.0109109247184218,0.00400471413473974,-0.0187601644225117,-0.00306168501433191,0.00644809449872924
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL,Podocalyxin,42070,0.00432167651539186,0.00158714768686688,0.00121086704913277,0.00743248598165095,0.00647909938838674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.0144607646932575,0.00531889594538968,-0.0248858007462213,-0.00403572864029374,0.00656308020928433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.017661678187742,0.00650397584834954,-0.0304094708505071,-0.00491388552497687,0.00662557884724247
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD70,CD70 antigen,42119,0.0125642502832798,0.00463235453065649,0.0034848354031931,0.0216436651633665,0.00669063088295537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00958310790586635,0.00353594407988366,-0.0165135583024383,-0.00265265750929438,0.00673440582200988
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.023878954398051,0.00884272827760656,-0.0412107018221599,-0.00654720697394215,0.00693575275052226
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.00794302409044744,0.00294980689580791,-0.0137246456062309,-0.00216140257466394,0.00709742879486346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0163156907993111,0.00607013927521236,0.00441821781989492,0.0282131637787274,0.00720196872865461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0163498036806248,0.00609149935808542,-0.0282891424224722,-0.00441046493877739,0.00728300932409321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.0143916659639165,0.00536722127946329,-0.0249114196716645,-0.0038719122561684,0.00734045615712915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0130842568607185,0.00488500930510782,0.0035096386227072,0.0226588750987299,0.00740737882990811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNW1,Interferon omega-1,39575,0.00996100163926717,0.00372310111698739,0.0026637234499719,0.0172582798285624,0.00747378903837177
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0155020422458388,0.00580113301973803,-0.0268722629645254,-0.00413182152715231,0.00754570656552003
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0211647453110348,0.0079287669387249,-0.0367051285109356,-0.00562436211113402,0.007610759695107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC2,Mucin-2,39966,-0.0260092786503015,0.00976729158251977,-0.0451531701520402,-0.00686538714856276,0.00775805616593058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0277064640485053,0.0104084993650522,-0.0481071228040076,-0.00730580529300301,0.00777910923413163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00938720440331199,0.0035300747844541,-0.016306150980842,-0.00246825782578195,0.00784176843426971
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX1B,Syntaxin-1B,39649,-0.0112445479064112,0.00423531422790052,-0.0195457637930962,-0.00294333201972619,0.00794338683258711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0201869480582291,0.00763282963650114,0.00522660197068683,0.0351472941457713,0.00818633409839795
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0111610414732643,0.00422973094407768,0.00287076882287208,0.0194513141236566,0.00833352224805984
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLN,Mesothelin,42048,-0.0160054841334038,0.00609804153596842,-0.0279576455439019,-0.00405332272290575,0.0086825303506172
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.0225914260780212,0.00863434479577173,-0.0395147418777337,-0.00566811027830857,0.00889449980343524
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0117470731707337,0.00449059132024946,-0.0205486321584226,-0.00294551418304474,0.00891065928468916
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0213943640711609,0.00819592893433266,-0.0374583847824529,-0.00533034335986886,0.00905677969864804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.0126632426683179,0.00485253629795755,-0.0221742138123147,-0.00315227152432105,0.00907466179930243
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INHBB,Inhibin beta B chain,39736,-0.0143830654108466,0.00551273517518025,-0.0251880263541999,-0.00357810446749329,0.00909122721987612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLU,Clusterin,39979,0.00826339753662273,0.00316953894543054,0.00205110120357886,0.0144756938696666,0.00914240297774232
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINI1,Neuroserpin,39713,0.00796393139177704,0.00305655270142861,0.00197308809697697,0.0139547746865771,0.00918552575280254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.0103082785658064,0.00396121166752663,-0.0180722534341586,-0.00254430369745422,0.00927235990624997
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.00501715156096788,0.0019330461035494,-0.00880592192392471,-0.00122838119801105,0.00945845965696728
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00919492961639042,0.00354298885924934,-0.0161391877805191,-0.00225067145226172,0.00946480497192117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.0200639739091533,0.00773900509389389,-0.0352324238931854,-0.00489552392512128,0.00953813114411034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.00757030831870243,0.00292303341156001,0.00184116283204481,0.0132994538053601,0.00961107897214553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.0258768139857702,0.00999412056565205,-0.0454652902944483,-0.00628833767709223,0.00963011703668228
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.0133891520417527,0.00520564073118852,-0.0235922078748822,-0.00318609620862316,0.0101225398398059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.010412181243523,0.00406332164390528,-0.0183762916655774,-0.00244807082146868,0.0104055268692406
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0238710468045594,0.00931632498133976,-0.0421310437679853,-0.00561104984113348,0.0104096136103952
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0230811171540047,0.00900831005165813,-0.0407374048552546,-0.00542482945275475,0.0104141463876878
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.0233596232391569,0.00912263943546284,-0.0412399965326641,-0.00547924994564977,0.0104616832044276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0173243527695576,0.00677153726169427,-0.0305965658024783,-0.00405213973663679,0.010528118604022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00747470035332054,0.00292631589321383,-0.0132102795040196,-0.00173912120262144,0.0106507926715967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.0124293554264369,0.00487236350782545,-0.0219791879017748,-0.00287952295109905,0.0107547504464369
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0190783956721465,0.00750508430304797,-0.0337883609061205,-0.0043684304381725,0.0110313297945302
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0282941488372563,0.0111324760973991,-0.0501138019881586,-0.00647449568635393,0.0110486150553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.0139144207540414,0.00548990106253066,-0.0246746268366015,-0.00315421467148135,0.0112725913416477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00950277512630117,0.0037559021104549,-0.0168643432627928,-0.00214120698980957,0.0114167317075797
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.0142258403121451,0.00562522140485675,-0.0252512742656643,-0.00320040635862585,0.0114542214203724
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00958506460261525,0.00379104469751087,-0.0170155122097366,-0.00215461699549395,0.0114717257009527
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.0178289891947253,0.0070559918130038,-0.0316587331482127,-0.00399924524123784,0.0115224149753665
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INSL3,Insulin-like 3,39929,0.0238876133735338,0.00949703329982116,0.00527342810588428,0.0425017986411832,0.0119078122403541
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0166065723808396,0.00663532843472335,-0.0296118161128973,-0.0036013286487818,0.0123371587663077
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0160803591409564,0.00644557934344335,0.00344702362780746,0.0287136946541054,0.0126149268409804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0119334689196246,0.00479225489232813,0.00254064933066149,0.0213262885085877,0.0127805151011259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.00996793978570981,0.00400305538481767,0.00212195123146718,0.0178139283399524,0.0127831925415103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0152378177986624,0.00612875470148757,0.0032254585837468,0.0272501770135781,0.0129232895186259
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.0178881531593722,0.00719686202737518,-0.0319940027330275,-0.00378230358571686,0.0129474242632031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.0121610316197297,0.00490226577823644,-0.0217694725450731,-0.00255259069438625,0.0131274839738711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.00802544938561758,0.00323713472242809,-0.0143702334415766,-0.00168066532965853,0.0131803024889067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0162009757902451,0.00655970222033077,-0.0290579921420934,-0.00334395943839683,0.0135348761132732
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.00895368351843484,0.00363252607966528,-0.0160734346345788,-0.0018339324022909,0.0137212559709672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00627966213445605,0.00255183116666875,-0.0112812512211268,-0.00127807304778529,0.0138758043070797
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.00683123071394384,0.00278711732359549,0.00136848075969667,0.012293980668191,0.0142613950335872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00871693993496904,0.00356255314763391,0.00173433576560658,0.0156995441043315,0.0144277005236255
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,-0.0203671749616763,0.00832721167138168,-0.0366885098375844,-0.00404584008576825,0.0144634028661476
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.016105008525924,0.00658450222636667,-0.0290106328896027,-0.00319938416224531,0.0144643814471293
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP6,Gastrotropin,41881,-0.0144632914294215,0.00595235040424671,-0.026129898221745,-0.00279668463709794,0.0151184256570075
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.0194134533755029,0.00800475689423882,-0.035102776888211,-0.00372412986279487,0.0153112705059346
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0161871293942293,0.00667595833686544,-0.0292720077344856,-0.00310225105397306,0.0153343826975249
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.0105924150998209,0.00437261523705227,-0.0191627409644433,-0.00202208923519843,0.0154295451667537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0352971606339534,0.0145964447173877,-0.0639061922800333,-0.00668812898787338,0.0156130056878676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0112856363389531,0.00467302497461582,0.00212650738870613,0.0204447652892002,0.0157457942555758
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.0109579572642222,0.00454080719192503,-0.0198579393603953,-0.00205797516804914,0.0158286397437896
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00795336836692625,0.0033050978596984,0.00147537656191739,0.0144313601719351,0.0161272900121434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.0111967421776891,0.00465627600526205,-0.0203230431480027,-0.00207044120737548,0.0162040576010637
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,-0.00981183391734631,0.00408089979053218,-0.0178103975067894,-0.00181327032790323,0.0162184654671348
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0129875369868957,0.00541475526411834,0.00237461666922372,0.0236004573045676,0.0164763458259139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.0110849936059963,0.00462670777519483,-0.0201533408453781,-0.00201664636661438,0.0165974572141453
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.0140539643508183,0.0058903103383762,-0.0255989726140356,-0.00250895608760093,0.0170491424347771
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG4,Desmoglein-4,42018,0.0119843957768576,0.00502576156385983,0.00213390311169235,0.0218348884420229,0.0171118330782231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.0121565696013155,0.00510360139011802,-0.0221596283259468,-0.00215351087668418,0.0172372329546059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERVV_1,,39575,0.0109259508372894,0.00459862407292609,0.00191264765435425,0.0199392540202245,0.0175224460956198
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.00783617937324341,0.00332321508486181,0.00132267780691426,0.0143496809395726,0.018390450131031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00202531346898503,0.000858969347943434,0.000341733547015903,0.00370889339095416,0.0183986493169418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.00978274238798032,0.00415648518764389,-0.0179294533557623,-0.00163603142019831,0.0186096749942395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVI2B,Protein EVI2B,39560,0.00990467232883015,0.00421662479127646,0.00164008773792828,0.018169256919732,0.0188437157145149
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0147416299887805,0.00627884481796728,-0.0270481658319964,-0.00243509414556465,0.0189010648004867
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRR1B,Cornifin-B,39757,-0.0214248736486169,0.00913838988780586,-0.0393361178287163,-0.00351362946851739,0.0190705061732192
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TTN,Titin,39575,-0.017122601024806,0.00730766679525627,-0.0314456279435083,-0.00279957410610367,0.0191419667582275
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00733515819073357,0.00313085727462019,-0.0134716384489891,-0.00119867793247801,0.0191542288440645
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTSH,Pro-cathepsin H,41865,-0.0183187558259691,0.00781962332953928,-0.0336452175518661,-0.00299229410007213,0.0191612798730145
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCN,Decorin,41900,-0.00564289271056978,0.00240968522102038,-0.0103658757437697,-0.000919909677369831,0.019207980962126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0144729377335309,0.00621570450141271,-0.0266557185562998,-0.00229015691076198,0.0199064386204169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-0.00648094049028545,0.00279086271202985,-0.011951031405864,-0.00101084957470694,0.0202397252468544
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.0188503783732944,0.00813662393127379,-0.034798161278591,-0.00290259546799775,0.0205365216869413
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CST6,Cystatin-M,41864,-0.0119811275271031,0.00520801571839699,-0.0221888383351612,-0.001773416719045,0.0214344007392466
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.0122503659252654,0.00532751757930756,-0.0226923003807082,-0.00180843146982255,0.0214978985453675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.0137325836820573,0.00602127812527308,-0.0255342888075925,-0.00193087855652207,0.0225866963988535
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.0214494072245708,0.00941058728325809,-0.0398941582997566,-0.00300465614938491,0.0226656632108096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.00828158678195037,0.00363363825745825,0.00115965579733219,0.0154035177665685,0.022677381392516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.0112931252293234,0.00497751154358704,-0.021049047854754,-0.00153720260389282,0.0232947136830139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.00887540850845279,0.00392713672443198,0.00117822052856612,0.0165725964883395,0.0238391920623929
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0183579081001465,0.00814873269880017,-0.0343294241897948,-0.00238639201049818,0.0242878869240996
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.0136215242223671,0.00604978422073748,0.00176394714972165,0.0254791012950126,0.0243690313387624
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0207595904726383,0.00922504547227259,0.00267850134698406,0.0388406795982926,0.0244462446470604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.0065478208196826,0.00291978023230342,-0.0122705900749973,-0.000825051564367902,0.0249441204456088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00409284641265588,0.00182562403116233,0.000514623311577715,0.00767106951373404,0.0249847226222703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0570126206695518,0.0254407429546656,-0.106876476860696,-0.00714876447840729,0.0250455823662881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP8,Caspase-8,42224,-0.0143136110454519,0.00640783458138069,-0.026872966824958,-0.0017542552659457,0.0255145555312326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.0142885220840849,0.00642210553476112,-0.0268758489322167,-0.00170119523595312,0.0261048607888794
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DAND5,DAN domain family member 5,39657,0.0128000594693435,0.00577395946671153,0.00148309891458886,0.0241170200240981,0.0266529300562386
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.0123983257792416,0.00559642403324827,0.00142933467407502,0.0233673168844082,0.0267522266217865
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00682582690158402,0.00308481616130606,0.000779587225424146,0.0128720665777439,0.026934042845808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHGA,Chromogranin-A,39966,-0.0198112804220841,0.00895355274472838,-0.0373602438017517,-0.00226231704241647,0.0269400281166539
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.0161699913774217,0.00731356274771921,-0.0305045743629514,-0.00183540839189209,0.0270553328531194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRH,Corticoliberin,41830,-0.0198723286259289,0.00899445832708081,-0.0375014669470073,-0.00224319030485052,0.027164109960985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00700814836901975,0.00317354228640634,-0.0132282912503762,-0.000788005487663329,0.0272429399097945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.00929558417904734,0.00421335458765226,-0.0175537591708458,-0.00103740918724892,0.0273857523996667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00606597443486844,0.00275202120729186,0.000672012868576395,0.0114599360011605,0.0275317745623099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.0229441768174431,0.0104219351793847,-0.0433711697690371,-0.00251718386584906,0.0277187382799023
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRL,Appetite-regulating hormone,42145,-0.0191829741356652,0.00871530921505899,-0.0362649801971808,-0.00210096807414955,0.0277481327651039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTRC,Chymotrypsin-C,42122,0.0150823681750704,0.00685324722713866,0.0016500036098786,0.0285147327402621,0.027769697094882
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,-0.0132580928514362,0.00602864372964618,-0.0250742345615427,-0.00144195114132971,0.0278855175170522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO2,Gamma-enolase,42249,-0.0149737136542176,0.0068169922012148,-0.0283350183685986,-0.00161240893983661,0.0280709346356684
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EFNB2,Ephrin-B2,39649,-0.0134003148453245,0.00610257069785403,-0.0253613534131184,-0.00143927627753061,0.0281235698870286
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.00925982107700138,0.00427125906226011,-0.0176314888390312,-0.000888153314971565,0.0301806188009195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMNB1,Lamin-B1,39908,-0.0139581422007511,0.00645000647948555,-0.0266001549005428,-0.00131612950095947,0.0304813116231838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.0120638805319092,0.00557791273101986,-0.0229965894847081,-0.00113117157911027,0.0305745054939108
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.0162650099676182,0.00754471417885446,-0.0310526497581729,-0.00147737017706344,0.0311158422791594
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.0195366017282207,0.00907913262354067,-0.0373317016703604,-0.00174150178608097,0.0314336176855706
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.0106023090239162,0.00494173503952193,0.000916508346453225,0.0202881097013792,0.0319377609314148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FBLN2,Fibulin-2,39966,-0.00725723893289041,0.00338340571835274,-0.0138887141408618,-0.000625763724919034,0.0319779088626493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.0100344660761904,0.00467917736570749,-0.019205653712977,-0.000863278439403689,0.0320150855679229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANPEP,Aminopeptidase N,42187,-0.00613066069996457,0.00286225710119897,-0.0117406846183145,-0.000520636781614593,0.0322194746070044
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.0138448908725925,0.00647814491475909,-0.0265420549055203,-0.00114772683966464,0.0326021111957391
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00701799979681372,0.00329008712916776,-0.0134665705699825,-0.000569429023644917,0.0329369757510794
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.0101440259106416,0.00477318533870259,-0.0194994691744987,-0.000788582646784528,0.0335909238951963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LPA,Apolipoprotein(a),39775,0.0407021260298344,0.0192117719484694,0.00304705301083439,0.0783571990488343,0.0341459993773204
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINB5,Serpin B5,41900,-0.0107789877043492,0.00510059956077114,-0.0207761628434606,-0.000781812565237747,0.0345955066392372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL7,Interleukin-7,42119,-0.0142024037228271,0.00676807416717196,-0.0274678290904841,-0.000936978355170029,0.0358847212101644
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0116443160591281,0.0055533310290796,0.000759787242132114,0.0225288448761241,0.0360283337416848
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0106850199985362,0.0051118676743202,-0.0207042806402038,-0.000665759356868557,0.0366149802823444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STX5,Syntaxin-5,39657,-0.00869370362971925,0.00419977996318402,-0.0169252723575599,-0.000462134901878563,0.0384719606165739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK4,Kallikrein-4,42262,-0.0135070797663925,0.00656324716921376,-0.0263710442180515,-0.000643115314733532,0.0396102731404157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0189413409933547,0.00921242350320634,-0.0369976910596391,-0.00088499092707028,0.0397998537674321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.009468187141648,0.00462280139840675,0.000407496400770774,0.0185288778825252,0.040568377466104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.00788524445073205,0.00386080033409051,-0.0154524131055494,-0.000318075795914656,0.0411371075269494
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARTN,Artemin,41913,-0.00967355921998613,0.00473678666709006,-0.0189576610874826,-0.00038945735248962,0.041149401396796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00567336694017182,0.0027792619184628,0.000226013579984726,0.0111207203003589,0.0412427870039191
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0133534615131433,0.00654876177899522,0.000517888426312705,0.026189034599974,0.0414657394371357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0212853353259929,0.0104486451458014,-0.0417646798117637,-0.000805990840222065,0.041659376140176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0150452531162527,0.00739548340559305,-0.0295404005912151,-0.000550105641290285,0.0419361261746951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0186844806185188,0.00922236154753975,-0.0367603092516967,-0.000608651985340904,0.0427846551299693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.0148195976063268,0.00731823341707059,-0.0291633351037852,-0.000475860108868428,0.0428886756506283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.0114500363070605,0.00566681014430302,0.000343088424226557,0.0225569841898944,0.0433509186561796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.0119380254567365,0.00590908746727092,-0.0235198368925875,-0.000356214020885459,0.0433742218654739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0120908364448733,0.00599023891716093,-0.0238317047225087,-0.000349968167237889,0.0435672318203101
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.0101333164145636,0.00502954634009113,-0.0199912272411423,-0.000275405587985044,0.0439501265429497
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GZMB,Granzyme B,42119,-0.0143192357142152,0.00710970565191486,-0.0282542587919684,-0.000384212636462124,0.0440250439754739
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00926840755231071,0.0046046467890013,-0.0182935152587533,-0.000243299845868154,0.0441560944977621
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0307450100748066,0.0153068782477632,0.000743528709190814,0.0607464914404224,0.044605803864742
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,-0.010923200358247,0.00545350035713989,-0.0216120610582412,-0.000234339658252793,0.0452046011819839
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00537511367062442,0.00269763929195195,-0.0106624866828502,-8.77406583986049e-05,0.0463374494978458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH4,Myosin-4,39575,0.00961676344349893,0.00483561570732612,0.000138956657139729,0.0190945702298581,0.0467551315918672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0128704612122185,0.00649763598948418,-0.0256058277516074,-0.000135094672829466,0.0476394338187126
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUK1,Guanylate kinase,39575,0.00840467591322169,0.00424758763219953,7.94041541106009e-05,0.0167299476723328,0.0478754348792489
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00623876227788637,0.00315405218365415,5.68199979242281e-05,0.0124207045578485,0.0479518090083081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00810568853151478,0.00409806058025312,-0.0161378872688109,-7.34897942186712e-05,0.0479569807380585
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRXN3,Neurexin-3,39649,-0.00747230698792527,0.00379377349980143,-0.0149081030475361,-3.65109283144791e-05,0.0489064308050265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.0111774939044652,0.00568120875765874,4.23247394540846e-05,0.0223126630694763,0.0491521988967563
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HRAS,GTPase Hras,39750,-0.0205914309893599,0.0104827642864141,-0.0411376489907315,-4.5212987988312e-05,0.049518596795417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,-0.00505887201563374,0.00258367465363599,-0.0101228743367603,5.13030549280889e-06,0.0502490921954038
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,-0.00879112209973634,0.00449119693953893,-0.0175938681012326,1.16239017599745e-05,0.0503241870966911
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRSS53,Serine protease 53,39929,0.00786730639039263,0.00402757996564392,-2.67503422694444e-05,0.0157613631230547,0.0508017447626875
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00577602376661779,0.00296011228341325,-0.0115778438421078,2.57963088721776e-05,0.0510477217775722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0174033916256654,0.00892513502482934,-8.98730230001338e-05,0.0348966562743309,0.0512098239591201
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.0183262313341821,0.00941680437854794,-0.0367831679161361,0.000130705247771874,0.0516650401831477
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00995261653756113,0.00512508212520806,-0.0199977775029689,9.25444278466817e-05,0.0521695486134958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171B,Protein FAM171B,39919,-0.00544417519087027,0.00280356832101983,-0.0109391691000691,5.08187183285904e-05,0.0521771873446122
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00687596612008364,0.00354394778264646,-0.0138221037740707,7.01715339034136e-05,0.0523762594798058
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.00826487242151291,0.00426244459935446,-0.0166192638362476,8.95189932218314e-05,0.052522414766838
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK7,Kallikrein-7,39475,-0.00808761600015692,0.00418684289754474,-0.0162938280793446,0.000118596079030765,0.0534256925327773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0125596171116265,0.00650475731101471,-0.0253089414412153,0.000189707217962354,0.0535291450100973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPLX2,Complexin-2,39560,0.00623822500550605,0.00323521307955807,-0.000102792630427759,0.0125792426414399,0.0538527061643944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPN1,Epsin-1,39757,-0.00880329953127904,0.00457586505643617,-0.0177719950418939,0.000165395979335849,0.0543982085556692
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00907383741904931,0.00471939269970833,-0.0183238471104776,0.000176172272379024,0.0545470943596776
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC1,Glypican-1,42262,-0.00595726281639948,0.00309863277285935,-0.0120305830512038,0.00011605741840485,0.0545579084076883
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.011993527683962,0.00624533991615071,-0.000247338551693418,0.0242343939196174,0.0548286535713573
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.0106216073220571,0.00555437504015365,-0.0215081824007583,0.000264967756644054,0.0558638620298969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0135685415586488,0.00711096576395183,-0.0275060344559943,0.000368951338696827,0.0564017542426647
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.00931419659078351,0.00488710981168755,-0.0188929318216911,0.000264538640124075,0.0566886872247886
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CENPJ,Centromere protein J,39757,-0.0141612838431754,0.00743257897903881,-0.0287291386420915,0.000406570955740612,0.0567669224273595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00687268331776851,0.00361261638282403,-0.000208044792566601,0.0139534114281036,0.0571435507083683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMBN,Ameloblastin,41913,0.00544997817423333,0.00286674428801786,-0.000168840630281671,0.0110687969787483,0.0573100035858618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.0139531122238045,0.00734217057466922,-0.0283437665501562,0.000437542102547176,0.0574006872746171
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0164577032104523,0.00866325574869631,-0.0334376844778971,0.000522278056992422,0.057496751069019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.00522540716929039,0.00275710754077582,-0.000178523610630209,0.010629337949211,0.0580853893909191
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0142381041739936,0.00751291262515018,-0.0289634129192879,0.000487204571300774,0.0580986838358676
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,-0.0183022530796142,0.009672365342467,-0.0372600891508495,0.00065558299162112,0.0584876380022921
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0125403667938679,0.00662778948302612,-0.0255308341805991,0.000450100592863312,0.0585052862244686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0167188534716881,0.00883734648140191,-0.0340400525752359,0.000602345631859624,0.0585385192294937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0154500318809018,0.00816891796664663,-0.0314611110955292,0.000561047333725546,0.0586078708503475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00946765662858576,0.0050098875262345,-0.0192870361800054,0.00035172292283385,0.0588072097026908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00503822265076122,0.00268172187366477,-0.000217952221621726,0.0102943975231442,0.0603083307574674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSTN,Osteocrin,39649,-0.00800262726753364,0.00426842980717778,-0.0163687496896021,0.000363495154534807,0.0608409568645136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANK2,Ankyrin-2,39575,0.0138206971024798,0.00737647828202105,-0.000637200330281449,0.0282785945352411,0.0610097481802815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00997792018580623,0.00533376819690936,-0.000476265480136113,0.0204321058517486,0.0614118435789994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.00701326374543487,0.00375071805529389,-0.0143646711338109,0.000338143642941166,0.0615309643994534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0222412534757411,0.0119238891921825,-0.0456120762924188,0.00112956934093665,0.0621700733558321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLB,Beta-klotho,41839,0.0146024783907063,0.00783246077884566,-0.000749144735831231,0.0299541015172438,0.0622941435809982
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00790254181377842,0.00424058399474464,-0.0162140864434779,0.000409002815921069,0.0624114089525103
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00715993933976522,0.00384594940643746,-0.000378121496852206,0.0146980001763826,0.0626744712249761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.00890162315496068,0.00478360519232871,-0.000474243022003593,0.0182774893319249,0.0627903672298703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00438868856595052,0.0023584294312634,-0.00901121025122678,0.000233833119325751,0.0627915963306543
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA6C,Semaphorin-6C,39657,-0.00505383036533645,0.00272485677186498,-0.0103945496381918,0.000286888907518898,0.0636636622691415
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00685785622228147,0.00370172785130471,-0.0141132428108387,0.000397530366275762,0.0639651500309067
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,-0.010830174976556,0.00584966885451751,-0.0222955259314103,0.000635175978298373,0.0641362833101347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENG,Endoglin,42310,-0.00334348718108052,0.00181033641289683,-0.0068917465503583,0.000204772188197264,0.0647850222486907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0179662027741248,0.00974386973334644,-0.0370641874514838,0.00113178190323425,0.0652324131356218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.00893309423999218,0.00484837980696655,-0.0184359186616466,0.000569730181662257,0.0654254711442147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C5,Complement C5,39979,-0.002912338433362,0.00158255651945409,-0.00601414921149202,0.000189472344768028,0.0657539703449281
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLG,Plasminogen,39742,-0.00423494943414206,0.00230263258865452,-0.00874810930790492,0.000278210439620807,0.065915714623347
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00514598623963456,0.00280607549469489,-0.000353921729967422,0.0106458942092365,0.0666999862150642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.0129900554355686,0.00709009577087182,-0.0268866431464774,0.000906532275340174,0.0669521905847142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00474180375620955,0.00259442261394761,-0.000343264567127769,0.00982687207954687,0.0676222085929028
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.00505896364854849,0.0027687866513174,-0.00036785818803361,0.0104857854851306,0.0677053202902343
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00939355406763496,0.00514164660452774,-0.0194711814125093,0.000684073277239405,0.0677291234127331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.00993014173524388,0.00544901531528578,-0.000749928282716247,0.020610211753204,0.0684207594674434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00665053626602587,0.00365125214886185,-0.000505917945743355,0.0138069904777951,0.0685672006182142
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.00995694090943175,0.00547652332119451,-0.020690926618973,0.000777044800109487,0.0690740747655981
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00727193180577608,0.00400041078527821,-0.000568873333369223,0.0151127369449214,0.0691223463881943
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCN1,Transcobalamin-1,39806,-0.00681725093485734,0.00376167954037581,-0.0141901428339939,0.000555640964279254,0.0699682853719048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00599710181161068,0.00331882069530483,-0.0125019903744082,0.000507786751186788,0.0707898076869759
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.0158102412114668,0.00878483507014561,-0.0330285179489522,0.0014080355260186,0.0719272692284791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BEX3,Protein BEX3,39560,0.00885745680395675,0.00493655014237881,-0.00081818147510573,0.0185330950830192,0.0727991540264525
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.0134235833250632,0.00749872706264011,-0.0281210883678378,0.00127392171771146,0.0734628004854967
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00777998413313259,0.00434783724931797,-0.000741776875530624,0.0163017451417958,0.0735794007603349
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0205409226082923,0.0114809891623293,-0.0430436613664577,0.00196181614987313,0.0736222558661508
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.0123861304483773,0.00695029776792184,-0.0260087140735041,0.0012364531767495,0.0747600015787416
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NECTIN1,Nectin-1,39657,-0.00619351956380856,0.00348471454244497,-0.0130235600670007,0.000636520939383573,0.0755399385286774
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.00505689204092406,0.00285027765881789,-0.000529652170359014,0.0106434362522071,0.0760566712018167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.00949302870208867,0.00535935239372391,-0.0010113019896102,0.0199973593937875,0.0765383318149785
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.00922642243075255,0.00521175951035401,-0.000988626209541295,0.0194414710710464,0.0766982871900628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.0193786317999517,0.0109846801923617,-0.0409086049769807,0.00215134137707729,0.0777335454394578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,-0.00457183329166819,0.002598127711542,-0.0096641636062905,0.000520497022954125,0.0784916798597686
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL25,Interleukin-25,39510,0.00637772463664078,0.00362482354086747,-0.00072692950345946,0.013482378776741,0.0785277793484682
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.0152888834623777,0.00869551689108126,-0.032332096568897,0.00175432964414158,0.0787330013315868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.0033811178523287,0.0019234444814404,-0.00715106903595188,0.000388833331294476,0.0788015487307186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0154754213518294,0.0088420569348551,-0.00185501024048661,0.0328058529441454,0.0801107115123297
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.00633844883374873,0.0036237603668094,-0.0134410191526952,0.000764121485197691,0.0802906212708321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.0222649005833197,0.0127385998220052,-0.0472325562344499,0.00270275506781046,0.0805206424546512
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.00891051757682134,0.00510599712873066,-0.00109723679549075,0.0189182719491334,0.0809940579578941
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPP1,Osteopontin,42286,0.00802750614761093,0.00460700688603722,-0.00100222734902203,0.0170572396442439,0.0814511702771446
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTF4,Neurotrophin-4,41843,-0.00691274918045947,0.0039738990192808,-0.0147015912582498,0.000876092897330897,0.0819633710280416
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00712067490782477,0.00410195833968431,-0.000919163437956479,0.015160513253606,0.0826058998552265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.00604931700224472,0.00348590588380056,-0.0128816925344938,0.000783058530004379,0.0826988289392012
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.00535498590990062,0.00308869806948366,-0.000698862306287346,0.0114088341260886,0.0829874812746404
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RELB,Transcription factor RelB,39657,-0.008574732849141,0.00495293699263124,-0.0182824893546982,0.00113302365641623,0.0834364950951461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0117489052447333,0.00681806956637011,-0.00161451110535214,0.0251123215948187,0.0848803245237851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00588990965513194,0.00342619702030112,-0.000825436504658258,0.0126052558149221,0.085627822871626
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.00550351488089319,0.00320814384024723,-0.000784447045991383,0.0117914768077778,0.0862841267946363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00875163589436047,0.00510495232109115,-0.0187573424436991,0.00125407065497818,0.086494105469312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.00471883783534309,0.00277433059248638,-0.00071885012593022,0.0101565257966164,0.0889915215320316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.0120612275568855,0.00709183275805225,-0.0259612197626679,0.0018387646488969,0.0890236292343833
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.00435121434211923,0.00256783267312411,-0.000681737697204021,0.00938416638144249,0.0901914053495569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.00780469336518686,0.00460896283862446,-0.00122887379851709,0.0168382605288908,0.0904119743203476
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3A,Uroplakin-3a,39586,0.00864525693580946,0.00511895607370444,-0.00138789696865125,0.0186784108402702,0.0912725145101775
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00732989638968393,0.0043438863540743,-0.0158439136436696,0.00118412086430169,0.0915534184639502
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00844950286501269,0.00502313450461891,-0.0182948464940658,0.00139584076404038,0.0925744897295368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00522188050340118,0.00310828576224377,-0.000870359590596613,0.011314120597399,0.0929882251636959
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0119612358165928,0.00712049054244052,-0.0259173972797762,0.00199492564659061,0.0930173499107338
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.004347019838707,0.00259281245356742,-0.000734892570285132,0.00942893224769914,0.0936504984444567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMI,N-myc-interactor,39875,0.012892142565932,0.00769062458417598,-0.00218148161905293,0.0279657667509169,0.0936982955066166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99,CD99 antigen,42137,0.0034954542998003,0.00208719972158862,-0.000595457154513387,0.007586365754114,0.0940142380570475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.0132462067435648,0.00793292253038212,-0.0287947349031138,0.00230232141598415,0.0949872545044997
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.0077319664837301,0.00464646437205306,-0.0168390366529541,0.0013751036854939,0.0961252221736894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.00599768490696904,0.00360481387498783,-0.0010677502880071,0.0130631201019452,0.0961802163362364
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EVPL,Envoplakin,39757,0.00587043883814727,0.00353223156383217,-0.00105273502696379,0.0127936127032583,0.0965482482008581
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00679741727584315,0.00409146544666156,-0.0148166895512998,0.0012218549996135,0.0966687350883985
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.0109799097751507,0.00661100796417946,-0.0239374853849425,0.00197766583464101,0.096771406236176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,-0.00590811457835334,0.00357526093332679,-0.0129156260076739,0.00109939685096717,0.0984612918787905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.012238966064502,0.00744187882166887,-0.026825048554973,0.00234711642596899,0.100079989644604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.0052746261388006,0.00321847617571369,-0.0115828394431994,0.00103358716559824,0.101270986210905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO6,Coronin-6,39586,-0.00674961868633234,0.00412592288555385,-0.0148364275420179,0.0013371901693532,0.101888076498725
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00405746470257457,0.00248957281775774,-0.000822098020230606,0.00893702742537974,0.103175795858031
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTC,Probetacellulin,41843,-0.0125430053462224,0.00769751644855459,-0.0276301375853894,0.00254412689294455,0.103233683551474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00576514132601709,0.00354954030949325,-0.00119195768058969,0.0127222403326239,0.104362704342053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN2,Contactin-2,42262,-0.00749085302218988,0.00461507312979409,-0.0165363963565863,0.00155469031220653,0.104585181639809
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00561474217176121,0.00346168868921064,-0.0123996520026141,0.00117016765909164,0.1048393019937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0196594241210702,0.0121370427832512,-0.0434480279762424,0.00412917973410213,0.105301725127279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DSG3,Desmoglein-3,42196,-0.00595446473504658,0.00368158770481509,-0.0131703766364842,0.001261447166391,0.105823087309705
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0111315472844343,0.00696249538000503,-0.00251494366037554,0.0247780382292442,0.109896718825974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00783958562563887,0.0049104053081527,-0.0174639800296182,0.00178480877834042,0.110400170075989
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00497239979633598,0.00312000975097182,-0.0110876189082408,0.00114281931556879,0.111028935762899
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCLRE1C,Protein artemis,39560,0.00511843061327612,0.0032130506392785,-0.00117914863970973,0.011416009866262,0.111186169349651
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00998716792140154,0.00628850801950842,-0.022312643639638,0.00233830779683496,0.112278544486203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00726135353617573,0.00458178552933673,-0.00171894610132426,0.0162416531736757,0.113028122438919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OTOA,Otoancorin,39586,0.00879635832543336,0.0055526071689471,-0.00208675172570296,0.0196794683765697,0.113180354308458
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.012784892344443,0.00807185335789777,-0.0286057249259226,0.00303594023703665,0.113248401807178
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.0137580450136042,0.00870211214742217,-0.0308141848225517,0.0032980947953432,0.113906759562382
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.0121205308434206,0.00769320656531675,-0.0271992157114414,0.00295815402460026,0.11517335329993
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PZP,Pregnancy zone protein,39979,-0.00547499754961516,0.00349542643041977,-0.0123260333532379,0.00137603825400758,0.117298768432329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CBLN1,Cerebellin-1,39586,0.0153159023240403,0.00979087621072036,-0.00387421504897161,0.0345060196970522,0.117775103684363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.0177717015055172,0.0114511906501843,-0.0402160351798785,0.00467263216884409,0.120702877154791
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00457700629922577,0.00295528886010959,-0.0103693724650406,0.00121535986658902,0.121470231155723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00638066580622937,0.00412223679000176,-0.00169891830217407,0.0144602499146328,0.121683689855702
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0309873100065447,0.0201256710169361,-0.0704336251997394,0.00845900518664998,0.123659128416764
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0272146824836104,0.0176831308666633,-0.00744425401504963,0.0618736189822705,0.123823271155537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.0093145701877313,0.00605996205013429,-0.0211920958059945,0.0025629554305319,0.124305669023318
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB5,Integrin beta-5,42181,0.00618694123223643,0.00402763943977237,-0.00170723206971742,0.0140811145341903,0.124532019825604
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00670534563533528,0.00437000608951189,-0.00185986630010802,0.0152705575707786,0.124959607432518
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOX9,Transcription factor SOX-9,39649,-0.00446848901965679,0.00291547528485075,-0.0101828205779643,0.00124584253865068,0.125383488469821
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00606057990407256,0.00395754469301139,-0.00169620769422976,0.0138173675023749,0.12569960947999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CES2,Cocaine esterase,42070,-0.00892912092582267,0.00583788320213414,-0.0203713720020056,0.00251313015036024,0.126160687160649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR4,Toll-like receptor 4,39657,-0.0045585010738944,0.00299757160999315,-0.010433741429481,0.00131673928169218,0.128355866423049
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS2,Podocin,39657,0.0163315297499818,0.0107592746499774,-0.00475664856397397,0.0374197080639376,0.129067572613761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00961261324692003,0.00634130123365783,-0.0220415636648894,0.0028163371710493,0.129579156998548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00475412450661414,0.00313695895074673,-0.00139431503684945,0.0109025640500777,0.129665266673901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.0104042766577237,0.00687650451271419,-0.0238822255026435,0.00307367218719615,0.130298766950162
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00830892694308977,0.00550140838555718,-0.0190916873787818,0.00247383349260231,0.130983810087519
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.00835998997115072,0.00554267126200508,-0.0192236256446807,0.00250364570237923,0.13150660962395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-0.0116661151751771,0.00774605370114713,-0.0268483804294255,0.00351615007907126,0.13207698228245
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RTKN2,Rhotekin-2,39575,0.00809358338013488,0.00537436761550211,-0.00244017714624927,0.018627343906519,0.132106187006209
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00835091385734839,0.00559759242766326,-0.0193221950155684,0.0026203673008716,0.135759521482752
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00561649437320608,0.00377396964836817,-0.00178048613759553,0.0130134748840077,0.136721806694234
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0121665903822767,0.00819558171144368,-0.0282299305367063,0.0038967497721529,0.137696104658655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00809641874420055,0.00547367046511437,-0.0188248128558247,0.00263197536742361,0.139127661257299
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF5,Fibroblast growth factor 5,41913,-0.00528038560290076,0.0035727412302513,-0.0122829584141933,0.00172218720839179,0.139440869967329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00707201715330725,0.004793019122087,-0.0164663346325978,0.00232230032598328,0.140111290808237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL33,Interleukin-33,41913,-0.00609643954119528,0.00413378275795779,-0.0141986537467925,0.00200577466440199,0.140294084363868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00472035934727123,0.00320285003821642,-0.0109979454221754,0.00155722672763295,0.140559304527039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.0030601773374339,0.00207662628440367,-0.00713036485486509,0.00101001017999728,0.140609140876761
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.00692388005530232,0.00470168973828514,-0.0161391919423412,0.00229143183173655,0.140877716937614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB2,Integrin beta-2,42079,-0.0044293696741127,0.00300789069977162,-0.0103248354456651,0.00146609609743967,0.140886773894373
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.00990617596891345,0.00674699233168356,-0.0231302809390132,0.00331792900118632,0.142068415591974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTH3,Cytohesin-3,39560,-0.0112956856603155,0.00771473679190878,-0.0264165697724567,0.00382519845182575,0.143176203488765
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DPEP2,Dipeptidase 2,42070,0.00460277646934524,0.00315535217957268,-0.00158171380261721,0.0107872667413077,0.144665406399734
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.010209920098178,0.00700906443415677,-0.0239476863891253,0.00352784619276925,0.145230177675355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALM,Paralemmin-1,39859,-0.00469809559105638,0.00323137645926748,-0.0110315934512207,0.00163540226910788,0.146002132980438
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00626183543543168,0.00430715772135354,-0.0147038645692846,0.00218019369842126,0.146024380505596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00562175738175565,0.00387201073980086,-0.0132108984317653,0.00196738366825402,0.146558884168444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.00738228934247711,0.00508780645135675,-0.0173543899871363,0.00258981130218213,0.146814860321088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERC2,ERC protein 2,39649,-0.0112348801292322,0.0077783944188841,-0.026480533190245,0.00401077293178068,0.148663259309877
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.00805932457957333,0.00559285888680715,-0.00290267883856867,0.0190213279977153,0.149612040212323
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM1,Myomesin-1,39586,-0.00743559033907936,0.00517492815806154,-0.01757844952888,0.00270726885072126,0.150789381734688
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.0101743576272553,0.00708236866836162,-0.00370708496273345,0.0240558002172441,0.150867179895843
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00687604038019882,0.0047883131619394,-0.0162611341776,0.00250905341720241,0.151029466067994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.00944699255353622,0.00658633292076549,-0.0223562050782366,0.00346221997116415,0.151505879075368
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TP73,Tumor protein p73,39649,0.00515900180100218,0.00361544715848125,-0.00192727462962108,0.0122452782316254,0.153627390079807
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.0092470062706118,0.00648729949554258,-0.00346810074065165,0.0219621132818752,0.154068756131793
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,-0.0076307302835954,0.00536491378536299,-0.0181459613029069,0.00288450073571607,0.154956055880872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.00890992583503718,0.0062880576408576,-0.00341466714104371,0.0212345188111181,0.156522832194094
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINA11,Serpin A11,42310,-0.00619368793248007,0.0043763087549967,-0.0147712530922736,0.00238387722731348,0.157010089323915
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEMA4C,Semaphorin-4C,42070,-0.00413025249774176,0.00292089339093888,-0.00985520354398196,0.00159469854849844,0.157374032978815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0145359504452979,0.010339284039941,-0.0348009471635823,0.0057290462729864,0.15978265324021
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.00682466796856212,0.00485738285465214,-0.00269580242655608,0.0163451383636803,0.160045926540147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00380929411501069,0.00272015943921883,-0.0091408066158796,0.00152221838585821,0.161422724542574
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,0.0188443674191988,0.0134604060428255,-0.00753802842473927,0.0452267632631368,0.161540520124452
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.015451478075904,0.0110767043706764,-0.0371618186424299,0.00625886249062179,0.163053297367534
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NINJ1,Ninjurin-1,41843,-0.00794990602895046,0.00570154625870605,-0.0191249366960143,0.00322512463811339,0.163237711871922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00506406890457609,0.00364790817310929,-0.0020858311147181,0.0122139689238703,0.165100731043114
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0100772510394295,0.00725954614715332,-0.00415145940899106,0.02430596148785,0.165123049643799
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5,Interleukin-5,41913,-0.0200588198359948,0.0144769733722272,-0.04843368764556,0.00831604797357047,0.165902302844846
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00761751460630458,0.005500934444659,-0.0183993461178362,0.00316431690522707,0.16615179465385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00695248683561206,0.00505424228512819,-0.0168588017144633,0.00295382804323919,0.168981477219229
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.0066760042188316,0.00485880508974574,-0.0161992621947332,0.00284725375707004,0.169464551759139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0223947925267035,0.0163936803653046,-0.0545264060427006,0.00973682098929352,0.171941913053623
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUC16,Mucin-16,42070,-0.0273324674117578,0.0200242294204873,-0.0665799570759129,0.0119150222523974,0.172285355910727
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.00705293603268045,0.00516937362005803,-0.00307903626263328,0.0171849083279942,0.172474182547895
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00860320496963861,0.00630929064511499,-0.020969414634064,0.00376300469478676,0.172723746008975
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGR,Progesterone receptor,39657,-0.0144102417633288,0.010582406898221,-0.0351517592838419,0.00633127575718435,0.173315005919522
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00890856439067148,0.00655085251834843,-0.0217482353266344,0.00393110654529144,0.173882141021362
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.00475333436744087,0.00351394130373858,-0.00213399058788675,0.0116406593227685,0.176176967784139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.00357141928722975,0.00264572824957368,-0.00161420808193467,0.00875704665639417,0.177076594436054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CORO1A,Coronin-1A,41883,-0.012534513714547,0.00929369387309263,-0.0307501537058085,0.00568112627671459,0.177452577318538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GKN1,Gastrokine-1,41538,-0.0040020335494318,0.00297495018036783,-0.00983293590295275,0.00182886880408916,0.178570064608065
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HLA_DRA,,42060,-0.00512829400336725,0.0038162350535497,-0.0126081147083247,0.00235152670159016,0.179032556216445
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.00517074926646431,0.00386053543629041,-0.0127373987215935,0.00239590018866489,0.180467088883433
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0138826643278005,0.0103866059120473,-0.0342404119154132,0.00647508325981222,0.18137850073163
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00601010829760503,0.00450525802212239,-0.00282019742575486,0.0148404140209649,0.182224692265385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.00637927678691362,0.00478725588351522,-0.0157622983186034,0.00300374474477621,0.182705682405276
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20,Interleukin-20,41913,0.006499029728939,0.00488934335982105,-0.00308408325631025,0.0160821427141883,0.183797046692745
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00657062840828848,0.0049524203311858,-0.0162773722574126,0.00313611544083569,0.184617808343578
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNTN4,Contactin-4,42137,0.00326072152226515,0.00246135941665772,-0.00156354293438397,0.00808498597891428,0.185271642291062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSB,Lupus La protein,41839,-0.00817238718877854,0.00617316915808899,-0.020271798738633,0.00392702436107588,0.185573722453449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN2,Neuroligin-2,39586,0.00652730166794392,0.00494045923364574,-0.00315599843000174,0.0162106017658896,0.186464433708248
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00609759233147321,0.00461788510371374,-0.0151486471347521,0.00295346247180573,0.186719122993203
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00861854874745921,0.00653610656430924,-0.0214293176135053,0.0041922201185869,0.187328384161624
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.0105409699873667,0.00800298979691093,-0.0262268299893121,0.00514489001457877,0.187822857196241
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00584485018903016,0.00444057885113395,-0.00285868435919238,0.0145483847372527,0.188121850829059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00470630104506073,0.00358582784768466,-0.0023219215364012,0.0117345236265227,0.189387964316015
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.0157263137938565,0.012028737314612,-0.00785001134278305,0.0393026389304961,0.191100707915966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.00872875216042417,0.00669658518034292,-0.00439655479304795,0.0218540591138963,0.192439222122493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00744947576921942,0.00571713540975824,-0.0186550611723456,0.00375610963390673,0.192599009593769
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00614375367825906,0.00471927588773574,-0.0153935344182211,0.003106027061703,0.192997126819467
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPM1B,Protein phosphatase 1B,39657,-0.00844455969012873,0.00651403290095131,-0.0212120641759933,0.00432294479573583,0.194877061553329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCIN,Adseverin,39586,-0.010085930235393,0.00779774069418996,-0.0253695019960053,0.00519764152521931,0.195885208909969
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FZD10,Frizzled-10,39649,-0.00813054810446816,0.00629330500287654,-0.0204654259101062,0.00420432970116985,0.196406286264513
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00555702645501597,0.00430393429692152,-0.00287868476695022,0.0139927376769822,0.196678545208282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00682282259302863,0.00529099182733474,-0.0171931665746047,0.00354752138854747,0.19724564337763
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NLGN1,Neuroligin-1,39649,0.00913278437697643,0.00708706519118732,-0.00475786339775071,0.0230234321517036,0.19754491794514
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00408077137173311,0.00317294450147098,-0.00213819985115001,0.0102997425946162,0.198425431250131
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0111379958848086,0.0086617725897744,-0.00583907839114919,0.0281150701607665,0.198511802413109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0082809383302646,0.00646165314848186,-0.00438390184075985,0.0209457785012891,0.200026416521442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,F2,Prothrombin,39979,0.00200570812544517,0.00156630453542038,-0.00106424876397877,0.0050756650148691,0.200383066361506
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.0232573682144082,0.0181759749796759,-0.058882279174573,0.0123675427457565,0.200723848711233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00866199224356991,0.00677555611735224,-0.0219420822335803,0.00461809774644048,0.201129186208949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00882364371567875,0.0069096941762804,-0.0223666443011883,0.00471935686983083,0.201630649167292
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,-0.00639644627606764,0.0050128048707135,-0.0162215438226661,0.00342865127053083,0.201974958809642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00771802773839386,0.00606597113298336,-0.00417127568225353,0.0196073311590412,0.203276169161035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.00491724997435345,0.0038820236908169,-0.0125260164083546,0.00269151645964767,0.205299156082674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00623441282011898,0.0049231792425177,-0.00341501849521571,0.0158838441354537,0.205418666320169
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCG3,Secretogranin-3,42144,-0.00441532475586254,0.0034895449174824,-0.011254832794128,0.00242418328240298,0.205785207209046
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00606857539431957,0.00479643584366031,-0.0154695896478938,0.00333243885925464,0.205816427879099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00994282595513759,0.00788660398145966,-0.00551491784852334,0.0254005697587985,0.20743533158288
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.00891087739475446,0.00708314255063952,-0.0227938367940079,0.00497208200449901,0.208404017059965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00564114682954693,0.00449764213323608,-0.00317423175159579,0.0144565254106897,0.209779581728355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.00458324879139186,0.00370573480117497,-0.00267999141891108,0.0118464890016948,0.216183676292979
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.00529364497173101,0.00428380119268187,-0.0136898953093875,0.00310260536592545,0.21658254039729
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.00519505740078983,0.00420934032264593,-0.0134453644331758,0.00305524963159619,0.217163783651328
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.00358723488970693,0.0029129547267248,-0.00929662615408754,0.00212215637467369,0.218166075633353
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.00340237934406305,0.00276315949144252,-0.00881817194729038,0.00201341325916428,0.218222565681828
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MB,Myoglobin,42310,-0.00722593940823199,0.0058774871783239,-0.0187458142777468,0.00429393546128285,0.218932979647184
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.00850548554587013,0.00692397606121242,-0.0220764786258465,0.00506550753410622,0.219313980980435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.0113630019964085,0.00927748008583961,-0.0295468629646542,0.00682085897183708,0.220678981102095
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00510093406633455,0.00416781838914077,-0.00306798997638137,0.0132698581090505,0.221021555270316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.0161887745768703,0.0132528680949311,-0.0421643960429352,0.00978684688919467,0.221907198045768
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00855640650459429,0.00705064576331431,-0.0223756722006903,0.00526285919150175,0.22494053352964
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.00485767982275572,0.00401543695588422,-0.0127279362562888,0.00301257661077735,0.226399594172709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.0076706678415566,0.00635777722341756,-0.020131911199455,0.00479057551634183,0.227649988796233
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFP,Alpha-fetoprotein,41976,0.00821420132184668,0.0068234312816065,-0.00515972399010206,0.0215881266337954,0.228679425362927
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.00400124604310252,0.00333158957724569,-0.00252866952829903,0.0105311616145041,0.229776283538847
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00497210851272832,0.00416861082064651,-0.0131425857211955,0.00319836869573885,0.23299285450218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00888780973860764,0.00747588560799825,-0.00576492605306892,0.0235405455302842,0.234518965529109
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00599766779684543,0.00507621835174369,-0.0159470557662631,0.0039517201725722,0.237420278835283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.00397643632821228,0.00338045686937835,-0.0106021317921938,0.00264925913576928,0.239495579336129
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.0051806134678811,0.00442676013476544,-0.00349583639625916,0.0138570633320214,0.241907658535631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00475802052113804,0.00407999483350778,-0.00323876935253722,0.0127548103948133,0.243565401278116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.0064365342122688,0.00552170350422561,-0.017259073080551,0.00438600465601339,0.243769531962331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00372795295787272,0.00321413939061161,-0.00257176024772603,0.0100276661634715,0.246130919026274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00494190548862185,0.00426125012730954,-0.00341014476090484,0.0132939557381485,0.246183419196389
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINC1,Antithrombin-III,39959,0.00176660606799401,0.00152400616577635,-0.00122044601692764,0.00475365815291567,0.246404889168383
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VCAN,Versican core protein,42249,0.00364040736551816,0.00315095011790353,-0.00253545486557277,0.00981626959660908,0.247972920097032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD2,Leiomodin-2,39586,-0.0075051607517882,0.00649815929186812,-0.0202415529638497,0.00523123146027331,0.24812898468944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.0061533844943262,0.00536019277841391,-0.0166593623400175,0.00435259335136507,0.251002414675274
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.00506844394813639,0.00441587877582926,-0.0137235663487617,0.00358667845248897,0.251085304495137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EP300,Histone acetyltransferase p300,39657,-0.00373139366284421,0.00325138831391688,-0.0101041147581213,0.00264132743243287,0.251145802304216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00623231490969495,0.00544154415859035,-0.016897741460532,0.00443311164114214,0.252096898545475
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.00843847580093804,0.00737521500440551,-0.0228938972095728,0.00601694560769675,0.252578662165345
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.00700329995822586,0.00614070154961809,-0.0050324750790256,0.0190390749954773,0.254114452500222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00672454140758073,0.00589854173200967,-0.00483660038715821,0.0182856832023197,0.25429675846091
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.00909760142616902,0.0079828228814669,-0.0065487314215061,0.0247439342738441,0.254457445159153
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.0060703492541599,0.00534019184223773,-0.00439642675662604,0.0165371252649458,0.255672298145088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.0070203317268184,0.00617736187203579,-0.0191279609960085,0.00508729754237175,0.255783829631272
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A3,Protein S100-A3,39919,-0.0051050908659868,0.00450782181812979,-0.0139404216295212,0.00373023989754759,0.257449890209914
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.00337260497066501,0.00299472210167905,-0.00924226028995595,0.00249705034862593,0.260107988354547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NEB,Nebulin,39575,-0.00471239254012262,0.00420093561097185,-0.0129462263376274,0.0035214412573822,0.26199399934282
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.00884831722769932,0.00789720123919357,-0.0243268316565187,0.00663019720112007,0.26255203667806
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00627607401589198,0.00561036460382283,-0.0172723886393847,0.00472024060760077,0.263310551724722
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00576010749826031,0.00515440505645985,-0.0158627414089216,0.00434252641240099,0.263800099973932
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00572170040549906,0.00512668192136253,-0.0157699969713696,0.0043265961603715,0.264415661100395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00332055525754753,0.0029761960926623,-0.00251278908407058,0.00915389959916564,0.264572924750808
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDAN1,Codanin-1,39929,0.00256061170948818,0.00230534554977691,-0.00195786556807455,0.00707908898705091,0.266709045787457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00735705376156903,0.00663431952545757,-0.0203603200314659,0.00564621250832781,0.267480920625401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00364861203165538,0.00329300304198627,-0.0101028979939485,0.00280567393063771,0.267890764828714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00551283680582142,0.00497716211990078,-0.015268074560827,0.00424240094918412,0.268046677503516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.00513336449903532,0.00464842497733484,-0.0142442774546116,0.00397754845654096,0.269477210462502
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANXA4,Annexin A4,42088,-0.00836727716421753,0.0075996215273594,-0.023262535357842,0.0065279810294069,0.270910929559712
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00260587860560173,0.00236775640782289,-0.00203492395373114,0.0072466811649346,0.271107733737868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.00895717633123758,0.00814389003863128,-0.0249192008069549,0.00700484814447972,0.271415279491635
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.0120226109978515,0.0109443698877722,-0.033473575977885,0.00942835398218198,0.272001354730674
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.0046464628564575,0.00424086762650579,-0.0129585634044089,0.00366563769149386,0.273260530878377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.0040464840186346,0.00370372991969271,-0.0113057946612323,0.00321282662396311,0.274614402549531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00556168088467867,0.00510299404693499,-0.0155635492166712,0.00444018744731391,0.275787444179648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00791927188665068,0.00729232922691561,-0.0222122371714053,0.00637369339810392,0.277514675927099
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.00350010854350678,0.00322869009768088,-0.00282812404794774,0.0098283411349613,0.278359240066751
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.0034285613738296,0.00316657042891181,-0.00963503941449676,0.00277791666683755,0.278945118893053
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00637372738956502,0.00590385095074439,-0.00519782047389397,0.017945275253024,0.280349331631207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00434465641718449,0.00403321868132894,-0.0122497650325892,0.00356045219822022,0.281406489913997
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.005710952592903,0.00533780155080762,-0.0161730436324859,0.00475113844667992,0.284680159838225
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK15,Kallikrein-15,39900,-0.00592459867792503,0.00555227872382166,-0.0168070649766155,0.00495786762076541,0.285968828806254
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,-0.00801927592291022,0.00752676510531754,-0.0227717355293326,0.00673318368351215,0.286702613541298
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00385573228424751,0.00362665959296086,-0.00325252051795577,0.0109639850864508,0.287731007807273
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP13,Collagenase 3,41839,0.00359288031218834,0.00338348831559219,-0.00303875678637234,0.010224517410749,0.288306618387216
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,-0.00518535141738496,0.00489033622401818,-0.0147704104164606,0.00439970758169067,0.289015005489493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00704941750834367,0.0066989047981841,-0.0201792709127845,0.00608043589609718,0.292673768154296
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,-0.00259375045044804,0.0024654852741022,-0.00742610158768836,0.00223860068679228,0.292807193147128
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.00885887507850205,0.008423516227743,-0.00765121672787423,0.0253689668848783,0.292967858591417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.00456886244322117,0.00434910896623913,-0.0130931160170499,0.00395539113060753,0.293498243858481
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,-0.00445981777198225,0.00424655440299817,-0.0127830644018587,0.00386342885789416,0.293635775045673
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00712764327984662,0.00679692089244402,-0.0204496082290369,0.00619432166934366,0.294358636699881
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,-0.00621145242033359,0.00595422719276742,-0.0178817377181577,0.00545883287749055,0.296877727977444
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00762859892636292,0.0073714803854607,-0.0220767004818659,0.00681950262914005,0.300747522420412
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00591295743185084,0.00572102687060284,-0.0171261700982324,0.00530025523453072,0.30136999763581
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00961813375686516,0.00936285404861161,-0.0279693276921439,0.00873306017841359,0.304318094960474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00582172975480872,0.00567233182637173,-0.0169395001344973,0.00529604062487988,0.304754219286244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.00409027699193552,0.00398804539548174,-0.0119068459670797,0.00372629198320868,0.305085791865417
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00296676812951747,0.00289312058758466,-0.00270374822214846,0.0086372844811834,0.305170265471081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDSN,Corneodesmosin,42246,-0.0047008488292813,0.00459060000111344,-0.0136984248314636,0.00429672717290105,0.305845769253963
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00391855228699192,0.00382900540561301,-0.00358629830800958,0.0114234028819934,0.30614700064078
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00329647198687113,0.00323905709564304,-0.00305207992058922,0.00964502389433149,0.308826775245835
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PALLD,Palladin,39657,0.00409158153641921,0.0040263193556634,-0.00380000440068105,0.0119831674735195,0.309552157533741
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00477812945253979,0.00471932714101806,-0.0044717517438556,0.0140280106489352,0.311340533788195
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESR1,Estrogen receptor,39657,-0.00607524791594053,0.00603545139626022,-0.0179047326526105,0.0057542368207295,0.314152045534499
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.00652168506198381,0.00650242828117067,-0.00622307436911069,0.0192664444930783,0.315901539369124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTR,Methionine synthase,39575,-0.00690516182946444,0.00689500901787291,-0.0204193795044953,0.00660905584556646,0.316620514367738
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00492280063156135,0.00494198954969005,-0.00476349888583115,0.0146091001489538,0.319215210764207
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00256268570517694,0.00258010260206304,-0.00249431539486661,0.0076196868052205,0.320609901327954
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.00341630071698859,0.00344473595705324,-0.0101679831928129,0.00333538175883577,0.321343648177113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00461124858120122,0.00465735539840866,-0.0137396651620822,0.00451716799967975,0.322146302567947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00249363985251639,0.00252207820964341,-0.00244963343838468,0.00743691314341747,0.322815753098043
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.0128241821516206,0.012990062037546,-0.0382847037452107,0.0126363394419695,0.323547813453537
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.00822742500143059,0.00835603765037674,-0.00815040879330782,0.024605258796169,0.324837804744782
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00399974967610547,0.00407012988253298,-0.00397770489365917,0.0119772042458701,0.325769072303617
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00511414052347867,0.00522210820410705,-0.00512119155657114,0.0153494726035285,0.327440380624278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,-0.00320114043991371,0.00326959577129759,-0.00960954815165698,0.00320726727182956,0.327570243103936
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00265767858960949,0.00272237711393208,-0.00267818055369739,0.00799353773291637,0.328965778323194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,-0.00582537819383021,0.00597487756718789,-0.0175361382255185,0.00588538183785806,0.329593321854156
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BSND,Barttin,39560,-0.00344600932362843,0.00354163582955986,-0.0103876155495658,0.0034955969023089,0.330575103542586
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00371127841346489,0.00381589471652572,-0.0111904320578553,0.00376787523092553,0.330781375360843
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00368476162656502,0.00383253130767263,-0.00382699973647334,0.0111965229896034,0.336346483971796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00861210099970957,0.00900517297718389,-0.02626224003499,0.00903803803557085,0.338912684930027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.00851310651407911,0.0089152391233286,-0.00896076216764495,0.0259869751958032,0.339648843213113
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00687810928894024,0.00720349663491633,-0.00724074411549578,0.0209969626933763,0.339685111708485
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00486935002583119,0.00513269407910866,-0.00519073036922178,0.0149294304208842,0.3427976151498
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.00593607053460965,0.00629246443153484,-0.0182693008204179,0.00639715975119864,0.34551598624675
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00472098641900563,0.00501231073613297,-0.0145451154618262,0.005103142623815,0.346275573859115
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00546586105038999,0.00580923348538249,-0.0168519586817397,0.00592023658095969,0.346780967536307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00520277819460636,0.00553726563601871,-0.016055818841203,0.00565026245199032,0.347446546987316
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ESPL1,Separin,39560,0.00528423025964565,0.005633170488478,-0.00575678389777124,0.0163252444170625,0.348236222209407
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.00728002669986386,0.0077999545799569,-0.0225679376765794,0.00800788427685167,0.350663829831117
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPN3,Calpain-3,39919,0.00383263356010424,0.00411977272822331,-0.00424212098721344,0.0119073881074219,0.352234488134193
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LCP1,Plastin-2,39966,-0.00463865244886948,0.00504460103900559,-0.0145260704853204,0.00524876558758147,0.357838924546715
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,-0.0184999429669641,0.0201542492715013,-0.0580022715391066,0.0210023856051784,0.358678349526244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASP4,Caspase-4,39757,0.0161115730080093,0.0175582763317493,-0.0183026486022194,0.050525794618238,0.358845210457658
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.00612811858321589,0.00671433844229617,-0.0070319847636846,0.0192882219301164,0.361421424411474
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00585863481080081,0.00642736376385538,-0.00673899816635575,0.0184562677879574,0.362040639351186
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00400126366454509,0.00439576719082178,-0.0046144400294656,0.0126169673585558,0.362708662410125
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.0027410224209279,0.00302494951640634,-0.00318787863122853,0.00866992347308433,0.364882561850862
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00510447282672362,0.00564409399143714,-0.00595795139649317,0.0161668970499404,0.365804002635461
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00737760209807873,0.00820333174719235,-0.00870092812641827,0.0234561323225757,0.368490195224199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL31,Interleukin-31,39657,0.0052603189317145,0.00587093364709413,-0.00624671101659,0.016767348880019,0.370275690869618
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.00338771797398077,0.00378153243546684,-0.00402408559953423,0.0107995215474958,0.370347857883104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.00478016048057277,0.00534014463471465,-0.0152468439646135,0.00568652300346793,0.370730187898627
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00553658233210514,0.00621267306885783,-0.0177134215470665,0.0066402568828562,0.372854391101134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00271307710004404,0.00304463560145191,-0.00868056287888978,0.00325440867880171,0.372891310924331
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.00997814405804647,0.0112665932488348,-0.0320606668257627,0.0121043787096698,0.37582763738309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.00380549494925304,0.00430098876250026,-0.0122354329237535,0.00462444302524747,0.376285722998667
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00781536091878921,0.00885538116714984,-0.0251719080064029,0.00954118616882447,0.377492944387868
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.00434004286220429,0.00496628032054165,-0.0140739522904659,0.00539386656605735,0.382187415782148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.00355208929690784,0.00406912542152425,-0.0115275751230954,0.00442339652927969,0.382716047921855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.00311394825095659,0.00358289430709057,-0.00390852459094093,0.0101364210928541,0.384799470151619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00490623953033368,0.00567453518133374,-0.00621584942508046,0.0160283284857478,0.387273808243157
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00347736529513613,0.004050830600258,-0.0114169932716418,0.00446226268136956,0.390671759880588
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD82,CD82 antigen,39757,0.00376265284330364,0.00438374110842495,-0.00482947972920926,0.0123547854158165,0.390734205167367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAPPA,Pappalysin-1,41913,0.00426325041345396,0.0049714727164572,-0.00548083611080215,0.0140073369377101,0.391160433006801
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00339120518189084,0.00395456642840133,-0.0111421553815575,0.00435974501777577,0.391163772421832
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.00437298028542318,0.00510916080329902,-0.0143869354598893,0.00564097488904289,0.392062832193773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.00881090695769599,0.0103100860528079,-0.0290186756211994,0.0113968617058074,0.392796235633341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00777512405295079,0.00911583553732677,-0.0256421617061113,0.0100919136002097,0.393719204775546
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00449591767963687,0.00527479656928056,-0.00584268359615302,0.0148345189554268,0.394044290931711
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.005039081296,0.00592721961240916,-0.0166564317363219,0.00657826914432195,0.395255058166798
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BRK1,Protein BRICK1,41839,-0.00400733737119332,0.00476272839561137,-0.0133422850265916,0.00532761028420497,0.400141704943863
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DNM1,Dynamin-1,39930,-0.0101677877789209,0.0122220621652145,-0.0341230296227414,0.0137874540648996,0.405471181587328
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.00239748808413035,0.0028850571678632,-0.00805220013314222,0.00325722396488153,0.405987146224666
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.00496134589468773,0.00597072235454707,-0.0166639617096,0.00674126992022453,0.406019302164402
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.00434160814216608,0.00524532305784484,-0.014622441335542,0.00593922505120981,0.407850113444661
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.0023549816674383,0.00285816837725763,-0.00324702835198667,0.00795699168686326,0.409986589146006
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.00524531371017028,0.00637978226513214,-0.0177496869498293,0.0072590595294887,0.410990596701215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00461714652643625,0.00567021489574883,-0.00649647466923147,0.015730767722104,0.415498812379804
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00447455760175739,0.00551158207880232,-0.0152772584762099,0.00632814327269515,0.416897453635398
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00452154686608543,0.00557079169718795,-0.00639720486040295,0.0154402985925738,0.417008698509957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.00264830523740609,0.00326484091140222,-0.00904739342375444,0.00375078294894226,0.417291338415025
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00742075993128851,0.0092987224380203,-0.0256462559098083,0.0108047360472313,0.424863979751002
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.0029015211285299,0.00364082447260942,-0.00423449483778457,0.0100375370948444,0.425499284520092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.00328430027503423,0.00413842421542367,-0.00482701118719616,0.0113956117372646,0.427435888756222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00354998596635153,0.00450499409319845,-0.0123797743890205,0.00527980245631744,0.430707026000202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00349048241744306,0.00443308338828046,-0.00519836102358665,0.0121793258584728,0.431081459712763
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00383590650770538,0.00489252241201752,-0.00575343741984896,0.0134252504352597,0.433036770156812
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK12,Kallikrein-12,41843,-0.010897699769889,0.0140013922004905,-0.0383404284828505,0.0165450289430725,0.436388560607992
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0061292734666288,0.00790045561813503,-0.00935561954491585,0.0216141664781735,0.437876309678681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00261095931161567,0.00336864770060843,-0.00921350880480819,0.00399159018157685,0.43830794695959
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.00255384789215398,0.00331041110649528,-0.00904225366088473,0.00393455787657677,0.440451153757701
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.00395657006479472,0.00512916574371933,-0.0140097349224846,0.00609659479289517,0.440493823252124
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.0019850789114853,0.00257534119187378,-0.0030625898245873,0.0070327476475579,0.440837576885989
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.00353891581334446,0.00460747398147897,-0.00549173319035431,0.0125695648170432,0.442454739166405
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00423330581269932,0.00554035414477277,-0.0066257883110553,0.0150923999364539,0.44482974368199
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTPN,Myotrophin,41900,0.00259647322617668,0.00340430536025851,-0.00407596527993,0.00926891173228335,0.445654187630395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00320943455074442,0.00420943261081181,-0.00504105336644673,0.0114599224679356,0.445814592380703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,-0.00630290748831585,0.00827634731915036,-0.0225245482338506,0.00991873325721886,0.446340490504042
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00806272122211408,0.0106283602147007,-0.0288943072429275,0.0127688647986993,0.448105252127079
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.00274853835201883,0.00370821022226713,-0.00451955368362474,0.0100166303876624,0.458582918416516
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00710772209901146,0.00966084365897438,-0.0260429756706012,0.0118275314725783,0.461913948826966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,-0.00228297518609586,0.00310838072309115,-0.00837540140335451,0.00380945103116279,0.462685204731257
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLPS,Colipase,42115,-0.00565750860547112,0.00772274483235214,-0.0207940884768813,0.00947907126593908,0.463828902032326
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.00372641606825868,0.00510538824661879,-0.00628014489511414,0.0137329770316315,0.465467706248435
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.00448206348917351,0.00614924502607789,-0.00757045676193916,0.0165345837402862,0.466087428604414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.00423294293881664,0.00582570138034821,-0.0156513176442991,0.00718543176666585,0.467485103543035
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.00245145287339839,0.00338277870743069,-0.00908169913996255,0.00417879339316577,0.46865711222781
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00368729145863286,0.0050883286209639,-0.00628583263845639,0.0136604155557221,0.468678130578681
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,-0.00187776585170547,0.00259296852468233,-0.00695998416008284,0.0032044524566719,0.468972946900253
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00406995519339865,0.00562991461048514,-0.00696467744315222,0.0151045878299495,0.469746446907372
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00265192657569814,0.00367863404500458,-0.00455819615251085,0.00986204930390712,0.470986265672974
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAPS,Calcyphosin,39929,0.00722165974777441,0.0100178804417354,-0.0124133859180271,0.0268567054135759,0.471000060465449
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENO1,Alpha-enolase,42119,0.00592815108679189,0.00823520438739592,-0.0102128495125041,0.0220691516860879,0.471626868680789
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00253230884193446,0.00352799730251129,-0.00438256587098767,0.0094471835548566,0.472911227789531
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00463461528877705,0.00649613091600409,-0.00809780130659098,0.0173670318841451,0.475587208562137
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00418321071881844,0.00586517885225999,-0.015678961269248,0.00731253983161113,0.4757195012158
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VWF,von Willebrand factor,42310,-0.00553217370283368,0.0077583161217291,-0.0207384733014227,0.00967412589575536,0.475818468684973
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.0029413988417036,0.0041261275165409,-0.0110286087741238,0.00514581109071658,0.475940300442385
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00420205068592337,0.00592733299898748,-0.0158196233639388,0.00741552199209209,0.478384287677478
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.00619067336597263,0.0088265976635328,-0.0234908047864969,0.0111094580545517,0.483089441267213
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00508674127699535,0.00729569959954233,-0.0193863124920983,0.00921282993810762,0.485676770062743
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00460816542415421,0.00661777470701151,-0.0175790038498968,0.00836267300158834,0.486235871495584
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.00705961650950109,0.010184124146795,-0.0270204998372192,0.012901266818217,0.488199832902238
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL3,Interleukin-3,39560,0.00447066874000916,0.00646419841155691,-0.00819916014664239,0.0171404976266607,0.489200381524344
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.0120921507610258,0.0175390777776183,-0.0222844416831061,0.0464687432051578,0.490560216070636
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPTN,Neuroplastin,41843,-0.00566569833250403,0.00821891470298523,-0.0217747711503551,0.010443374485347,0.490615923126848
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00401579706321205,0.00584733762959234,-0.00744498469078893,0.015476578817213,0.492239924124357
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.00264637870829939,0.00386300612276307,-0.010217870708915,0.00492511329231623,0.493322322138602
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.0019078579039853,0.00281503255003432,-0.00742532170205256,0.00360960589408197,0.497951374691642
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.00343780519282811,0.00507885455215825,-0.00651674972940205,0.0133923601150583,0.49848991340612
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00259586757056342,0.00384104237842438,-0.00493257549114836,0.0101243106322752,0.499166623368459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOM2,Myomesin-2,39575,0.00396674402946696,0.00588287745274147,-0.00756369577790631,0.0154971838368402,0.500143475436501
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00417858451510639,0.00620876354377821,-0.0163477610609117,0.0079905920306989,0.500952568548796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,S100A16,Protein S100-A16,41814,-0.00429357628366383,0.00638301808367594,-0.0168042917276687,0.00821713916034101,0.501177841357579
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NCLN,Nicalin,41913,-0.00360797210962666,0.00536699232838941,-0.0141272770732699,0.00691133285401657,0.501434855464459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD93,Complement component C1q receptor,41654,0.00220518027344585,0.00330831312730276,-0.00427911345606756,0.00868947400295925,0.505066730106876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPGN,Epigen,39919,0.00324391075260865,0.00489038855151024,-0.00634125080835141,0.0128290723135687,0.507136753195841
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00206882754257288,0.00312598957451835,-0.00819576710862885,0.00405811202348308,0.508103551311336
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.00352282347021557,0.00535202437334706,-0.0140127912419758,0.00696714430154468,0.510408810099484
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.0030940527726214,0.00470523114623999,-0.0123163058192518,0.00612820027400898,0.510821274733538
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00420965185854454,0.00640422805528349,-0.0167619388469002,0.00834263512981109,0.510986394603902
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.0012704527749887,0.00193302329727228,-0.00505917843764236,0.00251827288766496,0.511042382491595
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSPN,Claspin,41820,-0.00243057848936344,0.0037247615787648,-0.00973111118374244,0.00486995420501556,0.514060316319805
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.0043732335086637,0.00670252261246341,-0.017510177829092,0.00876371081176458,0.514107991929553
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00204922217096511,0.00314633693853813,-0.00821604257049984,0.00411759822856962,0.514861113920876
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.00240630124556408,0.00371949426304836,-0.00969651000113887,0.0048839075100107,0.517681871778272
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.000908326664731388,0.0014108870851979,-0.0018570120222565,0.00367366535171928,0.519719454709432
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00274509181679218,0.00427856205388404,-0.0111310734424049,0.00564088980882055,0.521151431576922
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGAX,Integrin alpha-X,39757,-0.00349135567263341,0.00546357363593188,-0.0141999599990599,0.00721724865379308,0.522820319171307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.00562150401714844,0.00879751403501343,-0.0116216234914779,0.0228646315257748,0.522844199227151
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00269120797445037,0.00421843483552763,-0.00557692430318378,0.0109593402520845,0.523510687921134
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.00315197814193644,0.0049544926722138,-0.0065588274956026,0.0128627837794755,0.52466616576071
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00333675293979817,0.00533195501568053,-0.013787384770532,0.00711387889093567,0.531457239315054
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00197003928853499,0.00317839786821816,-0.00819969911024259,0.0042596205331726,0.535388103204074
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ISM2,Isthmin-2,39966,0.00281494520400595,0.00457166352970018,-0.0061455153142064,0.0117754057222183,0.538080035738919
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00202468265948925,0.00330616566262923,-0.00850476735824255,0.00445540203926404,0.540286240562693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00285557758841603,0.00466721298631519,-0.00629215986476173,0.0120033150415938,0.540655194293845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00262778053069219,0.00432879991679546,-0.0058566673062269,0.0111122283676113,0.543830759686616
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.00181493175375769,0.00299095853674185,-0.00404734697825633,0.00767721048577172,0.543989805088894
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NPHS1,Nephrin,39657,0.00213298153196778,0.00351680442625826,-0.00475995514349842,0.00902591820743397,0.544187750342937
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.0030548061047412,0.00505393966432946,-0.00685091563734455,0.0129605278468269,0.545561133593048
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00292436151651416,0.00484438139085814,-0.00657062600956778,0.0124193490425961,0.546081788287381
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD177,CD177 antigen,42123,-0.0081196602210756,0.0134829163866529,-0.0345461763389152,0.018306855896764,0.547038871873774
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.0043828091822813,0.00733430658874835,-0.0187580500962281,0.00999243173166547,0.550134884687796
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00277749340039504,0.00468342932632508,-0.0119570148799922,0.00640202807920212,0.55316157585418
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.00263077046690962,0.00446233421946845,-0.0113769455370678,0.00611540460324854,0.555504119684388
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APCS,Serum amyloid P-component,39870,-0.00201956319980741,0.00342995871957549,-0.00874228229017537,0.00470315589056055,0.556006560699817
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00228926024554606,0.00389391872300877,-0.00534282045155112,0.00992134094264325,0.556606688515507
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.00198095669727149,0.00337849526121507,-0.00860280740925303,0.00464089401471005,0.557654828857556
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00241446384486122,0.00412585364038267,-0.0056722092902888,0.0105011369800113,0.558422881469436
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPH3,Neurexophilin-3,39657,0.00185121004379481,0.00316891730827208,-0.00435986788041846,0.00806228796800809,0.559112846551895
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00211977829042255,0.00363015771912572,-0.00499533083906386,0.00923488741990896,0.559275648092277
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.00282244034129522,0.00484307976871046,-0.00666999600537728,0.0123148766879677,0.560052406968215
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.00436127752545322,0.00754859046572905,-0.0191565148382822,0.0104339597873757,0.563437580686096
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00220199904317778,0.00381380284910718,-0.00967705262742786,0.0052730545410723,0.563695103757179
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.00400535874232929,0.00697716201372904,-0.0176805962892382,0.00966987880457962,0.565934113830895
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00438451695367607,0.00764722406567335,-0.0106040422150437,0.0193730761223958,0.566421151756146
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,-0.00458966897335559,0.00802238942379958,-0.0203135522440028,0.0111342142972916,0.567260869929424
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.00199010423622676,0.00350508042119237,-0.00886006186176379,0.00487985338931028,0.570197890697017
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00366838850677388,0.00649491130901985,-0.0163984146724528,0.00906163765890504,0.572214606077655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.00289908529174495,0.00515994686112247,-0.00721441055605508,0.013012581139545,0.574233785444926
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAGE2A,G antigen 2A,39560,-0.00386990534527321,0.00689849351613975,-0.0173909526369071,0.0096511419463607,0.574823780880051
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.00321843099574518,0.0057646590548005,-0.0145171627431542,0.00808030075166379,0.576648270501845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00235894070832965,0.004227973866842,-0.00592788807068067,0.01064576948734,0.576899179806631
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.00232933930966607,0.00428824657101338,-0.00607562396952015,0.0107343025888523,0.58700888041942
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HK2,Hexokinase-2,41900,0.00154077899911148,0.00285991061319763,-0.00406464580275586,0.00714620380097883,0.590067864829803
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MLLT1,Protein ENL,39560,0.00375786135856992,0.00700321688338439,-0.00996844373286349,0.0174841664500033,0.591561230226864
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.00168513579257835,0.003186906278435,-0.00793147209831095,0.00456120051315425,0.5969763464148
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TBR1,T-box brain protein 1,39649,0.00266914297625962,0.00506175435052705,-0.00725189555077339,0.0125901815032926,0.597984900853947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00445526513599435,0.00847021739514854,-0.0210568912304855,0.0121463609584968,0.598904339069657
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.00584796942493076,0.0111830408687055,-0.016070790677732,0.0277667295275936,0.601032162720107
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.00308082040219981,0.00590875376951063,-0.0146619777904406,0.00850033698604102,0.602097141898093
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00356518618451401,0.00684225029300301,-0.00984562438977188,0.0169759967587999,0.602339158745222
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00118550192856083,0.00228058703819891,-0.00328444866630903,0.00565545252343069,0.60319540534111
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DEFB116,Beta-defensin 116,39586,-0.00407535741707237,0.00793476364924637,-0.0196274941695953,0.0114767793354505,0.607536473443138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.00304005700304168,0.00596577808760371,-0.0147329820547449,0.00865286804866158,0.610352199966034
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEPTIN7,Septin-7,39757,0.00286451967243689,0.00562897658833434,-0.0081682744406984,0.0138973137855722,0.610840665955735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GH2,Growth hormone variant,41843,-0.00860363983465074,0.0170128831468354,-0.0419488908024481,0.0247416111331466,0.613066406832471
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00180623635143744,0.00359091991436816,-0.00523196668072415,0.00884443938359903,0.614973654298136
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00251283001150977,0.00502244807260959,-0.00733116821080502,0.0123568282338246,0.616859974897908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00371093595539815,0.00749309087781133,-0.0183973940759084,0.0109755221651121,0.620435195195356
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.00251642875671532,0.00508277243147413,-0.0124786627224046,0.00744580520897397,0.62054478397414
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,0.002802834161276,0.0056699864480745,-0.00831033927695003,0.013916007599502,0.621084300652822
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00228468887433667,0.00465410979736644,-0.00683736632850154,0.0114067440771749,0.623508764612616
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00111573484597615,0.00231690946991571,-0.00342540771505864,0.00565687740701094,0.630126874868367
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HSP90B1,Endoplasmin,41774,-0.00320439421897814,0.00665844138250491,-0.0162549393286878,0.00984615089073148,0.630344761310713
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00185476025138561,0.00387305891283469,-0.0094459557205416,0.00573643521777039,0.632028002657001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00199869851609089,0.00417702513875721,-0.010185667788055,0.00618827075587325,0.632305270986852
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PVALB,Parvalbumin alpha,42208,-0.00558920471113681,0.0117179242793229,-0.0285563362986098,0.0173779268763361,0.633384679981944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00180936262856167,0.00381946444266769,-0.005676787679067,0.00929551293619034,0.635707841418703
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.00458462039865644,0.00971464689486956,-0.0236253283126008,0.0144560875152879,0.636987075399049
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00502954310509509,0.0106815750410582,-0.0259654301855692,0.015906343975379,0.637748957036958
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00286307657395648,0.00611888182457889,-0.00912993180221814,0.0148560849501311,0.639859192612395
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.00365535668489919,0.00785983097602004,-0.0117499120281001,0.0190606253978985,0.641891621650454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.0028841141499453,0.00620476614534258,-0.00927722749492617,0.0150454557948168,0.642067895495672
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00164361137877216,0.00354147712416454,-0.00858490654213465,0.00529768378459034,0.642582923195401
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,-0.0011674379257626,0.00251651399435989,-0.00609980535470798,0.00376492950318278,0.642719253574312
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.0033181175828264,0.00717349664831161,-0.0173781710135172,0.0107419358478643,0.643694455304493
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.00220241255950633,0.00476930072383702,-0.0115502419782269,0.00714541685921423,0.644241432076523
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LHB,Lutropin subunit beta,41843,0.00425939415137856,0.00928608851030272,-0.0139413393288148,0.0224601276315719,0.646467555502907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00228089370982502,0.00498285034819753,-0.00748549297264214,0.0120472803922922,0.647141926651811
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.00242081070514381,0.00535938015308257,-0.00808357439489803,0.0129251958051856,0.651495198870425
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NRN1,Neuritin,39934,0.00165368234221162,0.00367516505473881,-0.00554964116507644,0.00885700584949968,0.65274689290098
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,-0.00177316680794658,0.00394137981418333,-0.0094982712437459,0.00595193762785274,0.65280227616459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00343657587637183,0.00764734344175104,-0.0115522172694602,0.0184253690222039,0.653165089602947
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPSG1,Tryptase gamma,39657,-0.00123264686305188,0.00276694331367339,-0.00665585575785172,0.00419056203174795,0.655974070782161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNPO1,Transportin-1,39757,-0.00166377047075415,0.00375363653295475,-0.00902089807534547,0.00569335713383717,0.657599083797824
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00283175714570664,0.00640262728883404,-0.00971739234040808,0.0153809066318214,0.658294952478585
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00160280341830726,0.0036442577542186,-0.0055399417799612,0.00874554861657572,0.660078921541628
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.00529422604154742,0.012039471107613,-0.0183031373293741,0.0288915894124689,0.660134441010873
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYL3,Myosin light chain 3,39638,-0.00363093676772549,0.00828613618752702,-0.0198717636952785,0.0126098901598275,0.661254092108454
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TLR2,Toll-like receptor 2,39757,-0.00106488757020488,0.0024487032218354,-0.00586434588500227,0.00373457074459251,0.663659273619202
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0019737791880878,0.0045476361315003,-0.00693958762965279,0.0108871460058284,0.664280125881244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYOC,Myocilin,42137,0.00201552980101704,0.00468399109964348,-0.00716509275428419,0.0111961523563183,0.666982968049723
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLC,Galectin-10,42119,-0.00299031383735918,0.00704926891204434,-0.0168068809049661,0.0108262532302477,0.671425265990905
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00140800541293466,0.00333763550161877,-0.00513376017023814,0.00794977099610745,0.673136133232032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00372264747962395,0.00884196879845288,-0.0210529063245916,0.0136076113653437,0.673747163266845
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00259498386572271,0.00617215310684435,-0.0146924039551376,0.0095024362236922,0.674176431562174
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KLK1,Kallikrein-1,42016,0.00560508518087399,0.0134104293590224,-0.02067935636281,0.031889526724558,0.675979665140434
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.00220284044158019,0.00530810156485425,-0.00820103862553415,0.0126067195086945,0.678153008863617
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-0.00233654037943644,0.00568877630698134,-0.0134865419411199,0.00881346118224698,0.681279918022912
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.0027018065564192,0.00657873648839365,-0.0155961300736708,0.0101925169608324,0.681309460889022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00301912210380685,0.00736387395778395,-0.0114140708534497,0.0174523150610634,0.681819147555009
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.00182509974488834,0.00447907498667161,-0.0106040867187647,0.006953887228988,0.683668957843333
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00152188043117913,0.00376216152000045,-0.00585195614802175,0.00889571701038001,0.685834606491874
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00325778825456233,0.00814581099141912,-0.0127080012886191,0.0192235777977438,0.689212726304533
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SAG,S-arrestin,39586,0.00220540096118811,0.0055258192576642,-0.00862520478383372,0.0130360067062099,0.689821080258176
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.0019597484731764,0.00492033102298437,-0.0116035972782258,0.00768410033187296,0.690419710249363
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.00153517567325255,0.0038579059840832,-0.00602632005555052,0.00909667140205562,0.690689636791944
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00185964737954669,0.00469779405911726,-0.0110673237354165,0.00734802897632313,0.692219237409265
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.00205987087775576,0.00524390095002432,-0.0123379167398034,0.0082181749842919,0.694465454737139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.00222451406518375,0.00568901726020106,-0.0133749878951778,0.00892595976481032,0.695790628945267
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00182602455893767,0.00468632451372026,-0.0110112206058294,0.00735917148795404,0.696803216817548
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00170622407156372,0.00445344795868501,-0.0070225339274589,0.0104349820705863,0.701634807704442
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00167543029585249,0.00440125700507179,-0.0103018940257932,0.00695103343408822,0.70345462716092
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00220766316906781,0.0058166562419027,-0.00919298306506148,0.0136083094031971,0.704293035210966
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00192372272370611,0.00507572642444472,-0.00802470106820553,0.0118721465156178,0.70469191722965
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.00233250798751182,0.00618621515932861,-0.0144574896997959,0.00979247372477226,0.706144263554591
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00101265743021893,0.0026885044923687,-0.00425681137482373,0.00628212623526159,0.706431850710039
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PFDN2,Prefoldin subunit 2,41839,-0.00217143076953871,0.00578607015549361,-0.0135121282743062,0.00916926673522877,0.707453834626062
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGLON5,IgLON family member 5,39560,-0.0036283802429169,0.00977968299703477,-0.022796558917105,0.0155397984312712,0.710635727042256
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NXPE4,NXPE family member 4,39575,0.0012469827172566,0.00337706811212462,-0.00537207078250764,0.00786603621702085,0.711948443950428
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PAEP,Glycodelin,42016,-0.00401673049635453,0.0109615814239036,-0.0255014300872056,0.0174679690944966,0.71404469223999
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.00107819899202542,0.00294566112939888,-0.00685169480564723,0.00469529682159639,0.714350034833991
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RSPO1,R-spondin-1,42016,-0.00126835802735627,0.00356738543347777,-0.0082604334769727,0.00572371742226016,0.722188614031827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00101767207680685,0.00288339245486614,-0.00666912128834449,0.00463377713473079,0.724136886934625
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00228176224362697,0.00655789953088006,-0.0151352453241519,0.0105717208368979,0.727891059158397
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00570019562583595,0.0165056620344019,-0.0380512932132636,0.0266509019615917,0.729839253419307
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TEF,Thyrotroph embryonic factor,39575,-0.00155382304659647,0.00452044911306272,-0.0104139033081994,0.00730625721500646,0.731054422734819
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00180521151612084,0.00531763975924001,-0.00861736241198959,0.0122277854442313,0.734257616079542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL2,Interleukin-2,41913,0.001130856217623,0.00335161518454702,-0.00543830954408915,0.00770002197933516,0.735815924128123
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.000900366766924345,0.00267406958288723,-0.00614154314938332,0.00434080961553463,0.736347174685702
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.00120384934354832,0.00359057652820527,-0.005833680651734,0.00824137933883065,0.737419906836557
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00166010394464429,0.00500071849636655,-0.0114615121975227,0.00814130430823414,0.739915922286709
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.00215823994493847,0.00652291975263576,-0.0149431626601046,0.0106266827702276,0.740747718432901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00305487543705784,0.00932952994797312,-0.0213407541350852,0.0152310032609695,0.74333914547251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.000997559806598558,0.00312802521279401,-0.0051333696104777,0.00712848922367482,0.749800473315569
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00189857415334289,0.0060393546084372,-0.00993856087919402,0.0137357091858798,0.753248240652619
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.00113404533918066,0.00361512589911719,-0.00821969210145037,0.00595160142308904,0.753758791257655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00250228012731969,0.0081499291567097,-0.0134715810198313,0.0184761412744707,0.758825692837577
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00223116242561206,0.00730327853056937,-0.0120832634943039,0.016545588345528,0.759989991163849
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00223952586250092,0.00734809817007916,-0.0121627465508542,0.0166417982758561,0.760541212146244
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.00104882540354223,0.00346795996500558,-0.00784602693495317,0.00574837612786871,0.762326759950492
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,0.000822109764488849,0.00274271882074492,-0.00455361912417119,0.00619783865314889,0.764378956621194
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00371150638581425,0.0124188019954119,-0.020629345525193,0.0280523582968215,0.765051094414205
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.0011344518857013,0.00381982073379175,-0.00635239675253053,0.00862130052393312,0.766478928610283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1R,Complement C1r subcomponent,39979,0.000586954488776804,0.00198070495322999,-0.00329522721955398,0.00446913619710759,0.766978786052907
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.00264680959191333,0.0090443443585635,-0.0203737245346978,0.0150801053508711,0.769796734599596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PMCH,Pro-MCH,39575,-0.00247810493899441,0.0087100625785016,-0.0195498275928575,0.0145936177148687,0.776024496531116
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00196117173511468,0.00690558041449995,-0.0154961093475346,0.0115737658773052,0.776417192163942
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OMP,Olfactory marker protein,39586,-0.00141263739832853,0.00506742606862167,-0.011344792492827,0.00851951769616994,0.780427943640842
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.000781028246161494,0.00281327336853365,-0.00629504404848746,0.00473298755616447,0.781307277703301
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,0.00102985445284208,0.00387102992896267,-0.00655736420792476,0.00861707311360891,0.790212242987283
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.00181160949552966,0.00686954189131079,-0.0152759116024988,0.0116526926114395,0.792003556329008
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00209302517924327,0.00796149018051199,-0.0135114955745602,0.0176975459330468,0.792636626166239
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.00165460190150512,0.00633174288064851,-0.010755614144566,0.0140648179475762,0.793850923490303
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.000968068059037618,0.00371543408685565,-0.00825031886927469,0.00631418275119945,0.794441085027231
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.0010965283509846,0.00422682706215798,-0.00938110939281424,0.00718805269084504,0.795315182704994
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00717448929331891,0.028109587284889,-0.0479203017850636,0.0622692803717014,0.798548037265648
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00180366360428861,0.00710577053740547,-0.0121236466490261,0.0157309738576033,0.799630980597167
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.00283593479106401,0.0113243219147923,-0.025031605744057,0.019359736161929,0.802260395703147
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTTG1,Securin,39757,-0.00110199796369186,0.00440274530640947,-0.00973137876425442,0.00752738283687071,0.802361578559735
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00219535238254745,0.00905652539313112,-0.0155554373879896,0.0199461421530845,0.808469589103382
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CA4,Carbonic anhydrase 4,42310,-0.000613337559873158,0.00254190611674856,-0.00559547354870033,0.00436879842895401,0.809333654251313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MELTF,Melanotransferrin,39958,0.000765151375734054,0.00317199690007228,-0.00545196254840761,0.00698226529987572,0.809388407094509
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.000791182074585388,0.00330392507122551,-0.0056845110650166,0.00726687521418738,0.810747677863278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00121418132680661,0.0051631051155869,-0.00890550469974372,0.0113338673533569,0.814085096527893
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL17F,Interleukin-17F,41913,-0.00179502302525649,0.00769155797870827,-0.0168704766635247,0.0132804306130117,0.815473238844309
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.00160438333135989,0.00689485209789603,-0.0119095267805163,0.0151182934432361,0.816003457223567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.000713588603908537,0.00307069178681043,-0.0053049672982399,0.00673214450605697,0.816241808844468
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.00131043690237802,0.00571800236228408,-0.0125177215324548,0.00989684772769878,0.81873531524649
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.000987291774081622,0.00440972210808477,-0.00963034710592777,0.00765576355776453,0.822847196877437
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.000861459994322832,0.00385845487766771,-0.00670111156590588,0.00842403155455154,0.823333009890355
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP1B4,Protein ATP1B4,39560,0.000985468486544862,0.00442064115643329,-0.00767898818006439,0.00964992515315411,0.823598551209063
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.000951596715736951,0.00427567588017736,-0.00742872800941068,0.00933192144088458,0.823880951863542
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.0012253195348268,0.00551446007540826,-0.012033661282627,0.00958302221297339,0.824160702161901
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.000922919747047282,0.00419853205726559,-0.00730620308519328,0.00915204257928784,0.826014910077088
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00095457932780679,0.00437082952430054,-0.00952140519543584,0.00761224653982226,0.827122585785262
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EXOSC10,Exosome component 10,39575,0.00133687729180184,0.00615289683650183,-0.0107228005077417,0.0133965550913454,0.827997237838782
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.000798370638308977,0.00373417400421139,-0.00652061040994535,0.0081173516865633,0.830706111857321
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.0017651465894662,0.00826135950622924,-0.0179574112216755,0.0144271180427431,0.830813866269639
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00146959116772409,0.00699772211550003,-0.012245944178656,0.0151851265141041,0.833663753539081
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00101772424847618,0.00486461754819502,-0.00851692614598607,0.0105523746429384,0.834287908467605
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000607298566623406,0.00301086766261651,-0.00650859918535177,0.00529400205210496,0.840153161457596
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH22,Cadherin-22,39757,-0.000572795370315763,0.00291628383365861,-0.00628871168428663,0.00514312094365511,0.844290683421613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.00187927566459762,0.00959961465162953,-0.0206945203817915,0.0169359690525963,0.844796469048457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.000744425121566313,0.0038097420022376,-0.00672266920281938,0.00821151944595201,0.845083130499159
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.000395392561477914,0.00203981803159676,-0.00439343590340755,0.00360265078045173,0.846306838772139
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LMOD1,Leiomodin-1,39934,-0.000703706524811086,0.00366647226275743,-0.00788999215981564,0.00648257911019347,0.847800368448823
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.000555812226506867,0.00289607079251038,-0.00512048652681348,0.00623211097982722,0.847808194606161
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CTNNA1,Catenin alpha-1,39586,-0.000684952487930403,0.00357403981529939,-0.00769007052591722,0.00632016555005641,0.848022599252614
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00117787245591495,0.00626242611252267,-0.0110964827246295,0.0134522276364594,0.850812885366547
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.000368857006208359,0.00201733207516387,-0.00358511386111282,0.00432282787352954,0.854923166219683
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.00094813157220444,0.00528271248006647,-0.0113022480331347,0.00940598488872585,0.857565566234949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00128833719114325,0.00720195145747666,-0.0154041620477975,0.012827487665511,0.858029547227827
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,-0.00128433154761342,0.00724007431950245,-0.0154748772138382,0.0129062141186114,0.859203680153218
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.000469221900726322,0.00270100332089668,-0.00576318840968382,0.00482474460823118,0.862087655797024
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,0.000546643834243885,0.00320302801444606,-0.00573129107407039,0.00682457874255816,0.86449055902957
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.000485569050633563,0.00286734514823205,-0.00513442743990126,0.00610556554116838,0.865528719503496
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000762331403112317,0.00464391541165378,-0.00833974280372909,0.00986440560995372,0.869610547247855
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00197897462467598,0.0123486722544311,-0.026182372243361,0.022224422994009,0.872680725144027
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.000355054675500786,0.00222262777722581,-0.00471140511886337,0.0040012957678618,0.873084431629329
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00098904254727658,0.00621078485443458,-0.0111840957674152,0.0131621808619684,0.873478006140851
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF174,Zinc finger protein 174,39657,-0.000613015962363104,0.00388345739140784,-0.00822459244952247,0.00699856052479626,0.874575402496
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.000475607677271913,0.00315879625558562,-0.0057156329836759,0.00666684833821973,0.88032072067019
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.000905265926093241,0.0060648647081035,-0.0109818689017896,0.0127924007539761,0.881347586929652
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00117431968060626,0.00806779090235786,-0.0146385504880152,0.0169871898492277,0.884274112740651
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RRP15,RRP15-like protein,39586,0.00138010351460549,0.00963778495838819,-0.0175099550038354,0.0202701620330463,0.886137092383313
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TAGLN3,Transgelin-3,39560,0.00090641457935857,0.00633465994799358,-0.0115095189187088,0.013322348077426,0.886223218105104
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.000593157165943684,0.00417048046572431,-0.00876729887876334,0.00758098454687597,0.886902400086825
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MN1,Transcriptional activator MN1,39649,-0.000838833771252759,0.0062147714602582,-0.0130197858333588,0.0113421182908533,0.892634736079143
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00073528347890073,0.00545541682482334,-0.00995733349775302,0.0114279004555545,0.892787943052792
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.000343746017559656,0.00264109446643894,-0.00483279913666068,0.00552029117177999,0.896447403575872
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL4,Interleukin-4,41913,-0.00127497354383486,0.0098918993199422,-0.0206630962109216,0.0181131491232519,0.89744610533279
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000514730091516044,0.00425710876201643,-0.00782920308203617,0.00885866326506825,0.903763961229102
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH23,Cadherin-23,39929,0.0003338602926621,0.00282222161300748,-0.00519769406883257,0.00586541465415677,0.905834447771945
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGA2,Integrin alpha-2,39736,0.000427169422919082,0.0036550397873625,-0.00673670856031142,0.00759104740614958,0.906964111939986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,0.000522781999178967,0.00449752931816922,-0.00829237546443271,0.00933793946279064,0.907466367533334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.000738744056845463,0.00639863809656483,-0.0118025866124216,0.0132800747261125,0.908087540523949
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL24,Interleukin-24,41913,-0.000564799559563105,0.00505379168420956,-0.0104702312606138,0.00934063214148763,0.911017302947251
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00296784385804858,0.0274420807522548,-0.0567543221324681,0.0508186344163709,0.913879117960731
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MYH7B,Myosin-7B,39560,-0.000487967317421692,0.00452715822964773,-0.00936119744753123,0.00838526281268785,0.91416688878693
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.000922346688044173,0.00861385323936236,-0.0159608056611061,0.0178054990371944,0.914729749851022
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDH4,Cadherin-4,39586,-0.000521417574686168,0.00491649897239877,-0.0101577555605878,0.00911492041121542,0.915540929031754
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.000254373253759636,0.00240822357137339,-0.00497449145365148,0.00446574494613221,0.915880220173908
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.000419380347391677,0.00425503233332417,-0.00875924372070705,0.0079204830259237,0.921488616949986
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ICOSLG,ICOS ligand,42070,-0.000194082716508867,0.00200576309160629,-0.00412537837605719,0.00373721294303946,0.922916418489655
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.000397243279628063,0.00413357189300403,-0.00770455763065984,0.00849904418991596,0.92344155701864
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.000518397902997146,0.00569179406921892,-0.0116743142786662,0.0106375184726719,0.927432182546773
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000369803135329063,0.00426846873280081,-0.00873600185161866,0.00799639558096053,0.930962404933689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.000446412927527281,0.00525434378726579,-0.0107449267505682,0.00985210089551366,0.932294153783689
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,0.000418227989994924,0.00517177557005682,-0.00971845212731645,0.0105549081073063,0.935548888855951
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL13,Interleukin-13,41913,0.000407283500356517,0.00509316710480941,-0.00957532402506992,0.010389891025783,0.9362649841026
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TSC1,Hamartin,39657,0.000614753949159425,0.0078144655607263,-0.0147015985498641,0.015931106448183,0.93729755522457
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.000297230206142802,0.0038633944425204,-0.00727502290119719,0.00786948331348279,0.938676419519208
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.000498071092510671,0.00662571391888993,-0.0134844703735349,0.0124883281885136,0.940078882695714
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.000274098548278525,0.00366440689239661,-0.00745633605737588,0.00690813896081883,0.940374963727278
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.000374868975329278,0.00531409382895353,-0.0100407549294196,0.0107904928800782,0.943763013335613
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.000311672217401138,0.0045083498460341,-0.00914803791562798,0.00852469348082571,0.94488562746187
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.000390207333890128,0.00611121021373428,-0.0123681793528093,0.0115877646850291,0.949089769809762
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.000432295030615211,0.00728919508071021,-0.0147191173888072,0.0138545273275768,0.952709044027559
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.000555822012372364,0.0094232236797447,-0.0179136963999273,0.019025340424672,0.952965502206166
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,SYT1,Synaptotagmin-1,39929,-0.000236361859346615,0.00422463380831683,-0.00851664412364761,0.00804392040495438,0.955383832825295
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.00023729221661995,0.00443858909576741,-0.00846234241108417,0.00893692684432407,0.95736543355001
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.000209883565422224,0.00404505487003911,-0.00771842397985443,0.00813819111069888,0.95862008314237
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.000266014577521462,0.00538425236241416,-0.0108191492078532,0.0102871200528103,0.96059646138032
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.000247490576065769,0.00570767761693544,-0.0109395575531277,0.0114345387052592,0.965414554091059
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.000278424604827659,0.0064709636296341,-0.0124046641092552,0.0129615133189105,0.965680971455448
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL9,Interleukin-9,39757,-0.000252279507437166,0.00594049711331097,-0.0118956538495267,0.0113910948346523,0.966126585468382
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.000165346266379767,0.00436853350361014,-0.0083969794006961,0.00872767193345564,0.969808459631138
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,GPC5,Glypican-5,42016,-0.000218622591390762,0.0058955257103323,-0.0117738529836421,0.0113366078008605,0.970419539207554
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.000216628630052331,0.00598323656855319,-0.0115105150443119,0.0119437723044166,0.971118814253305
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ITGB6,Integrin beta-6,41913,-0.000111880285261304,0.00322000195926508,-0.00642308412542086,0.00619932355489825,0.972283272478349
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.000112629654636234,0.00341815275349113,-0.00658694974220638,0.00681220905147885,0.973714601970659
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.000173795376053941,0.00540070287727754,-0.01041158226341,0.0107591730155179,0.97432895879987
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.000104649331316982,0.00382120437605562,-0.00738491124575202,0.00759420990838599,0.978151977431287
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGA,Fibrinogen alpha chain,39735,-8.42881397397057e-05,0.00327557294369654,-0.00650441110938492,0.0063358348299055,0.979471294041214
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,IL11,Interleukin-11,41913,0.000137637048045375,0.0063848202759949,-0.0123766106929046,0.0126518847889954,0.982801722942695
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,0.000134781148621501,0.00732557902972735,-0.0142233537496441,0.0144929160468871,0.985321121702405
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-8.29995357784677e-05,0.00522338970685083,-0.0103208433612061,0.0101548442896492,0.987322456020567
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FSHB,Follitropin subunit beta,39638,-6.65524052946242e-05,0.00432573199281984,-0.00854498711122151,0.00841188230063226,0.987725120482459
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PRKCQ,Protein kinase C theta type,41913,6.22250620333877e-05,0.00448250825813189,-0.00872349112390511,0.00884794124797189,0.988924529191815
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,TG,Thyroglobulin,39919,0.000151505242618971,0.0110622650127862,-0.021530534182442,0.0218335446676799,0.98907301129341
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-6.06130779989339e-05,0.00722027636099004,-0.0142123547455394,0.0140911285895416,0.993302114079334
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PXDNL,Peroxidasin-like protein,39919,2.36382759253306e-05,0.00604260122666845,-0.0118198601283448,0.0118671366801955,0.99687880268377
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,1.46148125522239e-05,0.00680551640144181,-0.0133241973342737,0.0133534269593782,0.998286587283354
NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,FGF20,Fibroblast growth factor 20,39657,3.99999613919657e-06,0.00455774529236426,-0.00892918077689476,0.00893718076917315,0.999299771622121
